Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Primary malignant neoplasm of lung	10/2268	3.409854794539622E-9	4.002944058063265E-6	0	0	78.52524357838796	1530.974959963796	HSP90AB1;NOS2;STAT1;INSR;BHLHE40;BHLHE41;TAP1;IRS2;APOE;EGFR
Diabetic Nephropathy	7/561	3.939905568959906E-9	4.002944058063265E-6	0	0	61.39214801444043	1188.067545104188	NOS2;STAT1;INSR;IRS2;APOE;HBA1;EGFR
Malignant neoplasm of lung	10/2449	7.291812232982565E-9	4.128626687466733E-6	0	0	71.95571955719558	1348.1993274490703	HSP90AB1;NOS2;STAT1;INSR;BHLHE40;BHLHE41;TAP1;IRS2;APOE;EGFR
Carcinoma of lung	10/2476	8.127217888714041E-9	4.128626687466733E-6	0	0	71.05839416058394	1323.6791186074895	HSP90AB1;NOS2;STAT1;INSR;BHLHE40;BHLHE41;TAP1;IRS2;APOE;EGFR
Cardiac Arrest	5/201	4.2903909395105777E-8	1.7436148778170987E-5	0	0	84.15391156462584	1427.6124449142942	NOS2;STAT1;APOE;HBA1;EGFR
Diabetes Mellitus, Insulin-Dependent	7/956	1.5550097408844236E-7	5.2662996557952484E-5	0	0	35.11064278187566	550.4159886047047	NOS2;STAT1;INSR;TAP1;APOE;HBA1;EGFR
Anoxia	5/288	2.573778388666048E-7	6.916839827945954E-5	0	0	58.02709069493522	880.42883675789	NOS2;STAT1;BHLHE40;BHLHE41;APOE
Cystic Fibrosis	6/594	2.723165286592895E-7	6.916839827945954E-5	0	0	39.593877551020405	598.5129604815093	NOS2;STAT1;TAP1;APOE;HBA1;EGFR
Carotid Artery Plaque	3/26	3.1955018249483204E-7	7.214733009216652E-5	0	0	325.5326086956522	4868.780123538342	NOS2;STAT1;APOE
Kidney Diseases	6/639	4.1864698855371935E-7	8.506906807411577E-5	0	0	36.69383886255924	538.8944426535402	NOS2;INSR;IRS2;APOE;HBA1;EGFR
Glioblastoma	8/1937	9.635420743532152E-7	1.4444386292684447E-4	0	0	24.96630378434422	345.8494601739504	NOS2;STAT1;INSR;BHLHE40;TAP1;IRS2;APOE;EGFR
Hyperinsulinism	5/377	9.75294611231838E-7	1.4444386292684447E-4	0	0	43.94489247311828	608.2204376617437	STAT1;INSR;BHLHE40;IRS2;APOE
Disorder of the optic nerve	3/38	1.0331048943235618E-6	1.4444386292684447E-4	0	0	213.79285714285714	2946.6945135819124	NOS2;APOE;EGFR
Gastric Adenocarcinoma	5/383	1.054252891248353E-6	1.4444386292684447E-4	0	0	43.23412698412698	595.0173770206371	NOS2;STAT1;INSR;TAP1;EGFR
Diabetes	7/1268	1.0662686731804464E-6	1.4444386292684447E-4	0	0	25.990483743061063	357.40411452458096	NOS2;STAT1;INSR;IRS2;APOE;HBA1;EGFR
Hypertensive disease	7/1310	1.3298130212972144E-6	1.6888625370474624E-4	0	0	25.096316193399847	339.5650088558883	NOS2;INSR;BHLHE41;TAP1;IRS2;APOE;EGFR
Renal Cell Carcinoma	7/1348	1.613844319547589E-6	1.7464572964740683E-4	0	0	24.335570469798657	324.560861706629	NOS2;STAT1;INSR;TAP1;IRS2;APOE;EGFR
Sickle Cell Trait	3/44	1.6190004743883632E-6	1.7464572964740683E-4	0	0	182.4512195121951	2432.7501157538336	NOS2;APOE;HBA1
HIV Infections	6/806	1.6330063303645324E-6	1.7464572964740683E-4	0	0	28.7835	383.54266663300456	HSP90AB1;NOS2;STAT1;APOE;HBA1;EGFR
Myocardial Ischemia	5/448	2.2794920538405305E-6	2.3159639267019788E-4	0	0	36.768246802106844	477.6768080648604	NOS2;BHLHE40;TAP1;APOE;HBA1
Eclampsia	4/194	2.6853782529748316E-6	2.598423147640408E-4	0	0	59.545864661654136	763.8358309474189	INSR;BHLHE40;TAP1;APOE
Insulin Sensitivity	3/55	3.196521188954781E-6	2.821470126096848E-4	0	0	143.77644230769232	1819.2676598709952	INSR;IRS2;EGFR
Diabetes Mellitus	7/1507	3.425297404124174E-6	2.821470126096848E-4	0	0	21.5705	271.4501232381248	NOS2;STAT1;INSR;IRS2;APOE;HBA1;EGFR
Colorectal cancer metastatic	4/208	3.542052280553613E-6	2.821470126096848E-4	0	0	55.42016806722689	695.5676813868033	NOS2;INSR;IRS2;EGFR
Infection	5/492	3.6081883955340174E-6	2.821470126096848E-4	0	0	33.3709787816564	418.2152755994991	NOS2;STAT1;TAP1;APOE;EGFR
Nonalcoholic Steatohepatitis	4/209	3.610148783391636E-6	2.821470126096848E-4	0	0	55.14703832752613	691.0895357353446	INSR;IRS2;APOE;HBA1
Herpes Simplex Infections	5/503	4.020521274428068E-6	2.9509251534385515E-4	0	0	32.61546184738956	405.21772671017067	NOS2;STAT1;TAP1;APOE;EGFR
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site	4/216	4.114407862231027E-6	2.9509251534385515E-4	0	0	53.307277628032345	661.0643831422935	NOS2;STAT1;TAP1;EGFR
Prostatic Neoplasms	7/1554	4.211458142210531E-6	2.9509251534385515E-4	0	0	20.861990950226243	258.2234991428008	HSP90AB1;STAT1;INSR;TAP1;APOE;HBA1;EGFR
Malnutrition	4/225	4.837367077909112E-6	3.2765099674371054E-4	0	0	51.113122171945705	625.5806569454487	STAT1;INSR;TAP1;APOE
Schistosomiasis	3/67	5.815869812131874E-6	3.812208857500635E-4	0	0	116.748046875	1407.388388866233	NOS2;APOE;EGFR
Migraine with Aura	3/68	6.082469780367734E-6	3.862368310533511E-4	0	0	114.94615384615385	1380.5147713403303	NOS2;INSR;APOE
Systemic Scleroderma	5/562	6.910473531001847E-6	4.255176428786592E-4	0	0	29.07241172950329	345.45212980770015	HSP90AB1;NOS2;TAP1;APOE;EGFR
Sensory denervation disorder	2/8	7.686024286039395E-6	4.5935298085976624E-4	0	0	740.1111111111111	8715.627566800247	STAT1;APOE
Malignant Fibrous Histiocytoma	3/75	8.178168673946682E-6	4.6745353940217955E-4	0	0	103.734375	1215.1488578452625	NOS2;STAT1;EGFR
Adenoma of large intestine	4/258	8.314065942597925E-6	4.6745353940217955E-4	0	0	44.39820022497188	519.3506903033758	INSR;IRS2;APOE;EGFR
Stable angina	3/76	8.511703227303467E-6	4.6745353940217955E-4	0	0	102.3082191780822	1194.353157896221	NOS2;STAT1;APOE
Cerebral arterial aneurysm	3/78	9.205516370396433E-6	4.8323775345079874E-4	0	0	99.57	1154.5846105236014	NOS2;STAT1;APOE
Arteriosclerosis	6/1087	9.274740346742692E-6	4.8323775345079874E-4	0	0	20.98945420906568	243.2303279386271	NOS2;STAT1;INSR;IRS2;APOE;EGFR
Hypothyroidism	4/268	9.661151258100672E-6	4.907864839115142E-4	0	0	42.6948051948052	493.01389697284526	NOS2;STAT1;INSR;APOE
Insulin Resistance	3/81	1.0314787736795368E-5	5.112109434431266E-4	0	0	95.72596153846153	1099.118980039264	INSR;IRS2;EGFR
Lupus Erythematosus, Systemic	6/1113	1.0629380887268126E-5	5.127257403020535E-4	0	0	20.46829268292683	234.40060782808587	HSP90AB1;NOS2;STAT1;TAP1;APOE;EGFR
Rectal Carcinoma	4/276	1.0850003362691093E-5	5.127257403020535E-4	0	0	41.42226890756302	473.51225352623806	NOS2;IRS2;APOE;EGFR
Atherosclerosis	6/1134	1.1838052521524098E-5	5.45335436277601E-4	0	0	20.064893617021276	227.61999411408323	NOS2;STAT1;INSR;IRS2;APOE;EGFR
Bile Duct Neoplasms	2/10	1.234519196297719E-5	5.45335436277601E-4	0	0	555.0277777777778	6273.059307633597	APOE;EGFR
Donohue Syndrome	2/10	1.234519196297719E-5	5.45335436277601E-4	0	0	555.0277777777778	6273.059307633597	INSR;EGFR
Pancreatic Neoplasm	5/665	1.5656950221418955E-5	6.76913252126028E-4	0	0	24.40530303030303	270.0348094033207	NOS2;BHLHE40;IRS2;APOE;EGFR
Impaired glucose tolerance	4/326	2.089247823523593E-5	8.303402231023825E-4	0	0	34.90150842945874	376.1028903719748	INSR;IRS2;APOE;HBA1
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma	2/13	2.137920088451626E-5	8.303402231023825E-4	0	0	403.5959595959596	4339.904496407951	STAT1;EGFR
Hydrosalpinx (disease)	2/13	2.137920088451626E-5	8.303402231023825E-4	0	0	403.5959595959596	4339.904496407951	NOS2;TAP1
Carcinogenesis	9/4065	2.1608633908023994E-5	8.303402231023825E-4	0	0	17.6771449704142	189.89527333942632	HSP90AB1;NOS2;STAT1;INSR;BHLHE40;TAP1;IRS2;APOE;EGFR
Osteopenia	4/329	2.165749597658773E-5	8.303402231023825E-4	0	0	34.574065934065935	371.33096295209526	NOS2;STAT1;IRS2;APOE
Diarrhea	4/329	2.165749597658773E-5	8.303402231023825E-4	0	0	34.574065934065935	371.33096295209526	NOS2;STAT1;APOE;EGFR
Malignant neoplasm of ovary	7/2026	2.473867463648155E-5	9.212332974100054E-4	0	0	15.575780089153046	165.2145230682031	NOS2;STAT1;INSR;IRS2;APOE;HBA1;EGFR
Subcortical Infarction	2/14	2.4934956376747194E-5	9.212332974100054E-4	0	0	369.94444444444446	3921.1299046658382	APOE;HBA1
Encephalomyelitis	4/348	2.6992529029463454E-5	9.284070351827861E-4	0	0	32.6328903654485	343.29638912552645	NOS2;STAT1;BHLHE40;APOE
Bronchiectasis	3/112	2.7299119109134506E-5	9.284070351827861E-4	0	0	68.39449541284404	718.7342330242068	NOS2;STAT1;TAP1
Endometriosis	5/749	2.7822097444844307E-5	9.284070351827861E-4	0	0	21.555779569892472	226.11322942687607	NOS2;INSR;IRS2;APOE;EGFR
Diabetes Mellitus, Experimental	3/113	2.8035215309221073E-5	9.284070351827861E-4	0	0	67.76931818181818	710.3613239355866	NOS2;INSR;IRS2
Streptozotocin Diabetes	3/113	2.8035215309221073E-5	9.284070351827861E-4	0	0	67.76931818181818	710.3613239355866	NOS2;INSR;IRS2
Alloxan Diabetes	3/113	2.8035215309221073E-5	9.284070351827861E-4	0	0	67.76931818181818	710.3613239355866	NOS2;INSR;IRS2
Liver neoplasms	6/1321	2.8415631789439197E-5	9.284070351827861E-4	0	0	17.040912547528517	178.39400544937374	NOS2;STAT1;INSR;IRS2;APOE;EGFR
Intracranial Aneurysm	3/114	2.8784273236474175E-5	9.284070351827861E-4	0	0	67.1554054054054	702.1555224109571	NOS2;STAT1;APOE
Respiratory Syncytial Virus Infections	3/116	3.0321705184547214E-5	9.530788652739542E-4	0	0	65.96017699115045	686.2263815886317	NOS2;STAT1;TAP1
Colon Carcinoma	7/2091	3.0487266851775108E-5	9.530788652739542E-4	0	0	15.0353886756238	156.34100020474034	NOS2;STAT1;BHLHE40;TAP1;IRS2;APOE;EGFR
Adenocarcinoma, Basal Cell	3/117	3.111029433049078E-5	9.578199709023827E-4	0	0	65.3782894736842	678.4940435839017	NOS2;APOE;EGFR
Colonic Neoplasms	5/778	3.3408717687155896E-5	0.0010132315573179221	0	0	20.715825786977145	213.51167078590058	NOS2;STAT1;TAP1;IRS2;EGFR
Hepatitis C	5/783	3.445467420963151E-5	0.0010295867352054593	0	0	20.57733504712939	211.44993529181045	NOS2;STAT1;TAP1;APOE;EGFR
Schistosomiasis mansoni	2/17	3.723204414400794E-5	0.001080793052866059	0	0	295.9111111111111	3017.8023474852107	NOS2;APOE
Hyperkeratosis lenticularis perstans	2/17	3.723204414400794E-5	0.001080793052866059	0	0	295.9111111111111	3017.8023474852107	APOE;EGFR
Chronic Kidney Diseases	4/380	3.808574005062301E-5	0.0010900031518713514	0	0	29.806990881458965	303.30612146585077	INSR;IRS2;APOE;EGFR
Hepatitis C, Chronic	4/386	4.0489886439327145E-5	0.0011427145728432327	0	0	29.329842931937172	296.6554742363083	NOS2;STAT1;APOE;EGFR
Ovarian Carcinoma	7/2203	4.301515574246148E-5	0.0011973533762833115	0	0	14.179303278688524	142.5581202747085	NOS2;STAT1;INSR;IRS2;APOE;HBA1;EGFR
Aortic Rupture	2/19	4.678583530599793E-5	0.0012541691201145894	0	0	261.0718954248366	2602.868539389068	STAT1;APOE
Vascular Diseases	4/401	4.6987622049933714E-5	0.0012541691201145894	0	0	28.200071968333933	281.03138032406497	NOS2;STAT1;APOE;EGFR
Bipolar Disorder	5/837	4.7466805708714674E-5	0.0012541691201145894	0	0	19.18770032051282	191.02276522118424	NOS2;BHLHE40;BHLHE41;APOE;EGFR
Hepatitis B	5/839	4.80132559014052E-5	0.0012541691201145894	0	0	19.13968824940048	190.32569961133314	STAT1;INSR;TAP1;APOE;EGFR
Malignant neoplasm of prostate	8/3239	4.872546745237404E-5	0.0012541691201145894	0	0	13.831012070566388	137.3323887439034	HSP90AB1;NOS2;STAT1;INSR;TAP1;IRS2;APOE;EGFR
Cholelithiasis	3/136	4.8759527799730596E-5	0.0012541691201145894	0	0	55.984962406015036	555.8528540988981	NOS2;APOE;HBA1
Carcinoma of ampulla of Vater	2/20	5.196871583395421E-5	0.0013200053821824367	0	0	246.55555555555554	2432.2381677726335	APOE;EGFR
Lymphatic Metastasis	3/142	5.545413774944302E-5	0.0013911457766280027	0	0	53.552158273381295	524.8086997655896	HSP90AB1;BHLHE41;EGFR
Pathological accumulation of air in tissues	2/21	5.74219267049387E-5	0.0013985195596458897	0	0	233.5672514619883	2280.8039070745754	NOS2;APOE
Disease Exacerbation	3/144	5.7812816442054495E-5	0.0013985195596458897	0	0	52.787234042553195	515.1136696058004	STAT1;APOE;EGFR
Encephalitis	3/144	5.7812816442054495E-5	0.0013985195596458897	0	0	52.787234042553195	515.1136696058004	NOS2;STAT1;APOE
Virus Diseases	5/875	5.871844772689926E-5	0.0014037163033065799	0	0	18.313218390804597	178.42122951229567	NOS2;STAT1;TAP1;APOE;EGFR
Shock	2/22	6.314522336867865E-5	0.001474840159599483	0	0	221.87777777777777	2145.5743861743645	NOS2;TAP1
Anaplastic large B-cell lymphoma	2/22	6.314522336867865E-5	0.001474840159599483	0	0	221.87777777777777	2145.5743861743645	INSR;EGFR
Primary Sj??gren's syndrome	3/151	6.658515048464627E-5	0.0015129144183391747	0	0	50.272804054054056	483.4750130399611	STAT1;APOE;EGFR
Pre-Eclampsia	3/152	6.790536245930654E-5	0.0015129144183391747	0	0	49.93288590604027	479.22565702731436	NOS2;TAP1;HBA1
Osteoporosis	4/441	6.804994986538388E-5	0.0015129144183391747	0	0	25.566525008172604	245.31767374252243	STAT1;BHLHE40;IRS2;APOE
Hypoxic-Ischemic Encephalopathy	2/23	6.9138361411835E-5	0.0015129144183391747	0	0	211.3015873015873	2024.1425993656733	NOS2;APOE
Familial lichen amyloidosis	3/153	6.924263824091696E-5	0.0015129144183391747	0	0	49.5975	475.03958405238	NOS2;APOE;EGFR
Cachexia	3/153	6.924263824091696E-5	0.0015129144183391747	0	0	49.5975	475.03958405238	NOS2;INSR;EGFR
Stomach Carcinoma	7/2378	7.105837875755196E-5	0.0015360704854823996	0	0	13.003584985238296	124.21035798625765	NOS2;STAT1;INSR;BHLHE40;TAP1;APOE;EGFR
Coronary heart disease	5/913	7.195069920032707E-5	0.0015367339925050746	0	0	17.511930983847282	167.0555805905074	NOS2;INSR;IRS2;APOE;EGFR
Ulcerative Colitis	5/915	7.270639898919367E-5	0.0015367339925050746	0	0	17.471611721611723	166.48840605961615	NOS2;STAT1;INSR;APOE;EGFR
Mucocutaneous Lymph Node Syndrome	3/156	7.335787267371665E-5	0.0015367339925050746	0	0	48.61764705882353	462.8478142602716	NOS2;STAT1;INSR
Malignant neoplasm of stomach	7/2398	7.506231998344162E-5	0.0015563942265954425	0	0	12.880175658720201	122.32549937434479	NOS2;STAT1;INSR;BHLHE40;IRS2;APOE;EGFR
Cholangiocarcinoma	4/455	7.683808650599246E-5	0.0015771211290926937	0	0	24.75514729173266	234.52556500111334	NOS2;STAT1;APOE;EGFR
Polycystic Kidney, Autosomal Dominant	3/161	8.0567412221651E-5	0.0016371298163439484	0	0	47.067246835443036	443.67546300469655	APOE;HBA1;EGFR
Malaria	4/469	8.643072394027219E-5	0.0017388834757092386	0	0	23.9926267281106	224.479030695244	NOS2;TAP1;APOE;HBA1
Hyperglycemia	4/488	1.0081608864233919E-4	0.0019772342919066755	0	0	23.028335301062572	211.9116373914926	NOS2;INSR;IRS2;APOE
Coronary Artery Disease	5/981	1.0132538118946211E-4	0.0019772342919066755	0	0	16.23377732240437	149.30486859792057	NOS2;STAT1;INSR;IRS2;APOE
Anemia	4/490	1.0242595012015017E-4	0.0019772342919066755	0	0	22.93121693121693	210.65465379030405	NOS2;STAT1;HBA1;EGFR
Hyperglycemia, Postprandial	2/28	1.0314312743213957E-4	0.0019772342919066755	0	0	170.6239316239316	1566.224114639988	INSR;IRS2
Hyperemia	2/28	1.0314312743213957E-4	0.0019772342919066755	0	0	170.6239316239316	1566.224114639988	NOS2;APOE
Multiple malignancy	3/176	1.0494363131932333E-4	0.0019904781648629162	0	0	42.95375722543353	393.5460691183147	INSR;BHLHE41;EGFR
Liver carcinoma	8/3593	1.057931308096432E-4	0.0019904781648629162	0	0	12.201952580195258	111.69697856321629	HSP90AB1;NOS2;STAT1;INSR;TAP1;IRS2;APOE;EGFR
Diabetes Mellitus, Non-Insulin-Dependent	6/1672	1.0812056031834135E-4	0.0020156053079529324	0	0	13.197839135654261	120.52614665244592	NOS2;INSR;IRS2;APOE;HBA1;EGFR
Salivary duct carcinoma	2/29	1.107501888077093E-4	0.0020458580332478665	0	0	164.2962962962963	1496.4490206891242	NOS2;EGFR
Hepatitis, Chronic	3/183	1.1779914249172865E-4	0.002114445450627014	0	0	41.26875	373.3389670322449	NOS2;STAT1;TAP1
Breast Carcinoma	9/4963	1.179144321703154E-4	0.002114445450627014	0	0	13.657145740815503	123.5364130608433	HSP90AB1;NOS2;STAT1;INSR;BHLHE40;BHLHE41;IRS2;APOE;EGFR
Delirium, Dementia, Amnestic, Cognitive Disorders	2/30	1.1862538453320847E-4	0.002114445450627014	0	0	158.4206349206349	1432.0496756090347	STAT1;APOE
Acute Chest Syndrome	2/30	1.1862538453320847E-4	0.002114445450627014	0	0	158.4206349206349	1432.0496756090347	NOS2;HBA1
Tumor Angiogenesis	4/511	1.2048606341215167E-4	0.0021289363552477584	0	0	21.95773457311919	198.14608007958057	HSP90AB1;NOS2;BHLHE41;EGFR
Adenocarcinoma	6/1712	1.234865049002313E-4	0.002163142913424741	0	0	12.860257913247363	115.73433088287646	NOS2;STAT1;INSR;BHLHE41;APOE;EGFR
ESTROGEN RESISTANCE	2/31	1.2676847134630674E-4	0.0021829960489465703	0	0	152.95019157088123	1372.4447355060008	INSR;EGFR
HIV Encephalopathy	2/31	1.2676847134630674E-4	0.0021829960489465703	0	0	152.95019157088123	1372.4447355060008	NOS2;APOE
Polycystic Ovary Syndrome	4/526	1.3473790872669446E-4	0.002251509399396368	0	0	21.310344827586206	189.92160943154957	INSR;IRS2;APOE;EGFR
Giant Cell Fibroblastoma	2/32	1.3517920606612052E-4	0.002251509399396368	0	0	147.84444444444443	1317.1327323844173	INSR;EGFR
HIV encephalitis	2/32	1.3517920606612052E-4	0.002251509399396368	0	0	147.84444444444443	1317.1327323844173	NOS2;APOE
Dermatofibrosarcoma Protuberans	2/32	1.3517920606612052E-4	0.002251509399396368	0	0	147.84444444444443	1317.1327323844173	INSR;EGFR
Malignant neoplasm of breast	9/5054	1.3742576663108497E-4	0.0022703183560517453	0	0	13.329633300297324	118.5327866034529	HSP90AB1;NOS2;STAT1;INSR;BHLHE40;BHLHE41;IRS2;APOE;EGFR
Fibrosis, Liver	4/545	1.5451072579307818E-4	0.0025200046354124338	0	0	20.541853710060735	180.25984099464063	STAT1;INSR;APOE;EGFR
Colorectal Neoplasms	5/1073	1.5501997019023338E-4	0.0025200046354124338	0	0	14.763576779026216	129.50545490526952	NOS2;INSR;TAP1;APOE;EGFR
Metabolic Syndrome X	4/548	1.5781574762138248E-4	0.002545092056878168	0	0	20.425420168067227	178.8058103831334	NOS2;INSR;IRS2;APOE
Malignant neoplasm of gallbladder	3/203	1.600918850848266E-4	0.0025614701613572255	0	0	37.104375	324.2834298781839	NOS2;APOE;EGFR
Low Grade Squamous Intraepithelial Neoplasia	2/35	1.6201486834500342E-4	0.0025719860349769294	0	0	134.3838383838384	1172.87828116532	NOS2;EGFR
Thymoma	3/205	1.6479511484798656E-4	0.0025958424292334007	0	0	36.73329207920792	319.9766392230096	STAT1;IRS2;EGFR
Hepatitis E	2/36	1.714937660463913E-4	0.00268057948158667	0	0	130.4248366013072	1130.9090161319034	APOE;EGFR
Multiple Sclerosis	5/1106	1.7887904770444988E-4	0.0027746734727896348	0	0	14.296094459582198	123.35814976098699	NOS2;STAT1;TAP1;APOE;EGFR
Rheumatoid Arthritis	6/1833	1.8102092077541818E-4	0.002786625083451892	0	0	11.929064039408868	102.79152745447193	NOS2;STAT1;BHLHE41;TAP1;APOE;EGFR
Steatohepatitis	4/569	1.8241342925680022E-4	0.0027869480319535193	0	0	19.645006321112515	169.12847319990755	INSR;IRS2;APOE;EGFR
Papillary thyroid carcinoma	4/571	1.8489318401026687E-4	0.002803753357528823	0	0	19.573696145124718	168.25025185941405	HSP90AB1;NOS2;INSR;EGFR
Restenosis	3/215	1.8966535013035415E-4	0.0028160961154658085	0	0	34.982900943396224	299.81218420581337	NOS2;INSR;APOE
Chronic Lymphocytic Leukemia	5/1120	1.8981956005003486E-4	0.0028160961154658085	0	0	14.106128550074738	120.88157457735342	NOS2;STAT1;INSR;APOE;EGFR
Mental Depression	4/575	1.8992621699547794E-4	0.0028160961154658085	0	0	19.432574430823117	166.51529914326784	HSP90AB1;NOS2;APOE;EGFR
Autosomal Recessive Polycystic Kidney Disease	2/38	1.9125062201490235E-4	0.0028160961154658085	0	0	123.16666666666667	1054.5438650851984	APOE;EGFR
Optic Neuropathy	2/39	2.01528095808739E-4	0.002907855636400852	0	0	119.83183183183183	1019.718769585136	NOS2;APOE
Neoplasm Metastasis	8/3920	2.017337838309175E-4	0.002907855636400852	0	0	10.959100204498977	93.24617951671269	NOS2;STAT1;INSR;BHLHE41;TAP1;IRS2;APOE;EGFR
Pancreatic carcinoma	6/1869	2.0177541571482293E-4	0.002907855636400852	0	0	11.67536231884058	99.33813066022239	HSP90AB1;STAT1;INSR;BHLHE41;IRS2;EGFR
Squamous cell carcinoma	6/1876	2.060249808041518E-4	0.0029481884577044824	0	0	11.62716577540107	98.68572218906857	NOS2;STAT1;INSR;IRS2;APOE;EGFR
Influenza	4/589	2.0832940808314444E-4	0.0029603171833912554	0	0	18.953846153846154	160.66019272544685	NOS2;STAT1;TAP1;EGFR
Motor symptoms	2/40	2.12071277436947E-4	0.0029925613593880297	0	0	116.67251461988305	986.8847467329822	NOS2;APOE
Acute Erythroblastic Leukemia	3/224	2.140348417737175E-4	0.002999439989546165	0	0	33.542986425339365	283.4171617172781	STAT1;HBA1;EGFR
Liver diseases	4/606	2.3238067926925615E-4	0.003233973571566033	0	0	18.40246796392976	153.9759093510499	NOS2;TAP1;APOE;EGFR
Clear Cell Sarcoma of Soft Tissue	2/42	2.3395379676191284E-4	0.003233973571566033	0	0	110.82777777777778	926.5631028013964	BHLHE40;EGFR
Schizophrenia	6/1923	2.3646175144084673E-4	0.003236659111647906	0	0	11.312676056338027	94.45772379714903	NOS2;INSR;BHLHE40;TAP1;APOE;EGFR
Hypoglycemia	3/232	2.3733376360016633E-4	0.003236659111647906	0	0	32.35807860262009	270.0619193722403	INSR;IRS2;APOE
Chloracne	2/43	2.4529265118944116E-4	0.0032625823347967185	0	0	108.11924119241192	898.8015841018229	HBA1;EGFR
Dissection of aorta	2/43	2.4529265118944116E-4	0.0032625823347967185	0	0	108.11924119241192	898.8015841018229	STAT1;APOE
Hepatoblastoma	3/235	2.4647832520898274E-4	0.0032625823347967185	0	0	31.934806034482758	265.32192106930296	INSR;APOE;EGFR
leukemia	6/1941	2.4903405580149876E-4	0.0032625823347967185	0	0	11.196279069767442	92.90583810157752	HSP90AB1;NOS2;STAT1;APOE;HBA1;EGFR
Adenocarcinoma of lung (disorder)	5/1187	2.4954031931089936E-4	0.0032625823347967185	0	0	13.259306260575297	109.99774694839954	INSR;BHLHE40;BHLHE41;APOE;EGFR
IGA Glomerulonephritis	3/237	2.5270017134364616E-4	0.0032625823347967185	0	0	31.658653846153847	262.23834475692706	NOS2;STAT1;APOE
Overweight	3/238	2.5584901115823823E-4	0.0032625823347967185	0	0	31.522340425531915	260.7188532022438	INSR;IRS2;APOE
Arthritis, Adjuvant-Induced	2/44	2.568962468343873E-4	0.0032625823347967185	0	0	105.53968253968254	872.4794859258211	STAT1;EGFR
Arthritis, Collagen-Induced	2/44	2.568962468343873E-4	0.0032625823347967185	0	0	105.53968253968254	872.4794859258211	STAT1;EGFR
Arthritis, Experimental	2/44	2.568962468343873E-4	0.0032625823347967185	0	0	105.53968253968254	872.4794859258211	STAT1;EGFR
Neurocognitive Disorders	2/44	2.568962468343873E-4	0.0032625823347967185	0	0	105.53968253968254	872.4794859258211	STAT1;APOE
Obesity	6/1961	2.636279275080429E-4	0.0033272791844493367	0	0	11.069462915601022	91.22313188809693	NOS2;STAT1;INSR;IRS2;APOE;EGFR
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	2/45	2.6876434233975995E-4	0.0033504855437692777	0	0	103.08010335917312	847.4911719840177	APOE;EGFR
Lipoatrophy	2/45	2.6876434233975995E-4	0.0033504855437692777	0	0	103.08010335917312	847.4911719840177	INSR;APOE
Vitiligo	3/243	2.7197603300258455E-4	0.0033618201080091075	0	0	30.8578125	253.33636443944548	NOS2;TAP1;APOE
Triple Negative Breast Neoplasms	4/632	2.729824398727868E-4	0.0033618201080091075	0	0	17.616924476797088	144.56629834408977	NOS2;STAT1;BHLHE41;EGFR
Colorectal Carcinoma	7/2931	2.7590296739401306E-4	0.003377318251473702	0	0	10.213320793433653	83.70287552639604	NOS2;STAT1;INSR;TAP1;IRS2;APOE;EGFR
Alzheimer's Disease	6/1982	2.7968330706638244E-4	0.0034030926943646057	0	0	10.939068825910931	89.5018491644756	NOS2;STAT1;INSR;IRS2;APOE;EGFR
Rhinovirus infection	2/47	2.932930686478756E-4	0.0035246559401500305	0	0	98.4888888888889	801.141932597962	NOS2;EGFR
Colonic Polyps	2/47	2.932930686478756E-4	0.0035246559401500305	0	0	98.4888888888889	801.141932597962	NOS2;EGFR
Malignant tumor of colon	6/2001	2.948777115282998E-4	0.0035246559401500305	0	0	10.823458646616542	87.98335226872096	NOS2;STAT1;TAP1;IRS2;APOE;EGFR
Brain Neoplasms	4/646	2.968594603412045E-4	0.0035275931193761846	0	0	17.220293724966623	139.86756047562943	NOS2;STAT1;APOE;EGFR
Fabry Disease	2/48	3.0595321755068756E-4	0.003552553931788555	0	0	96.34299516908213	779.6150655284314	NOS2;APOE
Sleep Disorders	2/48	3.0595321755068756E-4	0.003552553931788555	0	0	96.34299516908213	779.6150655284314	BHLHE41;APOE
Corneal Neovascularization	2/48	3.0595321755068756E-4	0.003552553931788555	0	0	96.34299516908213	779.6150655284314	INSR;APOE
Psychotic symptom	2/48	3.0595321755068756E-4	0.003552553931788555	0	0	96.34299516908213	779.6150655284314	NOS2;APOE
Sarcoma	4/658	3.185006181902098E-4	0.00367723441001424	0	0	16.89384010484928	136.02727702559176	NOS2;STAT1;IRS2;EGFR
Candidiasis	2/50	3.32063883264561E-4	0.003812168422562644	0	0	92.31944444444444	739.4956618223716	STAT1;EGFR
Endothelial dysfunction	3/262	3.3924966775060873E-4	0.003872782723984477	0	0	28.566602316602317	228.21213667161018	NOS2;STAT1;APOE
Cockayne Syndrome, Type I	2/51	3.455139191258262E-4	0.003922258567953513	0	0	90.43083900226758	720.7769792087644	STAT1;APOE
Refractory anemias	3/266	3.5465972749409525E-4	0.004003714257044454	0	0	28.126425855513308	223.44622024874872	STAT1;APOE;EGFR
Drug usage	2/52	3.5922676978951407E-4	0.004032866277415981	0	0	88.61777777777777	702.8769289105478	INSR;APOE
Cytomegalovirus Infections	3/270	3.70516358834525E-4	0.004136754072262389	0	0	27.69943820224719	218.84254046764525	STAT1;APOE;EGFR
Stevens-Johnson Syndrome	2/53	3.7320219519280473E-4	0.004142708878590571	0	0	86.87581699346406	685.744723074984	NOS2;EGFR
Tumor Progression	6/2090	3.7512718191961864E-4	0.004142708878590571	0	0	10.309980806142034	81.3276590568985	NOS2;STAT1;INSR;BHLHE40;IRS2;EGFR
Cerebral Aneurysm	2/54	3.8743995530845664E-4	0.00425555669830694	0	0	85.2008547008547	669.3336268156615	STAT1;APOE
Bacterial Infections	3/276	3.951508975009218E-4	0.0043169173318380275	0	0	27.082417582417584	212.22440106034094	NOS2;STAT1;EGFR
Atherogenesis	2/55	4.0193981025798004E-4	0.00436222579949471	0	0	83.58909853249476	653.6005652009715	NOS2;APOE
Essential Hypertension	3/278	4.0359175703986495E-4	0.00436222579949471	0	0	26.882727272727273	210.09138184275014	NOS2;INSR;APOE
Hyperandrogenism	2/56	4.1670152036731717E-4	0.004480092536435918	0	0	82.03703703703704	638.505774876317	INSR;IRS2
Experimental Organism Basal Cell Carcinoma	3/282	4.2082165576756524E-4	0.004500056311362509	0	0	26.491935483870968	205.92980010048888	STAT1;APOE;EGFR
Hyperactive behavior	4/709	4.233969855280401E-4	0.004500056311362509	0	0	15.630395136778116	121.40441009197183	NOS2;STAT1;APOE;EGFR
Cerebral Infarction	3/283	4.25202171152363E-4	0.004500056311362509	0	0	26.395982142857143	204.91057885315848	NOS2;APOE;HBA1
Prostate carcinoma	7/3145	4.3311698378220673E-4	0.004560071041686238	0	0	9.397466539196941	72.77870494888353	NOS2;STAT1;INSR;TAP1;IRS2;APOE;EGFR
Noninfiltrating Intraductal Carcinoma	3/287	4.4301897350040805E-4	0.00463987799988961	0	0	26.018926056338028	200.9154920166846	STAT1;IRS2;EGFR
Amnesia	2/58	4.4700954794706256E-4	0.00463987799988961	0	0	79.09920634920636	610.0866893648016	APOE;EGFR
Aortic Aneurysm, Abdominal	3/288	4.4754728739092694E-4	0.00463987799988961	0	0	25.926315789473684	199.93670463212115	NOS2;STAT1;APOE
Migraine Disorders	3/290	4.5669344898751377E-4	0.0047106654230590255	0	0	25.743031358885016	198.0024788989161	NOS2;INSR;APOE
Adenocarcinoma of large intestine	3/297	4.896540402446389E-4	0.005023403905564116	0	0	25.121173469387756	191.46884775072115	NOS2;INSR;EGFR
Leukoplakia	2/61	4.944295182641846E-4	0.005023403905564116	0	0	75.06591337099812	571.4096856916649	NOS2;EGFR
Bile duct carcinoma	2/61	4.944295182641846E-4	0.005023403905564116	0	0	75.06591337099812	571.4096856916649	APOE;EGFR
Depressive disorder	4/741	5.007470126336638E-4	0.005062278257072661	0	0	14.926923822446211	113.4358074367793	HSP90AB1;NOS2;APOE;EGFR
Choriocarcinoma	3/300	5.042369993995074E-4	0.005072324667226728	0	0	24.863636363636363	188.77626806559852	STAT1;INSR;EGFR
Bulbo-Spinal Atrophy, X-Linked	2/63	5.273453296094256E-4	0.005227149803738306	0	0	72.59744990892531	547.9405021349086	STAT1;INSR
Inclusion Body Myopathy, Sporadic	2/63	5.273453296094256E-4	0.005227149803738306	0	0	72.59744990892531	547.9405021349086	NOS2;APOE
Necrotizing Enterocolitis	2/63	5.273453296094256E-4	0.005227149803738306	0	0	72.59744990892531	547.9405021349086	NOS2;EGFR
Peripheral Neuropathy	3/309	5.496597553635696E-4	0.005394653963028885	0	0	24.121323529411764	181.05974636956043	INSR;APOE;EGFR
Coronary Arteriosclerosis	4/760	5.512203498401508E-4	0.005394653963028885	0	0	14.537414965986395	109.07968939174577	NOS2;INSR;IRS2;APOE
Non-Small Cell Lung Carcinoma	6/2243	5.532781995663138E-4	0.005394653963028885	0	0	9.522753687974966	71.4173159781871	NOS2;STAT1;INSR;BHLHE40;TAP1;EGFR
Kidney Failure, Acute	3/310	5.548635227721639E-4	0.005394653963028885	0	0	24.041530944625407	180.23426980799044	NOS2;APOE;EGFR
Multiple, subcutaneous nodules	2/65	5.613009114282874E-4	0.005405513990626919	0	0	70.28571428571429	526.1063826886168	INSR;APOE
Subcutaneous nodule	2/65	5.613009114282874E-4	0.005405513990626919	0	0	70.28571428571429	526.1063826886168	INSR;APOE
Celiac Disease	3/312	5.653661292187472E-4	0.005418981012134408	0	0	23.883495145631066	178.60166087493695	NOS2;STAT1;EGFR
Cerebrovascular accident	4/768	5.735302034145867E-4	0.005469085661798658	0	0	14.379207180254301	107.3220880232671	NOS2;STAT1;APOE;HBA1
Skeletal dysplasia	2/66	5.786680203182635E-4	0.005469085661798658	0	0	69.18402777777777	515.751818132609	STAT1;EGFR
Bronchiolitis	2/66	5.786680203182635E-4	0.005469085661798658	0	0	69.18402777777777	515.751818132609	NOS2;TAP1
Colorectal Cancer	7/3298	5.857862468637495E-4	0.005510729877903421	0	0	8.879216043755697	66.08405910227128	NOS2;STAT1;INSR;TAP1;IRS2;APOE;EGFR
Hepatitis	3/317	5.921810742381012E-4	0.005532740335327326	0	0	23.49721337579618	174.62419602846865	NOS2;STAT1;APOE
Uremia	2/67	5.962943570062423E-4	0.005532740335327326	0	0	68.11623931623932	505.7478274154551	NOS2;EGFR
Pustulosis of Palms and Soles	2/67	5.962943570062423E-4	0.005532740335327326	0	0	68.11623931623932	505.7478274154551	NOS2;APOE
Gastrointestinal Stromal Tumors	3/323	6.254237687629995E-4	0.005776641355120068	0	0	23.049609375	170.03883786629876	HSP90AB1;INSR;EGFR
Cardiovascular Diseases	4/787	6.291116882365223E-4	0.005784411540708656	0	0	14.016420361247947	103.31786232728068	NOS2;INSR;APOE;HBA1
Diabetic Angiopathies	2/69	6.323237618724635E-4	0.005787756234796603	0	0	66.07628524046434	486.7251202913541	NOS2;APOE
Heart Diseases	3/325	6.3676561722367E-4	0.005802276834970841	0	0	22.904114906832298	168.55387626850796	NOS2;APOE;EGFR
Glaucoma, Open-Angle	2/70	6.507263545424821E-4	0.0058767820108014375	0	0	65.10130718954248	477.6757213148116	TAP1;APOE
Cooley's anemia	2/70	6.507263545424821E-4	0.0058767820108014375	0	0	65.10130718954248	477.6757213148116	APOE;HBA1
Fatigue	3/330	6.656972100220753E-4	0.00598538376444627	0	0	22.548165137614678	164.93251404257717	NOS2;INSR;HBA1
West Nile viral infection	2/72	6.883061323478026E-4	0.006117662133274027	0	0	63.234920634920634	460.4309643116587	STAT1;TAP1
Benign melanocytic nevus	2/72	6.883061323478026E-4	0.006117662133274027	0	0	63.234920634920634	460.4309643116587	NOS2;EGFR
Non-alcoholic Fatty Liver Disease	3/334	6.894412541927914E-4	0.006117662133274027	0	0	22.271148036253777	162.1256965545456	INSR;IRS2;APOE
Dysplastic Nevus	2/73	7.074828428562862E-4	0.006250457116017277	0	0	62.341158059467915	452.21011647488814	STAT1;EGFR
Heart failure	4/815	7.179364740151664E-4	0.006315354611250295	0	0	13.512770829663555	97.82069752264884	NOS2;APOE;HBA1;EGFR
Necrotizing enterocolitis in fetus OR newborn	2/74	7.269171181885319E-4	0.006348549723294453	0	0	61.47222222222222	444.2411910549423	NOS2;EGFR
Psoriasis	4/818	7.279587035076808E-4	0.006348549723294453	0	0	13.460863460863461	97.25832228905288	NOS2;TAP1;APOE;EGFR
Ovarian Cysts	2/75	7.466087214173855E-4	0.006455782646468627	0	0	60.627092846270926	436.5132078500547	INSR;EGFR
Polycythemia	2/75	7.466087214173855E-4	0.006455782646468627	0	0	60.627092846270926	436.5132078500547	HBA1;EGFR
Acromegaly	2/76	7.66557415655506E-4	0.0065723403738902455	0	0	59.8048048048048	429.0158049324039	INSR;APOE
Early-Stage Breast Carcinoma	2/76	7.66557415655506E-4	0.0065723403738902455	0	0	59.8048048048048	429.0158049324039	APOE;EGFR
Mammary Neoplasms	6/2387	7.772044914236426E-4	0.006628073139670822	0	0	8.874254514909701	63.5379501413738	NOS2;STAT1;INSR;IRS2;APOE;EGFR
Amyloidosis	4/833	7.795814371955347E-4	0.006628073139670822	0	0	13.206961916250215	94.51896961486047	NOS2;INSR;APOE;EGFR
Stomach Neoplasms	4/835	7.86657270116986E-4	0.006633619681397974	0	0	13.173800928313563	94.16261262006311	NOS2;IRS2;APOE;EGFR
aggressive cancer	2/77	7.86762964181551E-4	0.006633619681397974	0	0	59.004444444444445	421.73919613452125	NOS2;EGFR
Endometrial Carcinoma	4/840	8.045481097002978E-4	0.006695026387871478	0	0	13.091592617908407	93.28060575335832	INSR;BHLHE41;APOE;EGFR
Giant Cell Glioblastoma	2/78	8.072251304274173E-4	0.006695026387871478	0	0	58.22514619883041	414.67413198594653	BHLHE40;EGFR
Multiple Sclerosis, Relapsing-Remitting	2/78	8.072251304274173E-4	0.006695026387871478	0	0	58.22514619883041	414.67413198594653	NOS2;APOE
Pleural Effusion, Malignant	2/78	8.072251304274173E-4	0.006695026387871478	0	0	58.22514619883041	414.67413198594653	APOE;EGFR
Retinal Diseases	3/355	8.230384224842788E-4	0.006798431197105912	0	0	20.920099431818183	148.58516672375978	NOS2;INSR;APOE
Extrahepatic Cholangiocarcinoma	2/80	8.489183706752518E-4	0.006983814288308144	0	0	56.72649572649573	401.1441103936546	NOS2;EGFR
Glioblastoma Multiforme	4/854	8.561922809670786E-4	0.007015252882762515	0	0	12.86655462184874	90.8766757518153	STAT1;BHLHE40;TAP1;EGFR
Presenile dementia	3/362	8.709908172656028E-4	0.007107844741701627	0	0	20.504874651810585	144.47486824771408	STAT1;INSR;APOE
Thalassemia	2/82	8.916352467573733E-4	0.00724721128564393	0	0	55.30277777777778	388.361181228883	APOE;HBA1
melanoma	6/2454	9.033629343703596E-4	0.0073132808073329515	0	0	8.598529411764705	60.27041309490033	NOS2;STAT1;BHLHE40;TAP1;APOE;EGFR
Hyperalgesia, Secondary	2/84	9.353738713083483E-4	0.007482990970466786	0	0	53.94850948509485	376.26734539254	NOS2;INSR
Thrombophilia	2/84	9.353738713083483E-4	0.007482990970466786	0	0	53.94850948509485	376.26734539254	APOE;EGFR
Allodynia	2/84	9.353738713083483E-4	0.007482990970466786	0	0	53.94850948509485	376.26734539254	NOS2;INSR
Alzheimer's Disease, Focal Onset	2/85	9.576257501889189E-4	0.007542230714666214	0	0	53.295850066934406	370.4623058756709	INSR;APOE
Hyperalgesia, Primary	2/85	9.576257501889189E-4	0.007542230714666214	0	0	53.295850066934406	370.4623058756709	NOS2;INSR
Acute Confusional Senile Dementia	2/85	9.576257501889189E-4	0.007542230714666214	0	0	53.295850066934406	370.4623058756709	INSR;APOE
Lesion of brain	2/85	9.576257501889189E-4	0.007542230714666214	0	0	53.295850066934406	370.4623058756709	APOE;EGFR
Congestive heart failure	4/884	9.747848098960182E-4	0.007601637229810162	0	0	12.408441558441558	86.0313711621158	NOS2;APOE;HBA1;EGFR
Headache	2/86	9.801323593554442E-4	0.007601637229810162	0	0	52.65873015873016	364.81035851387213	NOS2;APOE
Herpes NOS	2/86	9.801323593554442E-4	0.007601637229810162	0	0	52.65873015873016	364.81035851387213	STAT1;APOE
Diabetic Neuropathies	2/86	9.801323593554442E-4	0.007601637229810162	0	0	52.65873015873016	364.81035851387213	INSR;APOE
Adult type dermatomyositis	2/87	0.001002893463632885	0.007719240598871298	0	0	52.03660130718954	359.30575877593174	NOS2;STAT1
Nevus	2/87	0.001002893463632885	0.007719240598871298	0	0	52.03660130718954	359.30575877593174	NOS2;EGFR
Tactile Allodynia	2/89	0.001049178217319043	0.007984757069634064	0	0	50.83524904214559	348.7170015767893	NOS2;INSR
Acute Kidney Insufficiency	2/89	0.001049178217319043	0.007984757069634064	0	0	50.83524904214559	348.7170015767893	NOS2;EGFR
Cerebral Palsy	2/89	0.001049178217319043	0.007984757069634064	0	0	50.83524904214559	348.7170015767893	NOS2;APOE
Periodontitis, Juvenile	2/90	0.001072701396883102	0.00813331805397934	0	0	50.255050505050505	343.6226841007994	NOS2;STAT1
Acute Cerebrovascular Accidents	2/91	0.001096478131856052	0.008253627500903665	0	0	49.68789013732834	338.6553645055418	NOS2;APOE
Adenomatous Polyposis Coli	3/392	0.0010966926305334595	0.008253627500903665	0	0	18.894601542416453	128.77533164531206	NOS2;IRS2;EGFR
Lung diseases	3/393	0.0011047946644519172	0.0082839216168498	0	0	18.845192307692308	128.2998743232671	NOS2;INSR;EGFR
Acute kidney injury	2/92	0.0011205081876088584	0.008370855283901472	0	0	49.13333333333333	333.8105379857244	NOS2;EGFR
Rhabdomyosarcoma	3/397	0.0011375847324683465	0.008428318775618471	0	0	18.65006345177665	126.4259438347989	STAT1;INSR;EGFR
Subarachnoid Hemorrhage	2/93	0.0011447913297592018	0.008428318775618471	0	0	48.59096459096459	329.08390649715756	NOS2;APOE
Manic	2/93	0.0011447913297592018	0.008428318775618471	0	0	48.59096459096459	329.08390649715756	NOS2;BHLHE40
Childhood Medulloblastoma	2/93	0.0011447913297592018	0.008428318775618471	0	0	48.59096459096459	329.08390649715756	IRS2;EGFR
Squamous cell carcinoma of the head and neck	4/934	0.0011978379986082818	0.008787028206397216	0	0	11.710599078341014	78.77997558729086	NOS2;STAT1;TAP1;EGFR
ovarian neoplasm	4/938	0.0012171207807691016	0.00887010697698915	0	0	11.657999388192108	78.23994920568406	NOS2;INSR;APOE;EGFR
IMMUNE SUPPRESSION	2/96	0.001219156933395177	0.00887010697698915	0	0	47.033096926713945	315.57306477086036	STAT1;EGFR
Burkitt Lymphoma	3/407	0.0012222588354118909	0.00887010697698915	0	0	18.17914603960396	121.92852557297023	INSR;TAP1;EGFR
Mycobacterium Infections	2/98	0.001269995143403217	0.009183737122403333	0	0	46.048611111111114	307.0863162882841	NOS2;STAT1
Metastatic melanoma	3/417	0.0013108460759368972	0.009223634538232058	0	0	17.730978260869566	117.68196535913496	STAT1;TAP1;EGFR
Rhinitis	2/100	0.0013218400851343036	0.009223634538232058	0	0	45.10430839002267	298.984305122014	NOS2;EGFR
Leukemia, Myelocytic, Acute	5/1703	0.0013275346758007363	0.009223634538232058	0	0	8.976737338044758	59.46578324161764	HSP90AB1;NOS2;STAT1;INSR;EGFR
Generalized Absence Seizures	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Single Seizure	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Gustatory seizure	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Seizures, Auditory	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Seizures, Clonic	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Seizures, Sensory	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Seizures, Somatosensory	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Vertiginous seizure	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Jacksonian Seizure	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Atonic Absence Seizures	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Non-epileptic convulsion	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Nonepileptic Seizures	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Olfactory seizure	2/101	0.0013481394969758471	0.009223634538232058	0	0	44.64646464646464	295.06981475249296	NOS2;APOE
Epileptic Seizures	2/103	0.0014014910364866255	0.00952451433491914	0	0	43.75797579757976	287.4994657413395	NOS2;APOE
Severe Sepsis	2/103	0.0014014910364866255	0.00952451433491914	0	0	43.75797579757976	287.4994657413395	NOS2;APOE
Tonic Seizures	2/104	0.0014285426986205881	0.009675995878656784	0	0	43.326797385620914	283.8382016858443	NOS2;APOE
Pulmonary Fibrosis	3/432	0.0014512189968930737	0.009763288181354824	0	0	17.097902097902097	111.74079821112295	HSP90AB1;STAT1;EGFR
Biliary Atresia	2/105	0.0014558446451528107	0.009763288181354824	0	0	42.903991370010786	280.25612389042504	STAT1;EGFR
Carotid Atherosclerosis	2/105	0.0014558446451528107	0.009763288181354824	0	0	42.903991370010786	280.25612389042504	STAT1;APOE
Cirrhosis	3/433	0.001460901694954329	0.009764974487326305	0	0	17.057267441860464	111.36180641827004	STAT1;APOE;EGFR
Dementia	3/436	0.001490195790165633	0.009928124083988741	0	0	16.9364896073903	110.23703252566465	NOS2;STAT1;APOE
Kidney Failure, Chronic	3/437	0.0015000427174361754	0.00996106797983761	0	0	16.89660138248848	109.86612391105454	NOS2;INSR;APOE
Head and Neck Neoplasms	2/107	0.0015111984615165264	0.00996998465519994	0	0	42.08253968253968	273.3198779565988	NOS2;EGFR
Alcohol abuse	2/107	0.0015111984615165264	0.00996998465519994	0	0	42.08253968253968	273.3198779565988	APOE;EGFR
Mechanical Allodynia	2/108	0.001539249866364372	0.010122186823470563	0	0	41.683438155136265	269.96112325022307	NOS2;INSR
Fatty Liver	3/443	0.0015599924571061102	0.010209175874155357	0	0	16.661079545454545	107.68179490253537	INSR;APOE;EGFR
Hyperalgesia, Thermal	2/109	0.0015675506263466887	0.010209175874155357	0	0	41.29179646936656	266.6723724459786	NOS2;INSR
Convulsive Seizures	2/109	0.0015675506263466887	0.010209175874155357	0	0	41.29179646936656	266.6723724459786	NOS2;APOE
Cholera	2/112	0.0016539467166369409	0.010737443221106275	0	0	40.15959595959596	257.20578274015594	APOE;EGFR
Eczema	3/454	0.001673803714085974	0.01082388898074897	0	0	16.245565410199557	103.85232044334896	STAT1;TAP1;EGFR
Obesity, Morbid	2/113	0.001683242577714899	0.01082388898074897	0	0	39.7957957957958	254.1770705617978	INSR;IRS2
Lipodystrophy	2/113	0.001683242577714899	0.01082388898074897	0	0	39.7957957957958	254.1770705617978	INSR;APOE
Gingival Diseases	2/114	0.0017127866353649158	0.010944598877551916	0	0	39.43849206349206	251.20874510849845	STAT1;APOE
Dermatomyositis	2/114	0.0017127866353649158	0.010944598877551916	0	0	39.43849206349206	251.20874510849845	NOS2;STAT1
Epileptic drop attack	2/115	0.0017425786577592239	0.011030902905192345	0	0	39.087512291052114	248.29909388744773	NOS2;APOE
Carcinoma, Cribriform	2/115	0.0017425786577592239	0.011030902905192345	0	0	39.087512291052114	248.29909388744773	APOE;EGFR
Carcinoma, Granular Cell	2/115	0.0017425786577592239	0.011030902905192345	0	0	39.087512291052114	248.29909388744773	APOE;EGFR
Alzheimer Disease, Early Onset	2/116	0.0017726184138619496	0.011117162398047784	0	0	38.74269005847953	245.4464673026705	INSR;APOE
Familial (FPAH)	2/116	0.0017726184138619496	0.011117162398047784	0	0	38.74269005847953	245.4464673026705	INSR;EGFR
Complex partial seizures	2/116	0.0017726184138619496	0.011117162398047784	0	0	38.74269005847953	245.4464673026705	NOS2;APOE
Convulsions	2/118	0.0018334402039742494	0.011463232290694384	0	0	38.07088122605364	239.90598737606584	NOS2;APOE
Malignant Head and Neck Neoplasm	3/470	0.001848523399047443	0.011522084499584063	0	0	15.67612419700214	98.6556202864886	NOS2;STAT1;EGFR
Infarction, Middle Cerebral Artery	2/119	0.0018642217762422065	0.011549081247939524	0	0	37.743589743589745	237.21512467016996	NOS2;APOE
Hyperalgesia	2/119	0.0018642217762422065	0.011549081247939524	0	0	37.743589743589745	237.21512467016996	NOS2;INSR
Down Syndrome	3/475	0.0019053903922464925	0.011768247042689584	0	0	15.506091101694915	97.11570858313794	NOS2;STAT1;APOE
Malignant neoplasm of pancreas	5/1846	0.0019132596712535521	0.011772752831425964	0	0	8.214738366829621	51.41561088547027	STAT1;INSR;BHLHE41;IRS2;EGFR
Autoimmune Diseases	4/1060	0.0019177072771663355	0.011772752831425964	0	0	10.24512987012987	64.09993498682094	NOS2;STAT1;APOE;EGFR
Adenocarcinoma, Oxyphilic	2/122	0.0019580464345531415	0.011948199264300251	0	0	36.794444444444444	229.44309175285673	APOE;EGFR
Gastrointestinal Neoplasms	2/122	0.0019580464345531415	0.011948199264300251	0	0	36.794444444444444	229.44309175285673	HBA1;EGFR
Hyperplasia	2/123	0.001989813866519725	0.012069557542591286	0	0	36.48852157943067	226.94817503952012	IRS2;EGFR
Absence Seizures	2/123	0.001989813866519725	0.012069557542591286	0	0	36.48852157943067	226.94817503952012	NOS2;APOE
Encephalitis, St. Louis	2/124	0.0020218271883785093	0.012227240615431937	0	0	36.18761384335155	224.4990406593831	HSP90AB1;STAT1
Adenocarcinoma, Tubular	2/125	0.0020540861697512826	0.012312398516031288	0	0	35.89159891598916	222.09449408997813	APOE;EGFR
Myotonic Dystrophy	2/125	0.0020540861697512826	0.012312398516031288	0	0	35.89159891598916	222.09449408997813	INSR;APOE
Congenital hypoplasia of lung	2/125	0.0020540861697512826	0.012312398516031288	0	0	35.89159891598916	222.09449408997813	APOE;EGFR
Generalized seizures	2/126	0.002086590580927387	0.012397520644574417	0	0	35.60035842293907	219.73338118483002	NOS2;APOE
Left-Sided Heart Failure	2/126	0.002086590580927387	0.012397520644574417	0	0	35.60035842293907	219.73338118483002	NOS2;APOE
Memory Loss	2/126	0.002086590580927387	0.012397520644574417	0	0	35.60035842293907	219.73338118483002	APOE;EGFR
Acute leukemia	3/492	0.0021069659463117947	0.012482083973485618	0	0	14.95398773006135	92.15404369321062	HSP90AB1;STAT1;INSR
Renal glomerular disease	2/127	0.002119340192099299	0.012518893227749347	0	0	35.31377777777778	217.41458651355765	APOE;HBA1
beta^+^ Thalassemia	2/128	0.0021523347743621375	0.012676939888416994	0	0	35.03174603174603	215.13703175337076	APOE;HBA1
Seizures, Focal	2/129	0.002185574097671191	0.012798520364460692	0	0	34.75415573053368	212.8996742085833	NOS2;APOE
Pervasive Development Disorder	2/129	0.002185574097671191	0.012798520364460692	0	0	34.75415573053368	212.8996742085833	NOS2;APOE
Delayed Puberty	2/130	0.0022190579336778867	0.012920131006399615	0	0	34.48090277777778	210.70150532276614	STAT1;INSR
Primary sclerosing cholangitis	2/130	0.0022190579336778867	0.012920131006399615	0	0	34.48090277777778	210.70150532276614	NOS2;EGFR
Cervix carcinoma	4/1105	0.0022359234248128137	0.012981132569198965	0	0	9.803036200856365	59.828919754053715	STAT1;TAP1;HBA1;EGFR
Pseudohyperkalemia Cardiff	2/131	0.002252786052583026	0.01304176996822994	0	0	34.21188630490956	208.54154935693353	STAT1;APOE
precancerous lesions	2/132	0.002286758225307723	0.013200831573367308	0	0	33.947008547008544	206.41886204725594	BHLHE41;EGFR
Vesicular Stomatitis	2/133	0.0023209742239260786	0.013285125698641667	0	0	33.68617472434266	204.33252935417062	STAT1;APOE
Lewy Body Disease	2/133	0.0023209742239260786	0.013285125698641667	0	0	33.68617472434266	204.33252935417062	INSR;APOE
beta Thalassemia	2/133	0.0023209742239260786	0.013285125698641667	0	0	33.68617472434266	204.33252935417062	APOE;HBA1
Skin Carcinogenesis	2/134	0.0023554338192288255	0.013444498653575767	0	0	33.42929292929293	202.2816663112128	STAT1;EGFR
Malignant neoplasm of large intestine	3/516	0.0024136644726466924	0.013738280695848962	0	0	14.236842105263158	85.79988301603454	STAT1;IRS2;EGFR
Periodontal Diseases	2/137	0.0024602719008962578	0.013964448331344121	0	0	32.681481481481484	196.33345769415402	STAT1;APOE
Measles	2/138	0.002495703599748119	0.014086860318578273	0	0	32.439542483660134	194.4161659778713	STAT1;EGFR
Psoriasis vulgaris	2/138	0.002495703599748119	0.014086860318578273	0	0	32.439542483660134	194.4161659778713	NOS2;APOE
delta-Thalassemia	1/5	0.002747205358336921	0.015312380949148609	0	0	499.625	2946.3741195064317	HBA1
Frontotemporal dementia	2/145	0.0027505014992319104	0.015312380949148609	0	0	30.840714840714842	181.83599179531822	NOS2;APOE
Mammary Carcinoma, Animal	2/145	0.0027505014992319104	0.015312380949148609	0	0	30.840714840714842	181.83599179531822	HBA1;EGFR
Thrombocythemia, Essential	2/145	0.0027505014992319104	0.015312380949148609	0	0	30.840714840714842	181.83599179531822	STAT1;IRS2
Animal Mammary Neoplasms	2/145	0.0027505014992319104	0.015312380949148609	0	0	30.840714840714842	181.83599179531822	HBA1;EGFR
Lung Neoplasms	4/1177	0.0028196845305211295	0.015559239212887545	0	0	9.16624040920716	53.816191518505015	NOS2;BHLHE41;APOE;EGFR
Glaucoma, Primary Open Angle	2/147	0.0028254720814741654	0.015559239212887545	0	0	30.412260536398467	178.49198459045135	NOS2;APOE
Monosomy	2/147	0.0028254720814741654	0.015559239212887545	0	0	30.412260536398467	178.49198459045135	STAT1;EGFR
Depressive Symptoms	2/147	0.0028254720814741654	0.015559239212887545	0	0	30.412260536398467	178.49198459045135	APOE;EGFR
Low-set, posteriorly rotated ears	2/149	0.0029014043048095467	0.015574692498758282	0	0	29.99546485260771	175.25031561215707	INSR;HBA1
Pulmonary Hypertension	2/151	0.002978296357627942	0.015574692498758282	0	0	29.58985831469053	172.10656534950311	NOS2;APOE
Aneurysm	2/152	0.0030171017548155797	0.015574692498758282	0	0	29.391111111111112	170.57009631274764	STAT1;APOE
Osteochondrodysplasias	2/152	0.0030171017548155797	0.015574692498758282	0	0	29.391111111111112	170.57009631274764	STAT1;EGFR
Cervical Squamous Cell Carcinoma	2/153	0.003056146430416555	0.015574692498758282	0	0	29.194996320824135	169.0565600918128	APOE;EGFR
Hypercholesterolemia, Familial	2/154	0.0030954301593536697	0.015574692498758282	0	0	29.001461988304094	167.5654706378346	APOE;EGFR
Invasive Carcinoma	2/154	0.0030954301593536697	0.015574692498758282	0	0	29.001461988304094	167.5654706378346	STAT1;EGFR
Focal glomerulosclerosis	2/155	0.0031349527155465568	0.015574692498758282	0	0	28.81045751633987	166.0963552659853	NOS2;APOE
Biliary cirrhosis	2/155	0.0031349527155465568	0.015574692498758282	0	0	28.81045751633987	166.0963552659853	NOS2;STAT1
Myoclonic Seizures	2/156	0.0031747138731931905	0.015574692498758282	0	0	28.62193362193362	164.64875419279534	NOS2;APOE
Anoxia-Ischemia, Brain	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
Anoxia-Ischemia, Cerebral	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
RIPPLING MUSCLE DISEASE 1	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	EGFR
Scleritis	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	STAT1
Sea-Blue Histiocyte Syndrome	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Fibrocalculous pancreatic diabetes	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	INSR
Serrated polyp	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	EGFR
Shift-Work Sleep Disorder	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	BHLHE40
Giant cell carcinoma of lung	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	EGFR
Sleep-wake cycle disturbance	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Speech Sound Disorders	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Splenic Neoplasms	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	EGFR
Squamous cell carcinoma of pharynx	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	EGFR
Squamous Lung Dysplasia	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	EGFR
Hemoglobin E disease	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	HBA1
Stunned Myocardium	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
Subcortical Vascular Dementia	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Tension Headache	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Sleep Disorders, Circadian Rhythm	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	BHLHE40
Subarachnoid Hemorrhage, Aneurysmal	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
Subarachnoid Hemorrhage, Intracranial	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
Subarachnoid Hemorrhage, Spontaneous	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
Troyer syndrome	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	EGFR
Idiopathic normal pressure hydrocephalus (INPH)	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Immune dysregulation	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	STAT1
Acute and subacute liver necrosis (disorder)	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
Insulin resistance - type A	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	INSR
Intestinal-Type Sinonasal Adenocarcinoma	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	EGFR
Intracranial Atherosclerosis	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Iodine deficiency syndrome	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Anoxic-Ischemic Encephalopathy	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
LIPOPROTEIN GLOMERULOPATHY	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Localized amyloidosis	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Arcus juvenilis	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Bonnevie-Ullrich Syndrome	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
Mixed dementia	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Multiple Chemical Sensitivity	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
Mydriasis	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Nasal and nasal-type NK/T-cell lymphoma	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
Cerebral Hypoxia-Ischemia	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
Non-24 Hour Sleep-Wake Disorder	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	BHLHE40
Non-Metastatic Childhood Soft Tissue Sarcoma	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	EGFR
Nonorganic Sleep Wake Cycle Disorders	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	BHLHE40
Perinatal Subarachnoid Hemorrhage	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	NOS2
Pleomorphic carcinoma	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	EGFR
Pleural Neoplasms	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	EGFR
Dementia in Parkinson's disease	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Primary Cutaneous B-Cell Non-Hodgkin Lymphoma	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	APOE
Primary Hypothyroidism	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	STAT1
Disseminated Bacillus Calmette-Guerin infection	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	STAT1
Dominant beta-thalassemia	1/6	0.0032958256764104633	0.015574692498758282	0	0	399.68	2284.210591570385	HBA1
Malignant neoplasm of endometrium	3/577	0.003315049093622778	0.015629187374110173	0	0	12.684015679442508	72.41663313595384	INSR;BHLHE41;EGFR
Mammary Neoplasms, Experimental	2/160	0.003336140014377649	0.015692214141702274	0	0	27.89170182841069	159.06472502564156	HBA1;EGFR
Uterine Corpus Cancer	3/579	0.003347668952041562	0.015710076929673102	0	0	12.638671875	72.03399673700932	INSR;BHLHE41;EGFR
Neoplasms	4/1236	0.0033716147530352815	0.01578599349808224	0	0	8.699907235621522	49.523034350741035	NOS2;STAT1;INSR;EGFR
androgen independent prostate cancer	2/163	0.0034597039044708977	0.016161191572149115	0	0	27.36783988957902	155.0818426167617	NOS2;EGFR
Hodgkin Disease	3/592	0.003564579270710114	0.016479657201094244	0	0	12.35144312393888	69.62149369164025	STAT1;TAP1;APOE
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	2/166	0.003585399012736539	0.016479657201094244	0	0	26.863143631436316	151.2632862407391	NOS2;TAP1
Malignant neoplasm of brain	2/166	0.003585399012736539	0.016479657201094244	0	0	26.863143631436316	151.2632862407391	INSR;EGFR
Hereditary hemochromatosis	2/167	0.0036277699397877553	0.016479657201094244	0	0	26.6989898989899	150.02528630649724	APOE;EGFR
Progressive Neoplastic Disease	2/167	0.0036277699397877553	0.016479657201094244	0	0	26.6989898989899	150.02528630649724	APOE;EGFR
Fibrosis	2/169	0.0037132192855120413	0.016479657201094244	0	0	26.37658017298736	147.59954565176596	STAT1;EGFR
Tuberculosis, Pulmonary	2/169	0.0037132192855120413	0.016479657201094244	0	0	26.37658017298736	147.59954565176596	NOS2;EGFR
Progressive cGVHD	2/169	0.0037132192855120413	0.016479657201094244	0	0	26.37658017298736	147.59954565176596	APOE;EGFR
Tuberculosis	3/602	0.0037372414214943707	0.016479657201094244	0	0	12.1389816360601	67.84971533330258	NOS2;STAT1;TAP1
Complete atrioventricular block	2/170	0.0037562972571568037	0.016479657201094244	0	0	26.21825396825397	146.4111613938945	STAT1;TAP1
Colitis	3/608	0.003843287150170128	0.016479657201094244	0	0	12.01487603305785	66.81985897412955	NOS2;STAT1;EGFR
Endotoxic shock	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	NOS2
Rippling muscle disease	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Fat redistribution	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	APOE
Fibrosis of bile duct	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Hemoglobin M Disease	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	HBA1
Hemolytic disorder	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	HBA1
Subacute Bacterial Endocarditis	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Squamous cell carcinoma, metastatic	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
In situ cancer	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Absent axillary hair	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	APOE
Adenosarcoma	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Advanced breast cancer	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Alpha-thalassemia/mental retardation syndrome (301040) is an allelic disorder	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	HBA1
Arcus Senilis	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	APOE
Lymphoepithelioid lymphoma (clinical)	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	NOS2
Ataxic cerebral palsy	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Benign neoplasm of esophagus	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Memory performance	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	APOE
Metastatic Endometrial Carcinoma	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Bronchial Diseases	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	NOS2
Carcinoma in situ of esophagus	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
NADH cytochrome B5 reductase deficiency	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	APOE
Cerebral Atherosclerosis	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	APOE
Non-small cell lung cancer stage III	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Papillary adenocarcinoma	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Periampullary Adenocarcinoma	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	EGFR
Postoperative confusion	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	APOE
Primary ulcer of intestine	1/7	0.00384417200458596	0.016479657201094244	0	0	333.05	1852.1566750462314	NOS2
Tonic - clonic seizures	2/173	0.0038869416843507875	0.01662792737389642	0	0	25.75438596491228	142.94025790855406	NOS2;APOE
Prostatic Intraepithelial Neoplasias	2/174	0.00393095925369138	0.016780901688027067	0	0	25.603359173126616	141.81372405748354	IRS2;EGFR
Drug Dependence	2/175	0.003975211164777851	0.016934232886433108	0	0	25.45407835581246	140.70193389618012	INSR;EGFR
Mammary Tumorigenesis	2/176	0.00401969719407193	0.0169355609354901	0	0	25.306513409961685	139.60461375564674	IRS2;EGFR
Carcinomatosis	2/176	0.00401969719407193	0.0169355609354901	0	0	25.306513409961685	139.60461375564674	HBA1;EGFR
Intrahepatic Cholangiocarcinoma	2/177	0.00406441711956668	0.0169355609354901	0	0	25.16063492063492	138.52149654290153	NOS2;EGFR
Carcinoma of larynx	2/177	0.00406441711956668	0.0169355609354901	0	0	25.16063492063492	138.52149654290153	INSR;EGFR
Dengue Fever	2/177	0.00406441711956668	0.0169355609354901	0	0	25.16063492063492	138.52149654290153	STAT1;TAP1
Cerebrovascular Disorders	2/178	0.004109370718411461	0.0169355609354901	0	0	25.016414141414142	137.45232156169675	NOS2;APOE
Lymphoma	4/1307	0.004130619448579726	0.0169355609354901	0	0	8.194715491722398	44.98348034609106	NOS2;STAT1;APOE;EGFR
Asthma	4/1313	0.004199739285801892	0.0169355609354901	0	0	8.154534541089163	44.627588899882745	NOS2;STAT1;APOE;EGFR
Gastritis	2/181	0.0042456313335557	0.0169355609354901	0	0	24.593420235878337	134.32593497570505	NOS2;EGFR
insulinoma	2/181	0.0042456313335557	0.0169355609354901	0	0	24.593420235878337	134.32593497570505	STAT1;INSR
Conventional (Clear Cell) Renal Cell Carcinoma	3/631	0.004267028134332532	0.0169355609354901	0	0	11.56110668789809	63.08708261238629	STAT1;BHLHE40;EGFR
Glioma	5/2211	0.004278571421958208	0.0169355609354901	0	0	6.717663946811726	36.63905347370809	NOS2;STAT1;INSR;TAP1;EGFR
Neoplasm Invasiveness	2/183	0.004337636036469348	0.0169355609354901	0	0	24.319214241866174	132.30687989985157	NOS2;EGFR
Delayed bone age	2/183	0.004337636036469348	0.0169355609354901	0	0	24.319214241866174	132.30687989985157	STAT1;INSR
Proteinuria	2/184	0.004383987009758697	0.0169355609354901	0	0	24.184371184371184	131.3162186657197	INSR;APOE
Recurrent mycobacterial infections	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	STAT1
Reflux nephropathy (disorder)	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	NOS2
Amyloidosis, Primary Cutaneous	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	APOE
Aphasia, Progressive	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	APOE
Severe failure to thrive	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	INSR
Sleep-Related Neurogenic Tachypnea	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	BHLHE41
Macular Degeneration, Age-Related, 1	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	APOE
Subwakefullness Syndrome	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	BHLHE41
Histoplasmosis	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	STAT1
HYPERALPHALIPOPROTEINEMIA 1	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	APOE
Thanatophoric dysplasia, type 2	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	STAT1
Vasogenic Brain Edema	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	NOS2
Vasogenic Cerebral Edema	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	NOS2
Wernicke-Korsakoff Syndrome	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	APOE
Xanthelasma of periocular region	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	APOE
Xanthoma of periocular region	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	APOE
Alcohol Withdrawal Seizures	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	APOE
Long Sleeper Syndrome	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	BHLHE41
Melanoma recurrent	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	EGFR
Meningeal Carcinomatosis	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	EGFR
Metastases to adrenals	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	EGFR
Boutonneuse Fever	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	NOS2
Brenner Tumor	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	EGFR
Myocardial Stunning	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	NOS2
Non-obstructive reflux-associated chronic pyelonephritis (disorder)	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	NOS2
Old myocardial infarction	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	APOE
Common ventricle	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	APOE
Pancreatic adenocarcinoma metastatic	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	EGFR
Peritoneal Mesothelioma	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	EGFR
Cytotoxic Brain Edema	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	NOS2
Cytotoxic Cerebral Edema	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	NOS2
Pleural Mesothelioma	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	EGFR
delta beta^0^ Thalassemia	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	HBA1
Prodrome	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	APOE
Effects of heat	1/8	0.004392244396163033	0.0169355609354901	0	0	285.45714285714286	1549.43708775113	NOS2
Childhood Glioblastoma	2/187	0.004524431761429234	0.01741220708186402	0	0	23.78858858858859	128.41706443447274	STAT1;EGFR
Carcinoma, Spindle-Cell	2/188	0.004571709884427514	0.01752776317954096	0	0	23.659498207885303	127.47425305165838	HBA1;EGFR
Familial Alzheimer Disease (FAD)	2/188	0.004571709884427514	0.01752776317954096	0	0	23.659498207885303	127.47425305165838	INSR;APOE
Adult Glioblastoma	2/189	0.004619219241356662	0.017676560260709486	0	0	23.531788472964944	126.54288866714312	STAT1;EGFR
Muscular Dystrophy, Duchenne	2/190	0.004666959611265722	0.017798168828766545	0	0	23.405437352245862	125.62277432326741	NOS2;INSR
Amyotrophic Lateral Sclerosis	3/660	0.004840989628707053	0.017798168828766545	0	0	11.034246575342467	58.81955324572544	NOS2;APOE;EGFR
Recurrent hypoglycemia	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	INSR
Bare Lymphocyte Syndrome, Type I	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	TAP1
eyelids (symptom)	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	APOE
Female Pseudohermaphroditism	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	INSR
Short Sleeper Syndrome	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	BHLHE41
Hypoxia-Ischemia, Brain	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	NOS2
Keratitis, Herpetic	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	APOE
Glycogen storage disease type Ia	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	APOE
Prostatic Cancer, Castration-Resistant	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	EGFR
Thalassemia trait	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	HBA1
Hyperargininemia	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	NOS2
Ileal Pouches	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	NOS2
West Nile Fever	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	STAT1
Adult Soft Tissue Sarcoma	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	EGFR
LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	APOE
Low Grade Prostatic Intraepithelial Neoplasia	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	EGFR
Argyrophilic grain disease	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	APOE
Lung cancer stage I	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	EGFR
Atresia	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	STAT1
Attention deficit-hyperactivity	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	BHLHE40
Avascular Necrosis of Femur Head	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	STAT1
Mature Teratoma	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	EGFR
Metaplastic breast carcinoma	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	EGFR
Bronchial carcinoid	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	EGFR
Carcinoid tumor of lung	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	EGFR
Cardiovascular Pathology	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	NOS2
Cerebral Thrombosis	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	APOE
Peripheral Nervous System Neoplasms	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	EGFR
Premature tooth eruption	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	INSR
Dilatation of the cerebral artery	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	STAT1
Dysglycemia	1/9	0.0049400429229450454	0.017798168828766545	0	0	249.7625	1326.3340991921912	INSR
Chronic Obstructive Airway Disease	3/669	0.005028280694470798	0.01808401127639763	0	0	10.880067567567568	57.58468515269473	NOS2;STAT1;EGFR
Impaired cognition	3/671	0.0050704972966667166	0.018203622803580864	0	0	10.846369760479043	57.31564938950441	NOS2;INSR;APOE
Renal fibrosis	2/202	0.0052577828611460094	0.018430971080090293	0	0	21.98777777777778	115.39286592575218	STAT1;EGFR
Reticulocyte count (procedure)	2/202	0.0052577828611460094	0.018430971080090293	0	0	21.98777777777778	115.39286592575218	IRS2;APOE
Melanocytic nevus	2/203	0.0053085063609301	0.018430971080090293	0	0	21.877280265339966	114.60292441530726	NOS2;EGFR
Liver Cirrhosis	3/683	0.00532838007030582	0.018430971080090293	0	0	10.648345588235294	55.74097998414238	STAT1;APOE;EGFR
MYELODYSPLASTIC SYNDROME	3/683	0.00532838007030582	0.018430971080090293	0	0	10.648345588235294	55.74097998414238	NOS2;IRS2;HBA1
Anaplastic carcinoma	2/204	0.0053594577958809494	0.018430971080090293	0	0	21.76787678767877	113.82188694681741	HBA1;EGFR
Papilloma	2/204	0.0053594577958809494	0.018430971080090293	0	0	21.76787678767877	113.82188694681741	APOE;EGFR
Squamous cell carcinoma of skin	2/205	0.005410636946465624	0.018430971080090293	0	0	21.659551176792554	113.04961141831744	STAT1;EGFR
Cervical Intraepithelial Neoplasia	2/205	0.005410636946465624	0.018430971080090293	0	0	21.659551176792554	113.04961141831744	TAP1;EGFR
Fasting hyperinsulinemia	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	INSR
Severe beta thalassemia	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	HBA1
Severe dementia	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	APOE
Generalized osteoporosis with pathologic fractures	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	STAT1
Lipomatosis, Multiple Symmetrical	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	NOS2
Hallermann's Syndrome	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	APOE
Hypochromic anemia	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	HBA1
Abnormal hemoglobin finding	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	HBA1
Increased size of penis	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	INSR
Adenosquamous cell lung cancer	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	EGFR
Xanthoma tendinosum	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	APOE
Advanced Sleep Phase Syndrome	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	BHLHE40
Bladder Adenocarcinoma	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	EGFR
Merkel Cell Polyomavirus Infection	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	EGFR
Metastatic Malignant Neoplasm to the Leptomeninges	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	EGFR
Mild dementia	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	APOE
Miller-McKusick-Malvaux-Syndrome (3M Syndrome)	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	INSR
Burn injury	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	NOS2
Cancer Cell Growth	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	EGFR
cervical cancer metastasis	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	EGFR
Childhood Soft Tissue Sarcoma	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	EGFR
clinical depression	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	APOE
Osteitis	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	NOS2
cortex bone disorders	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	APOE
Polygenic hypercholesterolemia	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	APOE
Dementia due to Alzheimer's disease (disorder)	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	APOE
Dementia of frontal lobe type	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	APOE
Denys-Drash Syndrome	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	EGFR
Distemper	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	STAT1
Dysphoric mood	1/10	0.005487567669022947	0.018430971080090293	0	0	222.0	1155.5699775561973	APOE
Visual seizure	2/207	0.005513677519399177	0.018457648631662483	0	0	21.446070460704608	111.53079238540442	NOS2;APOE
Polycythemia Vera	2/207	0.005513677519399177	0.018457648631662483	0	0	21.446070460704608	111.53079238540442	STAT1;HBA1
Adenoid Cystic Carcinoma	2/208	0.005565538504975746	0.01860061552978736	0	0	21.340884573894282	110.78397907044943	NOS2;EGFR
Trisomy	2/209	0.005617626332017772	0.01871314214206576	0	0	21.23671497584541	110.0453879342315	HBA1;EGFR
Myxoid cyst	2/209	0.005617626332017772	0.01871314214206576	0	0	21.23671497584541	110.0453879342315	NOS2;APOE
Pancreatic Ductal Adenocarcinoma	3/701	0.005730063304797319	0.019036119630432134	0	0	10.364075931232092	53.49965740971864	BHLHE41;TAP1;EGFR
Recurrent respiratory infections	2/213	0.005828241690106335	0.019036119630432134	0	0	20.82991047919958	107.17072096641114	STAT1;INSR
Carcinoma	2/216	0.00598857436322126	0.019036119630432134	0	0	20.53478712357217	105.09502599440822	HBA1;EGFR
Dyslipidemias	2/216	0.00598857436322126	0.019036119630432134	0	0	20.53478712357217	105.09502599440822	INSR;APOE
Recurrent Endometrial Cancer	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	EGFR
Eyelid Xanthoma	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	APOE
Dendritic Cell Sarcoma, Follicular	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	EGFR
DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	INSR
Electron Transport Chain Deficiencies, Mitochondrial	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	NOS2
Short Bowel Syndrome	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	INSR
Sinonasal undifferentiated carcinoma	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	EGFR
INSULIN RESISTANCE, SUSCEPTIBILITY TO	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	INSR
Small face	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	INSR
Parkinson Disease, Secondary Vascular	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	NOS2
Thick nasal alae	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	INSR
Hypersensitive syndrome	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	APOE
Lipoatrophic Diabetes Mellitus	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	INSR
Apraxia of Phonation	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	APOE
Atherosclerotic Parkinsonism	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	NOS2
Malignant neoplasm of body of pancreas	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	APOE
Malignant neoplasm of fallopian tube	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	EGFR
malignant neoplasm of head of pancreas	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	APOE
Malignant neoplasm of other specified sites of pancreas	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	APOE
Malignant neoplasm of tail of pancreas	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	APOE
Malignant tumor of parathyroid gland	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	EGFR
Metaplastic carcinoma	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	NOS2
Multiple Endocrine Neoplasia Type 2b	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	EGFR
pediatric AIDS	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	NOS2
Delayed Sleep Phase Syndrome	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	BHLHE40
Postherpetic neuralgia	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	APOE
Primary Progressive Nonfluent Aphasia	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	APOE
Pulmonary Blastoma	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	EGFR
Pyogenic granuloma	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	NOS2
Elfin facies	1/11	0.006034818727760455	0.019036119630432134	0	0	199.79	1020.9687483548147	INSR
synovial sarcoma	2/217	0.006042469075604687	0.019036119630432134	0	0	20.43824289405685	104.4178090387619	HBA1;EGFR
Nasal Polyps	2/219	0.0061509329311502485	0.01934782618590914	0	0	20.247823860727088	103.08473907431406	TAP1;EGFR
Leukemogenesis	3/730	0.006415300292702791	0.019725973265607176	0	0	9.935694635488309	50.166012457109815	HSP90AB1;NOS2;EGFR
B-Cell Lymphomas	3/730	0.006415300292702791	0.019725973265607176	0	0	9.935694635488309	50.166012457109815	NOS2;INSR;IRS2
Exanthema	2/225	0.006481704325062646	0.019725973265607176	0	0	19.69706028898854	99.24899173152043	STAT1;EGFR
Gastrointestinal Carcinoid Tumor	2/225	0.006481704325062646	0.019725973265607176	0	0	19.69706028898854	99.24899173152043	STAT1;EGFR
Pulmonary Emphysema	2/225	0.006481704325062646	0.019725973265607176	0	0	19.69706028898854	99.24899173152043	NOS2;TAP1
Graft-vs-Host Disease	2/226	0.006537615175765244	0.019725973265607176	0	0	19.60813492063492	98.63250364607059	STAT1;EGFR
Endotoxemia	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	NOS2
Recurrent respiratory papillomatosis	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	TAP1
Alport Syndrome, X-Linked	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	APOE
Arterial Diseases, Common Carotid	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	APOE
External Carotid Artery Diseases	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	APOE
Cerebral Infarction, Left Hemisphere	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	HBA1
Cerebral Infarction, Right Hemisphere	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	HBA1
Secondary Parkinson Disease	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	NOS2
Senile dementia	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	APOE
Sleep Wake Disorders	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	BHLHE41
Stage IV Colorectal Cancer	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	EGFR
Hypoglycemic seizures	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	INSR
Internal Carotid Artery Diseases	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	APOE
Anterior Choroidal Artery Infarction	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	HBA1
Aplasia/Hypoplasia of the earlobes	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	HBA1
Asperger Syndrome	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	NOS2
Aspiration Pneumonia	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	NOS2
Lymphoepithelial carcinoma	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	EGFR
Malignant neoplasm of anus	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	EGFR
Childhood Ependymoma	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	EGFR
Non-small cell lung cancer recurrent	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	EGFR
Paronychia Inflammation	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	EGFR
Decreased circulating high-density lipoprotein levels	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	APOE
Delta-Beta Thalassemia	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	HBA1
Posterior Choroidal Artery Infarction	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	HBA1
Progressive multiple sclerosis	1/12	0.006581796197874835	0.019725973265607176	0	0	181.61818181818182	912.3494182081016	APOE
Ki-1+ Anaplastic Large Cell Lymphoma	2/228	0.0066501054637537966	0.019901346542485588	0	0	19.432645034414946	97.41823132411149	NOS2;INSR
Short stature	3/750	0.006915708490923918	0.020258898420528144	0	0	9.659638554216867	48.046654450127434	STAT1;INSR;HBA1
Gallbladder Carcinoma	2/233	0.006935221207731	0.020258898420528144	0	0	19.007215007215006	94.48757106794531	NOS2;EGFR
Chronic myeloproliferative disorder	2/233	0.006935221207731	0.020258898420528144	0	0	19.007215007215006	94.48757106794531	NOS2;IRS2
Epstein-Barr Virus Infections	2/234	0.0069929094949092874	0.020258898420528144	0	0	18.924329501915707	93.91877089900699	TAP1;EGFR
Tumor Initiation	2/234	0.0069929094949092874	0.020258898420528144	0	0	18.924329501915707	93.91877089900699	IRS2;EGFR
Plaque, Amyloid	2/235	0.00705081899238985	0.020258898420528144	0	0	18.84215546018121	93.35556012350106	NOS2;APOE
Sarcoidosis	2/236	0.007108949487609114	0.020258898420528144	0	0	18.76068376068376	92.79786111501161	STAT1;TAP1
Adenocarcinoma, intestinal type	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	EGFR
Angina Pectoris, Variant	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	APOE
Erythrocytosis	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	HBA1
Restrictive behavior	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	APOE
Cerebral Amyloid Angiopathy, Hereditary	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	APOE
Hallucinations, Visual	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	APOE
Hypothermia, Accidental	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	NOS2
Hearing abnormality	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	INSR
Stage IV Colorectal Cancer AJCC v7	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	EGFR
stage, pancreatic cancer	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	EGFR
Hypoglycemic coma	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	INSR
Abnormality of the abdominal wall	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	INSR
Islets of Langerhans hyperplasia	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	INSR
Age-related cognitive decline	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	APOE
Lecithin Acyltransferase Deficiency	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	APOE
Low density lipoprotein increased	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	APOE
Macular retinal edema	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	APOE
Malignant Mixed Mesodermal (Mullerian) Tumor	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	EGFR
Mediastinal lymphadenopathy	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	APOE
MILES-CARPENTER X-LINKED MENTAL RETARDATION SYNDROME	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	NOS2
Cerebral metastasis	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	EGFR
Nonspherocytic hemolytic anemia	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	HBA1
obsolete Combined hyperlipidemia	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	APOE
Occupational Diseases	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	EGFR
Oxidative Phosphorylation Deficiencies	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	NOS2
Curling Ulcer	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	NOS2
Pimples	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	EGFR
Proximal spinal muscular atrophy	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	APOE
pustule	1/13	0.00712850018242009	0.020258898420528144	0	0	166.475	822.994869532877	EGFR
Undifferentiated carcinoma	2/237	0.007167300763256765	0.0203123502802479	0	0	18.679905437352247	92.24559765664816	HBA1;EGFR
Cognition Disorders	2/237	0.007167300763256765	0.0203123502802479	0	0	18.679905437352247	92.24559765664816	NOS2;APOE
Hepatitis B, Chronic	2/238	0.0072258726070103954	0.020449823311204908	0	0	18.59981167608286	91.69869488433835	NOS2;STAT1
Medullary carcinoma of thyroid	2/239	0.007284664803173953	0.02058753668991582	0	0	18.52039381153305	91.15707927882511	NOS2;EGFR
Hypercholesterolemia	2/240	0.00734367713905345	0.02072548881466196	0	0	18.441643323996264	90.62067861983672	APOE;HBA1
Familial hypobetalipoproteinemia	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	APOE
Semantic Dementia	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	APOE
Familial Partial Lipodystrophy, Type 2	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	INSR
Hydatidiform Mole, Partial	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	EGFR
Genital ulcers	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	APOE
Supratentorial Embryonal Tumor, Not Otherwise Specified	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	EGFR
Abnormality of the thyroid gland	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	INSR
Venous Engorgement	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	NOS2
Active Hyperemia	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	NOS2
Adenocarcinoma of small intestine	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	EGFR
ALZHEIMER DISEASE 2	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	APOE
Anal squamous cell carcinoma	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	EGFR
ARTERIAL TORTUOSITY SYNDROME	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	APOE
B lymphocytopenia	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	STAT1
Manganese Poisoning	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	NOS2
Methemoglobinemia	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	HBA1
Myxoma of heart	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	EGFR
Corticobasal degeneration	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	APOE
Reactive Hyperemia	1/14	0.007674930787541144	0.021103463275079302	0	0	153.66153846153847	748.3003458854362	NOS2
Gastroesophageal reflux disease	2/246	0.007702362085675535	0.021121727068950998	0	0	17.982695810564664	87.5079020550734	NOS2;EGFR
Leukopenia	2/246	0.007702362085675535	0.021121727068950998	0	0	17.982695810564664	87.5079020550734	NOS2;STAT1
Splenomegaly	2/247	0.0077629094050822925	0.02117779171931359	0	0	17.908390022675736	87.00608791190685	APOE;HBA1
Acute myocardial infarction	2/247	0.0077629094050822925	0.02117779171931359	0	0	17.908390022675736	87.00608791190685	APOE;HBA1
Diabetic Retinopathy	2/247	0.0077629094050822925	0.02117779171931359	0	0	17.908390022675736	87.00608791190685	NOS2;APOE
Nasopharyngeal carcinoma	3/782	0.00776449548764204	0.02117779171931359	0	0	9.247432605905006	44.925819725178435	NOS2;STAT1;EGFR
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	2/249	0.00788465912083938	0.021472045073650897	0	0	17.76158344579397	86.01644089420382	STAT1;INSR
Immune System Diseases	2/250	0.00794586109135659	0.021472045073650897	0	0	17.689068100358423	85.5284857560142	STAT1;EGFR
Brain Diseases	2/250	0.00794586109135659	0.021472045073650897	0	0	17.689068100358423	85.5284857560142	NOS2;APOE
Alzheimer Disease, Late Onset	2/253	0.008130772898644877	0.021472045073650897	0	0	17.474988933156265	84.09138188093604	INSR;APOE
Recurrent hepatitis	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	APOE
Reiter Syndrome	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	TAP1
Executive dysfunction	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	APOE
Carcinoma of urinary bladder, invasive	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	INSR
Chromosome 10, monosomy 10q	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	EGFR
Salivary gland carcinoma	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	EGFR
Gastroschisis	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	NOS2
Genital Herpes	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	APOE
Smoker's lung	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	EGFR
Stage 0 Breast Carcinoma	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	EGFR
Hemoglobin H Disease	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	HBA1
Symmetric Diabetic Proximal Motor Neuropathy	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	INSR
Systolic hypertension	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	APOE
Humoral hypercalcemia of malignancy (disorder)	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	EGFR
Thalassemia Minor	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	HBA1
Thanatophoric Dysplasia	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	STAT1
Thyroid stimulating hormone measurement	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	INSR
Uterine Corpus Carcinosarcoma	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	EGFR
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	APOE
Left ventricular systolic dysfunction	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	APOE
Anovulation	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	INSR
Asymmetric Diabetic Proximal Motor Neuropathy	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	INSR
Mast-Cell Sarcoma	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	NOS2
Diabetic Amyotrophy	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	INSR
Diabetic Asymmetric Polyneuropathy	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	INSR
Diabetic Autonomic Neuropathy	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	INSR
Diabetic Mononeuropathy	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	INSR
Pulmonary Fibrosis - from Asbestos Exposure	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	NOS2
Rapidly progressive glomerulonephritis	1/15	0.008221088123671455	0.021472045073650897	0	0	142.67857142857142	685.0073410932765	EGFR
Acute Coronary Syndrome	2/255	0.008255133559476517	0.02153328805244709	0	0	17.335090030742204	83.15504046063784	APOE;EGFR
Behcet Syndrome	2/258	0.008443299491210594	0.021995877648897343	0	0	17.12934027777778	81.7820158090184	NOS2;TAP1
Muscle degeneration	2/259	0.008506453938582867	0.02204763331131893	0	0	17.06182447038478	81.33252491383246	INSR;BHLHE40
Sjogren's Syndrome	2/260	0.008569824269318392	0.02204763331131893	0	0	16.99483204134367	80.88703994168587	STAT1;EGFR
Malignant Pleural Mesothelioma	2/260	0.008569824269318392	0.02204763331131893	0	0	16.99483204134367	80.88703994168587	STAT1;EGFR
Renal Insufficiency	2/263	0.008761228438547198	0.02204763331131893	0	0	16.796934865900383	79.57412091441385	NOS2;APOE
Reoviridae Infections	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	STAT1
Glioblastoma, IDH-Mutant	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	EGFR
Skin Manifestations	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	EGFR
Growth hormone excess	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	INSR
Other specified forms of pleural effusion, except tuberculous	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	NOS2
Hereditary persistence of fetal hemoglobin thalassemia	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	HBA1
Homozygous alpha thalassemia	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	HBA1
SPHEROCYTOSIS, TYPE 1 (disorder)	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	EGFR
Thyroxine measurement	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	INSR
Tonsillitis	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	EGFR
Idiopathic bronchiectasis	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	TAP1
Achalasia	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	NOS2
Adenocarcinoma of salivary gland	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	EGFR
Inverted Papilloma	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	EGFR
alpha^0^ Thalassemia	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	HBA1
Myxoma of the Endocardium	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	EGFR
Neurofibrillary degeneration (morphologic abnormality)	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	APOE
Non-small cell carcinoma	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	EGFR
Chronic rhinitis	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	NOS2
Common Cold	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	NOS2
Ovarian Granulosa Cell Tumor	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	EGFR
Paracoccidioidomycosis	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	NOS2
Pleomorphic Xanthoastrocytoma	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	EGFR
Preleukemia	1/16	0.008766972300957528	0.02204763331131893	0	0	133.16	630.7474630602054	HBA1
Brain Ischemia	2/264	0.008825460184136635	0.022139919869340302	0	0	16.73197625106022	79.1441640144041	NOS2;APOE
Myeloproliferative disease	2/264	0.008825460184136635	0.022139919869340302	0	0	16.73197625106022	79.1441640144041	IRS2;HBA1
Trichohepatoenteric Syndrome	2/267	0.009019443536860237	0.0225708242203202	0	0	16.540041928721173	77.87668086435498	INSR;APOE
Adenocarcinoma of colon	2/267	0.009019443536860237	0.0225708242203202	0	0	16.540041928721173	77.87668086435498	NOS2;EGFR
Familial Intestinal Polyposis	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	EGFR
Gonadal Dysgenesis, 45,X	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	NOS2
Polyposis, Adenomatous Intestinal	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	EGFR
Hypopharyngeal Carcinoma	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	EGFR
Alagille Syndrome	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	APOE
Anal carcinoma	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	EGFR
Lipoprotein (a) measurement	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	APOE
Long foot	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	INSR
Macroangiopathy	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	APOE
Meconium Aspiration Syndrome	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	NOS2
Memory dysfunction	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	APOE
Mesangial proliferative glomerulonephritis	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	NOS2
Brain Stem Glioma	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	EGFR
Central nervous system lesion	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	EGFR
Chronic sinus disease	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	TAP1
Onychogryposis	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	INSR
Parainfluenza	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	STAT1
Parasitic infection	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	NOS2
Dermoid Cyst	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	EGFR
Psychological symptom	1/17	0.009312583434128836	0.022744194156430045	0	0	124.83125	583.7594513941907	APOE
Cerebral Ischemia	2/275	0.009546141626974149	0.02313082766968489	0	0	16.04884004884005	74.65307684917254	NOS2;APOE
Central neuroblastoma	4/1655	0.009600888596375682	0.02313082766968489	0	0	6.346975858786882	29.487412747430326	NOS2;STAT1;APOE;EGFR
Congenital Heart Defects	2/277	0.00967994549428526	0.02313082766968489	0	0	15.930505050505051	73.88088747707648	APOE;EGFR
Infant, Premature	2/278	0.009747165676635547	0.02313082766968489	0	0	15.871980676328503	73.4996306151928	NOS2;EGFR
Erythroid hyperplasia	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	HBA1
B-CELL MALIGNANCY, LOW-GRADE	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	EGFR
Central Nervous System Embryonal Tumor, Not Otherwise Specified	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	EGFR
Infarction, Lacunar	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	APOE
Small intestine biopsy shows villous atrophy	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	STAT1
Smith-Lemli-Opitz Syndrome	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	APOE
Hartnup Disease	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	HBA1
Stenosis	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	APOE
Teratoma, Malignant	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	EGFR
Hyperlipoproteinemia Type III	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	APOE
Variable degree of villous atrophy	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	STAT1
Venous malformation	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	STAT1
Villous atrophy	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	STAT1
Villous atrophy of intestine	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	STAT1
Xanthomatosis	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	APOE
Malignant neoplasm of other specified sites of female breast	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	STAT1
Malignant neoplasm tonsil	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	EGFR
Biopsy shows villous atrophy	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	STAT1
Niemann-Pick Diseases	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	APOE
Nongerminomatous Germ Cell Tumor	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	EGFR
Compression of spinal cord	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	APOE
Congenital hernia of foramen of Bochdalek	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	INSR
Congenital hernia of foramen of Morgagni	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	INSR
Papillomatosis	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	EGFR
Dental Plaque	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	APOE
Diabetic Neuralgia	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	INSR
Diastrophic dysplasia	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	APOE
Primary Cutaneous Anaplastic Large Cell Lymphoma	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	NOS2
Primary Progressive Aphasia (disorder)	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	APOE
Duodenal villous atrophy	1/18	0.009857921634816495	0.02313082766968489	0	0	117.48235294117647	542.7073703814344	STAT1
Byzanthine arch palate	2/280	0.0098822414961246	0.023161147312716478	0	0	15.756195043964828	72.7466033704218	INSR;HBA1
Squamous cell carcinoma of lung	2/283	0.010086440725437709	0.02353994389997788	0	0	15.58560695927244	71.64022832647571	STAT1;EGFR
Lupus Vulgaris	2/284	0.010154929101518861	0.02353994389997788	0	0	15.529550827423169	71.27747128835026	STAT1;EGFR
Neuropathy	2/284	0.010154929101518861	0.02353994389997788	0	0	15.529550827423169	71.27747128835026	INSR;APOE
polyps	2/285	0.01022362811243465	0.02353994389997788	0	0	15.473890851982725	70.91767358892629	NOS2;EGFR
Adenocarcinoma of lung, stage IV	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	EGFR
Eosinophilic leukemia	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	NOS2
Anaplastic Large Cell Lymphoma, ALK-Positive	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	STAT1
Aneurysm, Dissecting	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	APOE
Arteriovenous Malformations, Cerebral	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	EGFR
Exogenous Hyperinsulinism	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	INSR
Fallopian Tube Carcinoma	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	EGFR
Hypothermia, natural	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	NOS2
Somnolence	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	APOE
Squamous cell carcinoma of vulva	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	EGFR
Staphylococcal Infections	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	EGFR
Papilloma, Squamous Cell	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	EGFR
HER2-positive carcinoma of breast	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	EGFR
THANATOPHORIC DYSPLASIA, TYPE I (disorder)	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	STAT1
Thrombosis of cerebral veins	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	APOE
Inflammatory disease of mucous membrane	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	NOS2
Amyloid angiopathy	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	APOE
Lipidemias	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	APOE
Lobular Neoplasia	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	APOE
Massive Osteolyses	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	APOE
CADASIL Syndrome	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	APOE
Carcinoma in situ of endometrium	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	EGFR
Nasal Type Extranodal NK/T-Cell Lymphoma	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	NOS2
Cerebral Small Vessel Diseases	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	APOE
Parathyroid hyperplasia	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	EGFR
Pulmonary Infiltrate	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	APOE
Endogenous Hyperinsulinism	1/19	0.010402987018789436	0.02353994389997788	0	0	110.95	506.5602322657193	INSR
Neuroblastoma	4/1698	0.010505487309959032	0.023745439614946334	0	0	6.171361106426041	28.115842136022813	NOS2;STAT1;APOE;EGFR
Fanconi Anemia	2/290	0.010570275424340537	0.023865332958066632	0	0	15.20138888888889	69.16190225928311	STAT1;INSR
hearing impairment	2/294	0.010851363517033395	0.02420662497954663	0	0	14.990106544901066	67.80721536349225	STAT1;APOE
Adenocarcinoma of lung, stage I	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	EGFR
Enteropathy-Associated T-Cell Lymphoma	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	NOS2
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	EGFR
Squamous cell carcinoma of penis	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	EGFR
Thymoma, type C	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	EGFR
Tonsillar Carcinoma	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	EGFR
Idiopathic Nephrotic Syndrome	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	APOE
Beta thalassemia intermedia	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	HBA1
Carcinoma ex pleomorphic adenoma	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	EGFR
Cerebral Vasospasm	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	APOE
Cholesteryl Ester Transfer Protein Deficiency	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	APOE
Chronic multifocal osteomyelitis	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	STAT1
Clear cell sarcoma of kidney	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	EGFR
Compensatory Hyperinsulinemia	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	INSR
Congenital abnormality of vein	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	STAT1
Corneal pannus	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	NOS2
Pouchitis	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	NOS2
Dyslipoproteinemias	1/20	0.010947779702855981	0.02420662497954663	0	0	105.10526315789474	474.5101770765117	APOE
Kidney Failure	2/297	0.01106437019141297	0.02443782633581647	0	0	14.835404896421846	66.81903789267928	APOE;EGFR
Fibrosarcoma	2/298	0.011135788570771462	0.02456886251444909	0	0	14.784534534534535	66.49479185195716	STAT1;EGFR
Hereditary Diffuse Gastric Cancer	2/300	0.01127924832181666	0.024858386756975544	0	0	14.683818046234153	65.85385022173678	IRS2;EGFR
Pancreatitis, Chronic	2/302	0.011423537356484026	0.024895898933651475	0	0	14.584444444444445	65.22279314787393	APOE;EGFR
Fibrolamellar Hepatocellular Carcinoma	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	EGFR
Shared Paranoid Disorder	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	APOE
Siderosis	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	APOE
Simple renal cyst	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	EGFR
Polyarticular Juvenile Idiopathic Arthritis, Rheumatoid Factor Negative	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	STAT1
Herpes encephalitis	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	STAT1
Hypoalphalipoproteinemias	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	APOE
Xanthoma	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	APOE
Amyloid nephropathy	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	APOE
Asthma chronic	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	EGFR
Microcytic hypochromic anemia (disorder)	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	HBA1
Pancreatic Intraductal Papillary-Mucinous Neoplasm	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	EGFR
Paraplegia	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	NOS2
Periapical Granuloma	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	NOS2
Diabetic Ketoacidosis	1/21	0.011492299803033998	0.024895898933651475	0	0	99.845	445.91556292503236	INSR
Fetal Growth Retardation	2/304	0.011568654024928089	0.02500798401984455	0	0	14.486387049300957	64.60140677148877	INSR;APOE
Lupus Erythematosus	2/304	0.011568654024928089	0.02500798401984455	0	0	14.486387049300957	64.60140677148877	STAT1;EGFR
Acute lymphocytic leukemia	3/907	0.011667927958704272	0.02519578067171847	0	0	7.916897123893805	35.237407671327965	NOS2;STAT1;INSR
Serum total cholesterol measurement	2/307	0.011787877240255658	0.02539799002665327	0	0	14.341712204007287	63.687006583537446	NOS2;APOE
Inflammatory Bowel Diseases	3/911	0.011808727039433406	0.02539799002665327	0	0	7.880368942731278	34.98029926301954	NOS2;APOE;EGFR
Crohn Disease	3/912	0.01184408382244358	0.02539799002665327	0	0	7.871287128712871	34.91645345832282	NOS2;TAP1;APOE
Infection caused by Helicobacter pylori	2/308	0.011861363680670488	0.02539799002665327	0	0	14.294117647058824	63.386820309135295	NOS2;EGFR
Lupus Erythematosus, Discoid	2/309	0.0119350557965222	0.02539799002665327	0	0	14.24683315237061	63.08889998113216	STAT1;EGFR
Renal Artery Stenosis	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	STAT1
Breast cancer, lobular	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	EGFR
Familial generalized lipodystrophy	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	INSR
Severe depression	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	APOE
Squamous cell carcinoma of tonsil	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	EGFR
Hemoglobin F Disease	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	HBA1
Herpes zoster disease	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	APOE
Histiocytosis haematophagic	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	NOS2
THYROID CARCINOMA, SPORADIC MEDULLARY	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	EGFR
ANOPHTHALMIA AND PULMONARY HYPOPLASIA	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	EGFR
Liver calculus	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	EGFR
Bare Lymphocyte Syndrome	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	TAP1
Basal-Like Breast Carcinoma	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	EGFR
Cluster Headache	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	NOS2
Diabetic Polyneuropathies	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	INSR
Disorder of Achilles tendon	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	NOS2
Disorder of skeletal system	1/22	0.012036547438812547	0.02539799002665327	0	0	95.08571428571429	420.26056624547704	EGFR
Cholestasis	2/315	0.01238151619941701	0.026085328753387843	0	0	13.969471068512602	61.3476383198158	NOS2;INSR
Esophageal Achalasia	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	NOS2
response to statin	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	APOE
Exfoliation Syndrome	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	APOE
Retinal Vein Occlusion	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	APOE
Hypobetalipoproteinemias	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	APOE
Varicocele	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	STAT1
Job Syndrome	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	STAT1
Andersen Syndrome	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	APOE
Lipids measurement	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	APOE
beta^0^ Thalassemia	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	HBA1
Camurati-Engelmann Syndrome	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	APOE
Multi-infarct dementia	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	APOE
Capillary malformation (disorder)	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	STAT1
Cellulitis of eyelid	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	APOE
Neuroepithelioma	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	EGFR
Petechiae	1/23	0.012580522725551224	0.026085328753387843	0	0	90.75909090909092	397.1259752205777	APOE
High density lipoprotein measurement	2/324	0.013064979438067484	0.026598018947177886	0	0	13.5728088336784	58.876400988234316	NOS2;APOE
T-Cell Lymphoma	2/324	0.013064979438067484	0.026598018947177886	0	0	13.5728088336784	58.876400988234316	NOS2;EGFR
Candidiasis, Chronic Mucocutaneous	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	STAT1
Stage III Colon Cancer	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	EGFR
Hyperlipoproteinemia Type IIb	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	APOE
Thymus Neoplasms	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	EGFR
Uterine Neoplasms	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	EGFR
Lens dislocation	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	TAP1
Asymptomatic human immunodeficiency virus infection	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	EGFR
Behavioral variant of frontotemporal dementia	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	APOE
Bronchitis	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	EGFR
Carotid artery occlusion	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	APOE
Childhood Solid Neoplasm	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	INSR
Norrie disease	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	APOE
Cognitive changes	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	APOE
Complications of Diabetes Mellitus	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	HBA1
Penis carcinoma	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	EGFR
POLYCYSTIC KIDNEY DISEASE 1	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	HBA1
Elastosis perforans serpiginosa	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	INSR
Endemic Cretinism	1/24	0.013124225781325726	0.026598018947177886	0	0	86.80869565217391	376.1677267870623	APOE
Hepatitis, Toxic	2/325	0.013141934558546554	0.026598018947177886	0	0	13.530099759201926	58.61167573922563	APOE;HBA1
Chemical and Drug Induced Liver Injury	2/325	0.013141934558546554	0.026598018947177886	0	0	13.530099759201926	58.61167573922563	APOE;HBA1
Chemically-Induced Liver Toxicity	2/325	0.013141934558546554	0.026598018947177886	0	0	13.530099759201926	58.61167573922563	APOE;HBA1
Drug-Induced Acute Liver Injury	2/325	0.013141934558546554	0.026598018947177886	0	0	13.530099759201926	58.61167573922563	APOE;HBA1
Juvenile arthritis	2/326	0.013219091885409382	0.026727556926519267	0	0	13.487654320987655	58.34884882460206	STAT1;TAP1
Hepatitis, Drug-Induced	2/329	0.01345177507535568	0.02709529606213259	0	0	13.361875637104994	57.57156804215818	APOE;HBA1
Primary biliary cirrhosis	2/329	0.01345177507535568	0.02709529606213259	0	0	13.361875637104994	57.57156804215818	NOS2;APOE
Secondary malignant neoplasm of bone	2/330	0.01352973920132277	0.02709529606213259	0	0	13.320460704607045	57.31614564922814	APOE;EGFR
Enterocolitis	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	STAT1
Familial erythrocytosis	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	HBA1
Dystonia, Primary	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	APOE
Hydrocephalus, Normal Pressure	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	APOE
Hallervorden-Spatz Syndrome	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	APOE
Hepatic Form of Wilson Disease	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	APOE
Tooth Attrition	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	APOE
Uterine Carcinosarcoma	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	EGFR
Insulin-resistant diabetes mellitus	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	INSR
Malignant lymphoma - lymphoplasmacytic	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	NOS2
Malignant neoplasm of penis	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	EGFR
CNS metastases	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	EGFR
Perianal Squamous Intraepithelial Neoplasia	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	APOE
Prematurely aged appearance	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	INSR
Pulmonary Sclerosing Hemangioma	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	EGFR
Pyemia	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	NOS2
Quadriplegia	1/25	0.013667656724254873	0.02709529606213259	0	0	83.1875	357.1008995813401	APOE
Triglycerides measurement	2/336	0.014001741943112454	0.02773054544678802	0	0	13.077178975382568	55.82090005537726	INSR;APOE
Schizophreniform Disorders	1/26	0.014210815676953212	0.02784607276332587	0	0	79.856	339.6876146735057	APOE
Generalized pustular psoriasis	1/26	0.014210815676953212	0.02784607276332587	0	0	79.856	339.6876146735057	APOE
Tangier Disease	1/26	0.014210815676953212	0.02784607276332587	0	0	79.856	339.6876146735057	APOE
Human anaplasmosis due to Anaplasma phagocytophilum	1/26	0.014210815676953212	0.02784607276332587	0	0	79.856	339.6876146735057	NOS2
Hyperprolactinemia	1/26	0.014210815676953212	0.02784607276332587	0	0	79.856	339.6876146735057	INSR
Bare lymphocyte syndrome 2	1/26	0.014210815676953212	0.02784607276332587	0	0	79.856	339.6876146735057	TAP1
Beta thalassemia trait	1/26	0.014210815676953212	0.02784607276332587	0	0	79.856	339.6876146735057	HBA1
Blepharitis	1/26	0.014210815676953212	0.02784607276332587	0	0	79.856	339.6876146735057	APOE
Metastatic osteosarcoma	1/26	0.014210815676953212	0.02784607276332587	0	0	79.856	339.6876146735057	EGFR
Multiple lipomata	1/26	0.014210815676953212	0.02784607276332587	0	0	79.856	339.6876146735057	EGFR
Pituitary carcinoma	1/26	0.014210815676953212	0.02784607276332587	0	0	79.856	339.6876146735057	EGFR
Degenerative polyarthritis	3/976	0.014238726653230933	0.027873884931951115	0	0	7.328879753340185	31.160856161738494	NOS2;BHLHE41;APOE
Thrombocytopenia	2/341	0.014400578917092463	0.02816359611119527	0	0	12.88102261553589	54.621807281499194	STAT1;APOE
Generalized hyperpigmentation	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	INSR
Skin toxicity	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	EGFR
stage, neuroblastoma	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	STAT1
Leg Ulcer	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	HBA1
Anterior uveitis	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	NOS2
Apathy	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	APOE
Aphasia	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	APOE
Mucinous neoplasm	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	EGFR
Mumps	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	STAT1
Cervical dysplasia	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	EGFR
Corneal Diseases	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	APOE
Ectopia Lentis	1/27	0.01475370275603204	0.028524761180073365	0	0	76.78076923076924	323.7277777065472	TAP1
Ankylosing spondylitis	2/348	0.014967302050186992	0.028910226013288944	0	0	12.615928066795119	53.01070818097932	NOS2;TAP1
Uterine Fibroids	2/349	0.015049054389795983	0.029040530408419217	0	0	12.578930515529938	52.78672869469148	INSR;EGFR
Adenoma	3/1000	0.015204352818016067	0.029185087642812	0	0	7.143430290872618	29.903638743614977	INSR;APOE;EGFR
Ewings sarcoma	2/352	0.015295494837411893	0.029185087642812	0	0	12.469206349206349	52.12373833759424	STAT1;INSR
Extrinsic allergic alveolitis	1/28	0.015296318080509241	0.029185087642812	0	0	73.93333333333334	309.05191525436794	TAP1
Creutzfeldt-Jakob Disease, Sporadic	1/28	0.015296318080509241	0.029185087642812	0	0	73.93333333333334	309.05191525436794	HBA1
Seborrheic keratosis	1/28	0.015296318080509241	0.029185087642812	0	0	73.93333333333334	309.05191525436794	APOE
Liposarcoma, well differentiated	1/28	0.015296318080509241	0.029185087642812	0	0	73.93333333333334	309.05191525436794	EGFR
Hyperinsulinemic hypoglycemia	1/28	0.015296318080509241	0.029185087642812	0	0	73.93333333333334	309.05191525436794	INSR
Aortic valve disorder	1/28	0.015296318080509241	0.029185087642812	0	0	73.93333333333334	309.05191525436794	EGFR
Malignant Mesothelioma of Peritoneum	1/28	0.015296318080509241	0.029185087642812	0	0	73.93333333333334	309.05191525436794	EGFR
Odontogenic Tumors	1/28	0.015296318080509241	0.029185087642812	0	0	73.93333333333334	309.05191525436794	NOS2
Condylomata Acuminata	1/28	0.015296318080509241	0.029185087642812	0	0	73.93333333333334	309.05191525436794	STAT1
Rat Insulinoma	1/28	0.015296318080509241	0.029185087642812	0	0	73.93333333333334	309.05191525436794	IRS2
Adenocarcinoma of pancreas	2/354	0.015460772670756424	0.02947119143243626	0	0	12.39709595959596	51.68906255465721	IRS2;EGFR
Renal hypertension	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	NOS2
Gall Bladder Diseases	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	APOE
Hyalinosis, Segmental Glomerular	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	NOS2
Head Neoplasms	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	EGFR
Hereditary hemorrhagic telangiectasia	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	EGFR
Upper Aerodigestive Tract Neoplasms	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	EGFR
Acquired CJD	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	APOE
Acute monocytic/monoblastic leukemia	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	NOS2
Keratosis Follicularis	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	APOE
Asbestosis	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	NOS2
Autoinflammatory disorder	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	STAT1
Brain Aneurysm	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	STAT1
Breast cancer recurrent	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	EGFR
Cholesterol gallstones	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	APOE
Contiguous gene syndrome	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	HBA1
Disease of capillaries	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	APOE
Primary peritoneal carcinoma	1/29	0.01583866177167553	0.02971759992617237	0	0	71.28928571428571	295.5155744703354	EGFR
Lymphoma, Follicular	2/359	0.01587740031470611	0.029762802065943558	0	0	12.220354808590102	50.627201338115356	NOS2;STAT1
Squamous cell carcinoma of esophagus	3/1023	0.01616478121454828	0.03027358103959641	0	0	6.973897058823529	28.766770262264785	STAT1;BHLHE41;EGFR
Leukemia, T-Cell	2/364	0.016298912453850758	0.030314800899361647	0	0	12.048496009821976	49.599524161381915	NOS2;STAT1
Recurrent bronchitis	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	TAP1
Fasting Hypoglycemia	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	INSR
Serum cholesterol raised	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	APOE
gastritis h pylori	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	NOS2
Horseshoe Kidney	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	EGFR
Tendinopathy	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	NOS2
Thymic Carcinoma	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	EGFR
Malignant transformation	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	EGFR
Cancer of Head	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	EGFR
Cancer of Neck	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	EGFR
Childhood Rhabdomyosarcoma	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	EGFR
Christ-Siemens-Touraine syndrome	1/30	0.01638073395054089	0.030314800899361647	0	0	68.82758620689656	282.994903106762	EGFR
Orbital separation excessive	2/368	0.016639622333122512	0.030765889518566826	0	0	11.914389799635702	48.80096579467083	INSR;HBA1
Nephroblastoma	2/370	0.01681113964107373	0.030812357149102913	0	0	11.848429951690822	48.409290662831886	STAT1;EGFR
Recurrent upper respiratory tract infection	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	STAT1
Major depression, single episode	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	APOE
Acute colitis	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	EGFR
Acute interstitial pneumonia	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	EGFR
Adenocarcinoma in Situ	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	EGFR
AIDS-Associated Nephropathy	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	APOE
Large hand	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	INSR
Longevity	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	APOE
Atherosclerosis of aorta	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	APOE
Mycoplasma-Induced Stevens-Johnson Syndrome	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	NOS2
Myxoma	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	STAT1
Opportunistic Infections	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	APOE
Pericardial effusion	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	EGFR
Progressive intrahepatic cholestasis (disorder)	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	APOE
Drug-Induced Stevens Johnson Syndrome	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	NOS2
Endocrine Gland Neoplasms	1/31	0.016922534733464	0.030812357149102913	0	0	66.53	271.3831303578043	EGFR
Hepatomegaly	2/373	0.017069864128960322	0.03105278774399944	0	0	11.750823599880203	47.831030661171724	APOE;HBA1
Drug-Induced Liver Disease	2/377	0.01741752573627405	0.0313766388482183	0	0	11.623111111111111	47.07683533308895	APOE;HBA1
Gastrinoma	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	EGFR
Grade I Astrocytoma	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	EGFR
MICROPHTHALMIA, SYNDROMIC 7	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	EGFR
Idiopathic Hypereosinophilic Syndrome	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	NOS2
Verrucous carcinoma	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	EGFR
Iron deficiency anemia	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	HBA1
African Trypanosomiasis	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	NOS2
Lipid Metabolism Disorders	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	APOE
Aortic valve calcification	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	APOE
Bowen's Disease	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	APOE
Chronic Persistent Hepatitis	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	NOS2
Oropharyngeal disorders	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	EGFR
Complete hydatidiform mole	1/32	0.017464064240814415	0.0313766388482183	0	0	64.38064516129032	260.5877419554691	EGFR
Glaucoma	2/381	0.017768256528704212	0.03189496224940544	0	0	11.498094400469071	46.341249963002355	NOS2;APOE
Mesothelioma	2/383	0.01794476894604306	0.03192566798941619	0	0	11.436570428696413	45.980235406101094	STAT1;EGFR
Parkinson Disease	3/1064	0.01796260257966112	0.03192566798941619	0	0	6.689915174363808	26.88986863603164	NOS2;INSR;APOE
Gerstmann-Straussler-Scheinker Disease	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	APOE
Spastic	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	APOE
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	NOS2
Hereditary Motor and Sensory Neuropathies	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	EGFR
Thalassemia Intermedia	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	HBA1
Trigeminal Neuralgia	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	EGFR
Iron-Refractory Iron Deficiency Anemia	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	HBA1
Angiomyolipoma	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	EGFR
Meniere Disease	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	NOS2
Chronic Airflow Obstruction	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	NOS2
Delusions	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	APOE
Primary Lesion	1/33	0.01800532259639319	0.03192566798941619	0	0	62.365625	250.52819538044852	EGFR
Chronic kidney disease stage 5	2/388	0.018389382897081044	0.03257822671915317	0	0	11.285549798503167	45.096851568111575	NOS2;APOE
Amyotrophic Lateral Sclerosis, Guam Form	1/34	0.018546309917010683	0.03262865952499196	0	0	60.472727272727276	241.13405880391542	APOE
Gestational trophoblastic disease	1/34	0.018546309917010683	0.03262865952499196	0	0	60.472727272727276	241.13405880391542	EGFR
Sarcoma, Spindle Cell	1/34	0.018546309917010683	0.03262865952499196	0	0	60.472727272727276	241.13405880391542	NOS2
Anastomosis	1/34	0.018546309917010683	0.03262865952499196	0	0	60.472727272727276	241.13405880391542	NOS2
Malignant neoplasm of vulva	1/34	0.018546309917010683	0.03262865952499196	0	0	60.472727272727276	241.13405880391542	EGFR
Metastatic Carcinoma	1/34	0.018546309917010683	0.03262865952499196	0	0	60.472727272727276	241.13405880391542	EGFR
Neuroectodermal Tumors	1/34	0.018546309917010683	0.03262865952499196	0	0	60.472727272727276	241.13405880391542	EGFR
prostatitis	1/34	0.018546309917010683	0.03262865952499196	0	0	60.472727272727276	241.13405880391542	NOS2
COLORBLINDNESS, PARTIAL, DEUTAN SERIES	1/35	0.01908702632439229	0.033435204733763046	0	0	58.69117647058823	232.34348501767582	APOE
Acanthosis	1/35	0.01908702632439229	0.033435204733763046	0	0	58.69117647058823	232.34348501767582	EGFR
Acanthosis Nigricans	1/35	0.01908702632439229	0.033435204733763046	0	0	58.69117647058823	232.34348501767582	INSR
Acinar Cell Carcinoma	1/35	0.01908702632439229	0.033435204733763046	0	0	58.69117647058823	232.34348501767582	EGFR
PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	1/35	0.01908702632439229	0.033435204733763046	0	0	58.69117647058823	232.34348501767582	EGFR
Ataxia Telangiectasia	2/396	0.019110617981424823	0.03344769658764448	0	0	11.051889452904682	43.73797610464593	IRS2;EGFR
Astrocytoma, low grade	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	EGFR
Familial medullary thyroid carcinoma	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	EGFR
EAR, PATELLA, SHORT STATURE SYNDROME	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	INSR
Germ Cell Cancer	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	EGFR
Hepatic Encephalopathy	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	NOS2
Thickened nuchal skin fold	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	INSR
Large cell neuroendocrine carcinoma	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	EGFR
Low Tension Glaucoma	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	APOE
Barrett's Adenocarcinoma	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	EGFR
Ocular Hypertension	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	NOS2
Oestrogen deficiency	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	APOE
Peripheral arterial occlusive disease	1/36	0.01962747193991364	0.034000872107335475	0	0	57.011428571428574	224.10195239289595	APOE
Sessile Serrated Adenoma/Polyp	1/37	0.020167646885642113	0.0346413004831993	0	0	55.425	216.36122001333428	HBA1
Hemorrhage	1/37	0.020167646885642113	0.0346413004831993	0	0	55.425	216.36122001333428	APOE
Hereditary pyropoikilocytosis	1/37	0.020167646885642113	0.0346413004831993	0	0	55.425	216.36122001333428	EGFR
Tubular Aggregate Myopathy	1/37	0.020167646885642113	0.0346413004831993	0	0	55.425	216.36122001333428	EGFR
ACTH-Secreting Pituitary Adenoma	1/37	0.020167646885642113	0.0346413004831993	0	0	55.425	216.36122001333428	EGFR
Juvenile Pilocytic Astrocytoma	1/37	0.020167646885642113	0.0346413004831993	0	0	55.425	216.36122001333428	EGFR
Leukoaraiosis	1/37	0.020167646885642113	0.0346413004831993	0	0	55.425	216.36122001333428	APOE
Atypical Lipoma	1/37	0.020167646885642113	0.0346413004831993	0	0	55.425	216.36122001333428	EGFR
Malignant neoplasm of oropharynx	1/37	0.020167646885642113	0.0346413004831993	0	0	55.425	216.36122001333428	EGFR
Combined immunodeficiency	1/37	0.020167646885642113	0.0346413004831993	0	0	55.425	216.36122001333428	STAT1
Attention deficit hyperactivity disorder	2/412	0.020589107128280503	0.03524099178164596	0	0	10.611924119241193	41.206028379153466	NOS2;APOE
Septic Shock	1/38	0.020707551273270317	0.03524099178164596	0	0	53.924324324324324	209.07845583696505	NOS2
Takayasu Arteritis	1/38	0.020707551273270317	0.03524099178164596	0	0	53.924324324324324	209.07845583696505	NOS2
Abnormality of the eye	1/38	0.020707551273270317	0.03524099178164596	0	0	53.924324324324324	209.07845583696505	APOE
Vitamin D Deficiency	1/38	0.020707551273270317	0.03524099178164596	0	0	53.924324324324324	209.07845583696505	APOE
Anti-Basement Membrane Glomerulonephritis	1/38	0.020707551273270317	0.03524099178164596	0	0	53.924324324324324	209.07845583696505	NOS2
Arteriovenous hemangioma	1/38	0.020707551273270317	0.03524099178164596	0	0	53.924324324324324	209.07845583696505	APOE
Neurobehavioral Manifestations	1/38	0.020707551273270317	0.03524099178164596	0	0	53.924324324324324	209.07845583696505	APOE
Chronic eosinophilic leukemia	1/38	0.020707551273270317	0.03524099178164596	0	0	53.924324324324324	209.07845583696505	NOS2
Comedone	1/38	0.020707551273270317	0.03524099178164596	0	0	53.924324324324324	209.07845583696505	EGFR
Prostatic Diseases	1/38	0.020707551273270317	0.03524099178164596	0	0	53.924324324324324	209.07845583696505	NOS2
Myopathy	2/415	0.020871620847489544	0.03549048833648431	0	0	10.533225719666397	40.756893850989364	INSR;APOE
Recurrent pulmonary infections	1/39	0.021247185233602552	0.035805806627871535	0	0	52.502631578947366	202.2155053364779	EGFR
Sense of smell impaired	1/39	0.021247185233602552	0.035805806627871535	0	0	52.502631578947366	202.2155053364779	APOE
Short toe	1/39	0.021247185233602552	0.035805806627871535	0	0	52.502631578947366	202.2155053364779	HBA1
heavy drinking	1/39	0.021247185233602552	0.035805806627871535	0	0	52.502631578947366	202.2155053364779	APOE
Stage IV Ovarian Carcinoma	1/39	0.021247185233602552	0.035805806627871535	0	0	52.502631578947366	202.2155053364779	EGFR
Sweet Syndrome	1/39	0.021247185233602552	0.035805806627871535	0	0	52.502631578947366	202.2155053364779	HBA1
Adenocarcinoma of rectum	1/39	0.021247185233602552	0.035805806627871535	0	0	52.502631578947366	202.2155053364779	EGFR
Anosmia	1/39	0.021247185233602552	0.035805806627871535	0	0	52.502631578947366	202.2155053364779	APOE
Benign Ovarian Neoplasm	1/39	0.021247185233602552	0.035805806627871535	0	0	52.502631578947366	202.2155053364779	EGFR
Multiple pulmonary infections	1/39	0.021247185233602552	0.035805806627871535	0	0	52.502631578947366	202.2155053364779	EGFR
Cardiomyopathy, Dilated	2/419	0.021250887201384384	0.035805806627871535	0	0	10.430055955235812	40.16986519441411	NOS2;EGFR
Benign Prostatic Hyperplasia	2/420	0.02134616347627951	0.03593654033454844	0	0	10.404572036150984	40.02517391130644	NOS2;EGFR
Malignant neoplasm of kidney	2/421	0.02144162324306293	0.03603753385434564	0	0	10.379209758684699	39.881295975985715	NOS2;EGFR
Metabolic Diseases	2/421	0.02144162324306293	0.03603753385434564	0	0	10.379209758684699	39.881295975985715	INSR;APOE
Alcoholic Intoxication, Chronic	2/424	0.021729101592399592	0.03632349067705359	0	0	10.303844128488679	39.454478709004825	APOE;EGFR
Anemia, severe	1/40	0.02178654888216798	0.03632349067705359	0	0	51.15384615384615	195.7382752343542	HBA1
Neoplasm Recurrence, Local	1/40	0.02178654888216798	0.03632349067705359	0	0	51.15384615384615	195.7382752343542	EGFR
AIDS Dementia Complex	1/40	0.02178654888216798	0.03632349067705359	0	0	51.15384615384615	195.7382752343542	APOE
Malignant neoplasm of stomach stage IV	1/40	0.02178654888216798	0.03632349067705359	0	0	51.15384615384615	195.7382752343542	EGFR
Mitochondrial Respiratory Chain Deficiencies	1/40	0.02178654888216798	0.03632349067705359	0	0	51.15384615384615	195.7382752343542	NOS2
Chronic rejection of renal transplant	1/40	0.02178654888216798	0.03632349067705359	0	0	51.15384615384615	195.7382752343542	EGFR
Prostate cancer recurrent	1/40	0.02178654888216798	0.03632349067705359	0	0	51.15384615384615	195.7382752343542	EGFR
Psychiatric symptom	1/40	0.02178654888216798	0.03632349067705359	0	0	51.15384615384615	195.7382752343542	APOE
Malignant neoplasm of urinary bladder	3/1144	0.02179051925951197	0.03632349067705359	0	0	6.194566170026293	23.70214650425185	NOS2;STAT1;EGFR
Recurrent pneumonia	1/41	0.022325642342211446	0.03688268718648265	0	0	49.8725	189.61621154431046	EGFR
Schwartz-Jampel Syndrome	1/41	0.022325642342211446	0.03688268718648265	0	0	49.8725	189.61621154431046	EGFR
Genitourinary Cancer	1/41	0.022325642342211446	0.03688268718648265	0	0	49.8725	189.61621154431046	EGFR
Gestational Trophoblastic Neoplasms	1/41	0.022325642342211446	0.03688268718648265	0	0	49.8725	189.61621154431046	EGFR
Nephrotic Syndrome, Minimal Change	1/41	0.022325642342211446	0.03688268718648265	0	0	49.8725	189.61621154431046	APOE
Hypoplastic Left Heart Syndrome	1/41	0.022325642342211446	0.03688268718648265	0	0	49.8725	189.61621154431046	APOE
Intestinal Polyps	1/41	0.022325642342211446	0.03688268718648265	0	0	49.8725	189.61621154431046	EGFR
Alcohol withdrawal syndrome	1/41	0.022325642342211446	0.03688268718648265	0	0	49.8725	189.61621154431046	APOE
Malabsorption Syndrome	1/41	0.022325642342211446	0.03688268718648265	0	0	49.8725	189.61621154431046	EGFR
Chronic viral hepatitis	1/41	0.022325642342211446	0.03688268718648265	0	0	49.8725	189.61621154431046	NOS2
Endometrioid carcinoma ovary	1/41	0.022325642342211446	0.03688268718648265	0	0	49.8725	189.61621154431046	EGFR
Carcinoma of bladder	3/1162	0.022710643259648288	0.037468221266957424	0	0	6.092536669542709	23.05977362907423	NOS2;STAT1;EGFR
Ewings sarcoma-primitive neuroectodermal tumor (PNET)	1/42	0.022864465733773234	0.037468221266957424	0	0	48.65365853658537	183.82185575175376	EGFR
exudative macular degeneration	1/42	0.022864465733773234	0.037468221266957424	0	0	48.65365853658537	183.82185575175376	APOE
Ganglioneuroblastoma	1/42	0.022864465733773234	0.037468221266957424	0	0	48.65365853658537	183.82185575175376	EGFR
Infection by Cryptococcus neoformans	1/42	0.022864465733773234	0.037468221266957424	0	0	48.65365853658537	183.82185575175376	TAP1
Aortic aneurysm without mention of rupture NOS	1/42	0.022864465733773234	0.037468221266957424	0	0	48.65365853658537	183.82185575175376	APOE
Cerebral Edema	1/42	0.022864465733773234	0.037468221266957424	0	0	48.65365853658537	183.82185575175376	NOS2
Oligoarticular Juvenile Idiopathic Arthritis	1/42	0.022864465733773234	0.037468221266957424	0	0	48.65365853658537	183.82185575175376	STAT1
Optic Neuritis	1/42	0.022864465733773234	0.037468221266957424	0	0	48.65365853658537	183.82185575175376	APOE
Diffuse Scleroderma	1/42	0.022864465733773234	0.037468221266957424	0	0	48.65365853658537	183.82185575175376	EGFR
nervous system disorder	2/436	0.022895409202105692	0.03748869580876613	0	0	10.012800819252432	37.816534976004725	NOS2;APOE
Meningioma	2/438	0.02309232894600752	0.03778068632712341	0	0	9.96585117227319	37.553866484757776	NOS2;EGFR
Seizures	3/1174	0.02333613899431299	0.037922595665590954	0	0	6.0262596071733565	22.645189635040158	NOS2;INSR;APOE
CATARACT, ANTERIOR POLAR	1/43	0.02340301917551725	0.037922595665590954	0	0	47.49285714285714	178.33046577189359	EGFR
Sarcoma, Epithelioid	1/43	0.02340301917551725	0.037922595665590954	0	0	47.49285714285714	178.33046577189359	EGFR
Hyperlipoproteinemias	1/43	0.02340301917551725	0.037922595665590954	0	0	47.49285714285714	178.33046577189359	APOE
Transient Cerebral Ischemia	1/43	0.02340301917551725	0.037922595665590954	0	0	47.49285714285714	178.33046577189359	APOE
intracranial glioma	1/43	0.02340301917551725	0.037922595665590954	0	0	47.49285714285714	178.33046577189359	EGFR
Yolk Sac Tumor	1/43	0.02340301917551725	0.037922595665590954	0	0	47.49285714285714	178.33046577189359	EGFR
Autoimmune hemolytic anemia	1/43	0.02340301917551725	0.037922595665590954	0	0	47.49285714285714	178.33046577189359	STAT1
Non-small cell lung cancer metastatic	1/43	0.02340301917551725	0.037922595665590954	0	0	47.49285714285714	178.33046577189359	EGFR
Depressive Syndrome	1/43	0.02340301917551725	0.037922595665590954	0	0	47.49285714285714	178.33046577189359	APOE
Primary Carcinoma	1/43	0.02340301917551725	0.037922595665590954	0	0	47.49285714285714	178.33046577189359	EGFR
Pyruvate Carboxylase Deficiency Disease	1/43	0.02340301917551725	0.037922595665590954	0	0	47.49285714285714	178.33046577189359	EGFR
Precancerous Conditions	2/446	0.023887195699622863	0.03848791714908175	0	0	9.782282282282281	36.53107927204108	STAT1;EGFR
Multiple Sclerosis, Acute Fulminating	1/44	0.023941302793523297	0.03848791714908175	0	0	46.38604651162791	173.11969096681065	APOE
Split hand foot deformity 1	1/44	0.023941302793523297	0.03848791714908175	0	0	46.38604651162791	173.11969096681065	EGFR
Thyroiditis	1/44	0.023941302793523297	0.03848791714908175	0	0	46.38604651162791	173.11969096681065	STAT1
Toxic Shock Syndrome	1/44	0.023941302793523297	0.03848791714908175	0	0	46.38604651162791	173.11969096681065	NOS2
Apraxias	1/44	0.023941302793523297	0.03848791714908175	0	0	46.38604651162791	173.11969096681065	APOE
Medullomyoblastoma	1/44	0.023941302793523297	0.03848791714908175	0	0	46.38604651162791	173.11969096681065	IRS2
Melanotic medulloblastoma	1/44	0.023941302793523297	0.03848791714908175	0	0	46.38604651162791	173.11969096681065	IRS2
Memory Disorders	1/44	0.023941302793523297	0.03848791714908175	0	0	46.38604651162791	173.11969096681065	APOE
CARCINOMA OF VULVA	1/44	0.023941302793523297	0.03848791714908175	0	0	46.38604651162791	173.11969096681065	EGFR
Rough hair texture	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	INSR
gallbladder neoplasm	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	EGFR
Obesity, Visceral	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	APOE
Abetalipoproteinemia	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	APOE
Hypopituitarism	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	APOE
Young onset Parkinson disease	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	APOE
Atypical Teratoid Rhabdoid Tumor	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	INSR
Malignant Central Nervous System Neoplasm	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	EGFR
Bronchogenic Carcinoma	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	EGFR
Cerebral Amyloid Angiopathy	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	APOE
Chondrodysplasia	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	STAT1
Coarse hair	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	INSR
Delirium	1/45	0.02447931669919003	0.0389522095009821	0	0	45.32954545454545	168.16929253740548	APOE
Dysautonomia, Familial	1/46	0.025017061022238465	0.039467909935705404	0	0	44.32	163.46090194189088	APOE
Single tumor	1/46	0.025017061022238465	0.039467909935705404	0	0	44.32	163.46090194189088	EGFR
Sleep Apnea, Central	1/46	0.025017061022238465	0.039467909935705404	0	0	44.32	163.46090194189088	APOE
Infiltrating Cervical Carcinoma	1/46	0.025017061022238465	0.039467909935705404	0	0	44.32	163.46090194189088	EGFR
Acute periodontitis	1/46	0.025017061022238465	0.039467909935705404	0	0	44.32	163.46090194189088	STAT1
Ketosis	1/46	0.025017061022238465	0.039467909935705404	0	0	44.32	163.46090194189088	INSR
Malignant neoplasm of male breast	1/46	0.025017061022238465	0.039467909935705404	0	0	44.32	163.46090194189088	EGFR
Moyamoya disease 1	1/46	0.025017061022238465	0.039467909935705404	0	0	44.32	163.46090194189088	APOE
Peptic Esophagitis	1/46	0.025017061022238465	0.039467909935705404	0	0	44.32	163.46090194189088	EGFR
Drusen	1/46	0.025017061022238465	0.039467909935705404	0	0	44.32	163.46090194189088	APOE
Early gastric cancer	1/46	0.025017061022238465	0.039467909935705404	0	0	44.32	163.46090194189088	EGFR
Serum triglycerides raised	1/47	0.02555453587694348	0.04006698835026941	0	0	43.35434782608696	158.97781166869382	APOE
FRAGILE X TREMOR/ATAXIA SYNDROME	1/47	0.02555453587694348	0.04006698835026941	0	0	43.35434782608696	158.97781166869382	APOE
Hypertension, Renovascular	1/47	0.02555453587694348	0.04006698835026941	0	0	43.35434782608696	158.97781166869382	STAT1
Hemangioblastoma	1/47	0.02555453587694348	0.04006698835026941	0	0	43.35434782608696	158.97781166869382	EGFR
Hemoglobinopathies	1/47	0.02555453587694348	0.04006698835026941	0	0	43.35434782608696	158.97781166869382	HBA1
Hyperparathyroidism	1/47	0.02555453587694348	0.04006698835026941	0	0	43.35434782608696	158.97781166869382	EGFR
Carcinoma in situ of uterine cervix	1/47	0.02555453587694348	0.04006698835026941	0	0	43.35434782608696	158.97781166869382	TAP1
Muscular Atrophy	1/47	0.02555453587694348	0.04006698835026941	0	0	43.35434782608696	158.97781166869382	HSP90AB1
Bladder Neoplasm	3/1217	0.025657100791782444	0.040196783969854995	0	0	5.799526359143328	21.243287572167834	NOS2;STAT1;EGFR
Synovial Cyst	1/48	0.026091741385155156	0.04075205111040375	0	0	42.42978723404255	154.70479323760136	NOS2
Alcoholic Steatohepatitis	1/48	0.026091741385155156	0.04075205111040375	0	0	42.42978723404255	154.70479323760136	APOE
Manic Disorder	1/48	0.026091741385155156	0.04075205111040375	0	0	42.42978723404255	154.70479323760136	BHLHE40
Dupuytren Contracture	1/48	0.026091741385155156	0.04075205111040375	0	0	42.42978723404255	154.70479323760136	EGFR
Gingival Overgrowth	1/49	0.02662867767591582	0.04136809865249308	0	0	41.54375	150.62793852241148	INSR
Thromboangiitis Obliterans	1/49	0.02662867767591582	0.04136809865249308	0	0	41.54375	150.62793852241148	STAT1
Hypermelanotic macule	1/49	0.02662867767591582	0.04136809865249308	0	0	41.54375	150.62793852241148	INSR
Intracranial Hemorrhages	1/49	0.02662867767591582	0.04136809865249308	0	0	41.54375	150.62793852241148	APOE
Cardiovascular Abnormalities	1/49	0.02662867767591582	0.04136809865249308	0	0	41.54375	150.62793852241148	NOS2
Oral soft tissue hyperplasia	1/49	0.02662867767591582	0.04136809865249308	0	0	41.54375	150.62793852241148	INSR
Dryness of eye	1/49	0.02662867767591582	0.04136809865249308	0	0	41.54375	150.62793852241148	EGFR
Lip and Oral Cavity Carcinoma	2/473	0.026653682691910305	0.04137531186398911	0	0	9.208775654635527	33.380227383760484	STAT1;EGFR
Acute Promyelocytic Leukemia	2/475	0.026863684936389024	0.04162894475975909	0	0	9.168898285177354	33.16372086510065	STAT1;EGFR
Mammary Neoplasms, Human	2/476	0.02696894589358131	0.04162894475975909	0	0	9.149085794655415	33.05628033985141	NOS2;EGFR
Erythroblastosis	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	EGFR
Fibromyalgia	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	NOS2
Leishmaniasis, Cutaneous	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	NOS2
Hypertrichosis	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	INSR
Varicella zoster	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	APOE
Advanced bone age	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	INSR
Li-Fraumeni Syndrome	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	EGFR
Atypical Ductal Breast Hyperplasia	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	APOE
Microscopic Polyarteritis	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	EGFR
Moyamoya Disease	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	APOE
Carcinosarcoma	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	EGFR
Muscular fasciculation	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	EGFR
Cervical Squamous Intraepithelial Neoplasia	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	EGFR
Chronic inflammatory disorder	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	NOS2
Endocardial Cushion Defects	1/50	0.027165344857992397	0.04162894475975909	0	0	40.69387755102041	146.73452100035948	EGFR
Cardiomyopathies	2/480	0.02739171766920438	0.04194421273837475	0	0	9.07066480706648	32.63184894930791	NOS2;EGFR
Gingival Hyperplasia	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	INSR
Tardive Dyskinesia	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	APOE
Adult Lymphoma	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	EGFR
Lafora Disease	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	APOE
Angioimmunoblastic Lymphadenopathy	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	NOS2
Malignant neoplasm of female breast	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	EGFR
Bicuspid aortic valve	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	EGFR
Metaplasia	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	EGFR
Breast Diseases	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	EGFR
C-reactive protein measurement	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	APOE
NONAKA MYOPATHY	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	EGFR
Premature coronary artery disease	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	APOE
Drug-induced tardive dyskinesia	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	APOE
Rabies (disorder)	1/51	0.027701743059261864	0.04197609388249076	0	0	39.878	143.01287394480332	STAT1
Dermatitis, Atopic	2/484	0.027817245317235846	0.04211970378883997	0	0	8.99354541263255	32.21577106745382	TAP1;EGFR
Pain	2/485	0.027924056454956388	0.04224994990057437	0	0	8.974465148378192	32.113029998421496	HBA1;EGFR
Generalized hirsutism	1/52	0.02823787239566386	0.0423776637429756	0	0	39.09411764705882	139.4522833938583	INSR
Gingival Hypertrophy	1/52	0.02823787239566386	0.0423776637429756	0	0	39.09411764705882	139.4522833938583	INSR
Hippocampal sclerosis	1/52	0.02823787239566386	0.0423776637429756	0	0	39.09411764705882	139.4522833938583	APOE
Idiopathic crescentic glomerulonephritis	1/52	0.02823787239566386	0.0423776637429756	0	0	39.09411764705882	139.4522833938583	EGFR
Invasive Lobular Breast Carcinoma	1/52	0.02823787239566386	0.0423776637429756	0	0	39.09411764705882	139.4522833938583	NOS2
Malignant ascites	1/52	0.02823787239566386	0.0423776637429756	0	0	39.09411764705882	139.4522833938583	EGFR
Carcinomatosis of peritoneal cavity	1/52	0.02823787239566386	0.0423776637429756	0	0	39.09411764705882	139.4522833938583	EGFR
Non-arthropod borne lymphocytic choriomeningitis	1/52	0.02823787239566386	0.0423776637429756	0	0	39.09411764705882	139.4522833938583	STAT1
Parasitic Diseases	1/52	0.02823787239566386	0.0423776637429756	0	0	39.09411764705882	139.4522833938583	NOS2
Coronary Stenosis	1/52	0.02823787239566386	0.0423776637429756	0	0	39.09411764705882	139.4522833938583	APOE
Desmoplastic Medulloblastoma	1/52	0.02823787239566386	0.0423776637429756	0	0	39.09411764705882	139.4522833938583	IRS2
Malignant neoplasm of mouth	2/492	0.028676521236631503	0.04286526792011958	0	0	8.843083900226757	31.407773863158003	STAT1;EGFR
granulosa cell tumor	1/53	0.02877373299362358	0.04286526792011958	0	0	38.340384615384615	136.0428936891653	EGFR
Other specified types of schizophrenia, unspecified	1/53	0.02877373299362358	0.04286526792011958	0	0	38.340384615384615	136.0428936891653	APOE
Thrombocytopenia due to platelet alloimmunization	1/53	0.02877373299362358	0.04286526792011958	0	0	38.340384615384615	136.0428936891653	STAT1
Tumor-Associated Vasculature	1/53	0.02877373299362358	0.04286526792011958	0	0	38.340384615384615	136.0428936891653	EGFR
Interstitial Cystitis	1/53	0.02877373299362358	0.04286526792011958	0	0	38.340384615384615	136.0428936891653	NOS2
Mental deterioration	1/53	0.02877373299362358	0.04286526792011958	0	0	38.340384615384615	136.0428936891653	APOE
Childhood Lymphoma	1/53	0.02877373299362358	0.04286526792011958	0	0	38.340384615384615	136.0428936891653	EGFR
NEUROTICISM	1/53	0.02877373299362358	0.04286526792011958	0	0	38.340384615384615	136.0428936891653	APOE
Nodular glomerulosclerosis	1/53	0.02877373299362358	0.04286526792011958	0	0	38.340384615384615	136.0428936891653	APOE
Pneumonia	2/497	0.029219101041716124	0.0434968595727232	0	0	8.751515151515152	30.91851351339465	NOS2;APOE
Rotavirus Infections	1/54	0.02930932497110778	0.0435354885535753	0	0	37.615094339622644	132.7756240232595	STAT1
Xeroderma Pigmentosum, Complementation Group D	1/54	0.02930932497110778	0.0435354885535753	0	0	37.615094339622644	132.7756240232595	EGFR
Drug Withdrawal Symptoms	1/54	0.02930932497110778	0.0435354885535753	0	0	37.615094339622644	132.7756240232595	NOS2
Renal carcinoma	2/500	0.02954667996708659	0.043823980797897774	0	0	8.697456492637215	30.63056219889971	NOS2;EGFR
Adult T-Cell Lymphoma/Leukemia	2/500	0.02954667996708659	0.043823980797897774	0	0	8.697456492637215	30.63056219889971	NOS2;STAT1
Russell-Silver syndrome	1/55	0.029844648447595826	0.04407291107958918	0	0	36.916666666666664	129.64209444665414	EGFR
Gingivitis	1/55	0.029844648447595826	0.04407291107958918	0	0	36.916666666666664	129.64209444665414	NOS2
Systemic onset juvenile chronic arthritis	1/55	0.029844648447595826	0.04407291107958918	0	0	36.916666666666664	129.64209444665414	STAT1
Adenosquamous carcinoma	1/55	0.029844648447595826	0.04407291107958918	0	0	36.916666666666664	129.64209444665414	EGFR
Lymphocytic Choriomeningitis	1/55	0.029844648447595826	0.04407291107958918	0	0	36.916666666666664	129.64209444665414	STAT1
Brugada Syndrome (disorder)	1/55	0.029844648447595826	0.04407291107958918	0	0	36.916666666666664	129.64209444665414	BHLHE40
Malignant Glioma	2/504	0.029985811242578528	0.04424921455694958	0	0	8.62638335546702	30.252993567572418	STAT1;EGFR
Familial Mediterranean Fever	1/56	0.03037970354233477	0.04457152173142545	0	0	36.24363636363636	126.63456015986765	HBA1
Glucocorticoid Receptor Deficiency	1/56	0.03037970354233477	0.04457152173142545	0	0	36.24363636363636	126.63456015986765	HSP90AB1
HER2 gene amplification	1/56	0.03037970354233477	0.04457152173142545	0	0	36.24363636363636	126.63456015986765	EGFR
Adenoviral infections	1/56	0.03037970354233477	0.04457152173142545	0	0	36.24363636363636	126.63456015986765	IRS2
Laryngeal Diseases	1/56	0.03037970354233477	0.04457152173142545	0	0	36.24363636363636	126.63456015986765	EGFR
Carotid Stenosis	1/56	0.03037970354233477	0.04457152173142545	0	0	36.24363636363636	126.63456015986765	APOE
Parathyroid Neoplasms	1/56	0.03037970354233477	0.04457152173142545	0	0	36.24363636363636	126.63456015986765	EGFR
Pituitary-dependent Cushing's disease	1/56	0.03037970354233477	0.04457152173142545	0	0	36.24363636363636	126.63456015986765	EGFR
Secondary malignant neoplasm of liver	2/508	0.030427628307833916	0.04460962534020095	0	0	8.556433904259992	29.8825261952846	NOS2;EGFR
Geographic Atrophy	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	APOE
Hyperaldosteronism	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	INSR
Hypertrophy of clitoris	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	INSR
Ameloblastoma	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	EGFR
Long eyelashes	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	EGFR
Atrophic	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	APOE
Malignant neoplasm of colon stage IV	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	EGFR
Carotid Artery Diseases	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	APOE
Necrosis	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	NOS2
Pallor	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	HBA1
Peutz-Jeghers Syndrome	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	EGFR
Pneumocystis jiroveci pneumonia	1/57	0.030914490381785415	0.0449343665635107	0	0	35.59464285714286	123.7458530082544	NOS2
Major Depressive Disorder	2/513	0.030983658897024955	0.045002712565228524	0	0	8.4705370732768	29.429147530401018	APOE;EGFR
Multiple Myeloma	3/1312	0.031228087128983183	0.045194049823189975	0	0	5.351413292589763	18.55033896963886	HSP90AB1;STAT1;EGFR
Unipolar Depression	2/517	0.03143147671327853	0.045194049823189975	0	0	8.40302049622438	29.073992490829117	APOE;EGFR
SCHIZOPHRENIA 1 (disorder)	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	APOE
Severe Dengue	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	TAP1
Silicosis	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	NOS2
Heart valve disease	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	APOE
Hepatosplenomegaly	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	STAT1
Substance Withdrawal Syndrome	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	NOS2
Inclusion Body Myositis (disorder)	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	APOE
Large cell carcinoma of lung	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	EGFR
Maternal oligohydramnios	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	HBA1
Carcinoma of Male Breast	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	EGFR
Mycoplasma Infections	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	NOS2
Nerve Sheath Tumors	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	EGFR
Chlamydia Infections	1/58	0.03144900907971979	0.045194049823189975	0	0	34.96842105263158	120.96932931919562	NOS2
Cataract	2/519	0.03165637943843692	0.0454599031935716	0	0	8.369653986675264	28.898871756940654	APOE;EGFR
Sleep Apnea Syndromes	1/59	0.03198325976038446	0.04567110599655742	0	0	34.36379310344827	118.2988232215442	APOE
Squamous cell carcinoma of mouth	1/59	0.03198325976038446	0.04567110599655742	0	0	34.36379310344827	118.2988232215442	EGFR
SVEINSSON CHORIORETINAL ATROPHY	1/59	0.03198325976038446	0.04567110599655742	0	0	34.36379310344827	118.2988232215442	EGFR
Anaplastic Oligodendroglioma	1/59	0.03198325976038446	0.04567110599655742	0	0	34.36379310344827	118.2988232215442	EGFR
Angina Pectoris	1/59	0.03198325976038446	0.04567110599655742	0	0	34.36379310344827	118.2988232215442	APOE
Leukocyte adhesion deficiency type 1	1/59	0.03198325976038446	0.04567110599655742	0	0	34.36379310344827	118.2988232215442	EGFR
Body fluid retention	1/59	0.03198325976038446	0.04567110599655742	0	0	34.36379310344827	118.2988232215442	APOE
Drug Resistant Epilepsy	1/59	0.03198325976038446	0.04567110599655742	0	0	34.36379310344827	118.2988232215442	APOE
Epithelial ovarian cancer	3/1329	0.03228957116968026	0.04607612964662239	0	0	5.277997737556561	18.119424158488226	STAT1;INSR;EGFR
AURAL ATRESIA, CONGENITAL	1/60	0.03251724254582002	0.04627103421085874	0	0	33.779661016949156	115.72860487101575	APOE
Factor V Leiden mutation	1/60	0.03251724254582002	0.04627103421085874	0	0	33.779661016949156	115.72860487101575	APOE
Oropharyngeal Carcinoma	1/60	0.03251724254582002	0.04627103421085874	0	0	33.779661016949156	115.72860487101575	EGFR
Dry Eye Syndromes	1/60	0.03251724254582002	0.04627103421085874	0	0	33.779661016949156	115.72860487101575	EGFR
Undergrowth	2/529	0.03279077392535457	0.04662760854885969	0	0	8.20662028252161	28.047011835645844	HBA1;EGFR
Epithelial hyperplasia of skin	1/61	0.03305095755598113	0.046833713914751496	0	0	33.215	113.25334294423654	EGFR
Depression, Bipolar	1/61	0.03305095755598113	0.046833713914751496	0	0	33.215	113.25334294423654	BHLHE40
Ganglioglioma	1/61	0.03305095755598113	0.046833713914751496	0	0	33.215	113.25334294423654	EGFR
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	1/61	0.03305095755598113	0.046833713914751496	0	0	33.215	113.25334294423654	EGFR
Bradykinesia	1/61	0.03305095755598113	0.046833713914751496	0	0	33.215	113.25334294423654	APOE
Low grade glioma	1/62	0.03358440490598319	0.04732559692715523	0	0	32.66885245901639	110.86807091829407	EGFR
Macular degeneration	1/62	0.03358440490598319	0.04732559692715523	0	0	32.66885245901639	110.86807091829407	APOE
Bardet-Biedl Syndrome	1/62	0.03358440490598319	0.04732559692715523	0	0	32.66885245901639	110.86807091829407	INSR
Marijuana Abuse	1/62	0.03358440490598319	0.04732559692715523	0	0	32.66885245901639	110.86807091829407	EGFR
Cancer of Nasopharynx	1/62	0.03358440490598319	0.04732559692715523	0	0	32.66885245901639	110.86807091829407	EGFR
Osteomyelitis	1/62	0.03358440490598319	0.04732559692715523	0	0	32.66885245901639	110.86807091829407	STAT1
Pemphigus Vulgaris	1/62	0.03358440490598319	0.04732559692715523	0	0	32.66885245901639	110.86807091829407	EGFR
Phyllodes Tumor	1/62	0.03358440490598319	0.04732559692715523	0	0	32.66885245901639	110.86807091829407	EGFR
Retinoblastoma	2/539	0.033941505550653533	0.04764737605191683	0	0	8.049658597144631	27.232934115180058	NOS2;EGFR
Failure to gain weight	2/539	0.033941505550653533	0.04764737605191683	0	0	8.049658597144631	27.232934115180058	HBA1;EGFR
Lymphoma, Non-Hodgkin	2/539	0.033941505550653533	0.04764737605191683	0	0	8.049658597144631	27.232934115180058	NOS2;INSR
Lichen Planus, Oral	1/63	0.03411758472221407	0.04764737605191683	0	0	32.14032258064516	108.56815667877291	EGFR
gliosarcoma	1/63	0.03411758472221407	0.04764737605191683	0	0	32.14032258064516	108.56815667877291	EGFR
Abdomen distended	1/63	0.03411758472221407	0.04764737605191683	0	0	32.14032258064516	108.56815667877291	INSR
Viral hepatitis	1/63	0.03411758472221407	0.04764737605191683	0	0	32.14032258064516	108.56815667877291	APOE
Iron deficiency	1/63	0.03411758472221407	0.04764737605191683	0	0	32.14032258064516	108.56815667877291	HBA1
Brain Edema	1/63	0.03411758472221407	0.04764737605191683	0	0	32.14032258064516	108.56815667877291	NOS2
Neuro-degenerative disease	1/63	0.03411758472221407	0.04764737605191683	0	0	32.14032258064516	108.56815667877291	APOE
Chronic ear infection	1/63	0.03411758472221407	0.04764737605191683	0	0	32.14032258064516	108.56815667877291	TAP1
Papule	1/63	0.03411758472221407	0.04764737605191683	0	0	32.14032258064516	108.56815667877291	EGFR
Dystrophia myotonica 2	1/63	0.03411758472221407	0.04764737605191683	0	0	32.14032258064516	108.56815667877291	INSR
Pediatric failure to thrive	2/543	0.034406332776589825	0.048017629259636346	0	0	7.988498665023619	26.91736319705049	HBA1;EGFR
Adenocarcinoma, Endometrioid	1/64	0.03465049711893463	0.048028519881088104	0	0	31.62857142857143	106.3492751339043	EGFR
Extrapyramidal sign	1/64	0.03465049711893463	0.048028519881088104	0	0	31.62857142857143	106.3492751339043	APOE
Retinopathy of Prematurity	1/64	0.03465049711893463	0.048028519881088104	0	0	31.62857142857143	106.3492751339043	NOS2
Febrile Convulsions	1/64	0.03465049711893463	0.048028519881088104	0	0	31.62857142857143	106.3492751339043	APOE
High-Grade Squamous Intraepithelial Lesions	1/64	0.03465049711893463	0.048028519881088104	0	0	31.62857142857143	106.3492751339043	NOS2
Uterine Cancer	1/64	0.03465049711893463	0.048028519881088104	0	0	31.62857142857143	106.3492751339043	EGFR
Adult Medulloblastoma	1/64	0.03465049711893463	0.048028519881088104	0	0	31.62857142857143	106.3492751339043	IRS2
Chronic Fatigue Syndrome	1/64	0.03465049711893463	0.048028519881088104	0	0	31.62857142857143	106.3492751339043	NOS2
Oligohydramnios	1/64	0.03465049711893463	0.048028519881088104	0	0	31.62857142857143	106.3492751339043	HBA1
Diaphragmatic Hernia	1/64	0.03465049711893463	0.048028519881088104	0	0	31.62857142857143	106.3492751339043	NOS2
HEMOCHROMATOSIS, TYPE 1	1/65	0.035183142220876845	0.04866721919184599	0	0	31.1328125	104.20738341965524	APOE
Hepatic methionine adenosyltransferase deficiency	1/65	0.035183142220876845	0.04866721919184599	0	0	31.1328125	104.20738341965524	EGFR
Stress, Psychological	1/65	0.035183142220876845	0.04866721919184599	0	0	31.1328125	104.20738341965524	APOE
Shigella Infections	1/66	0.03571552014502453	0.0492026691082643	0	0	30.65230769230769	102.13869848967185	NOS2
Giant Cell Tumor of Bone	1/66	0.03571552014502453	0.0492026691082643	0	0	30.65230769230769	102.13869848967185	EGFR
GRN-related frontotemporal dementia	1/66	0.03571552014502453	0.0492026691082643	0	0	30.65230769230769	102.13869848967185	APOE
stage, non-small cell lung cancer	1/66	0.03571552014502453	0.0492026691082643	0	0	30.65230769230769	102.13869848967185	EGFR
Congenital arteriovenous malformation	1/66	0.03571552014502453	0.0492026691082643	0	0	30.65230769230769	102.13869848967185	APOE
Diffuse Astrocytoma	1/66	0.03571552014502453	0.0492026691082643	0	0	30.65230769230769	102.13869848967185	EGFR
High, narrow palate	1/67	0.03624763101785663	0.04956607417784971	0	0	30.186363636363637	100.13967676460433	INSR
Gestational Diabetes	1/67	0.03624763101785663	0.04956607417784971	0	0	30.186363636363637	100.13967676460433	INSR
Toxic Epidermal Necrolysis	1/67	0.03624763101785663	0.04956607417784971	0	0	30.186363636363637	100.13967676460433	NOS2
Arteriopathic disease	1/67	0.03624763101785663	0.04956607417784971	0	0	30.186363636363637	100.13967676460433	APOE
Multiple Chronic Conditions	1/67	0.03624763101785663	0.04956607417784971	0	0	30.186363636363637	100.13967676460433	EGFR
Nail dysplasia	1/67	0.03624763101785663	0.04956607417784971	0	0	30.186363636363637	100.13967676460433	INSR
Cerebral Hemorrhage	1/67	0.03624763101785663	0.04956607417784971	0	0	30.186363636363637	100.13967676460433	APOE
Cervical Adenocarcinoma	1/67	0.03624763101785663	0.04956607417784971	0	0	30.186363636363637	100.13967676460433	EGFR
neurofibroma	1/67	0.03624763101785663	0.04956607417784971	0	0	30.186363636363637	100.13967676460433	EGFR
Congenital Hypothyroidism	1/67	0.03624763101785663	0.04956607417784971	0	0	30.186363636363637	100.13967676460433	NOS2
Parasitemia	1/67	0.03624763101785663	0.04956607417784971	0	0	30.186363636363637	100.13967676460433	APOE
Recurrent infections	1/68	0.036779474955290804	0.05005753054866103	0	0	29.734328358208955	98.20699568293153	INSR
Carcinoma, Large Cell	1/68	0.036779474955290804	0.05005753054866103	0	0	29.734328358208955	98.20699568293153	EGFR
Human papilloma virus infection	1/68	0.036779474955290804	0.05005753054866103	0	0	29.734328358208955	98.20699568293153	EGFR
Adenomatous polyp of colon	1/68	0.036779474955290804	0.05005753054866103	0	0	29.734328358208955	98.20699568293153	NOS2
Alveolar rhabdomyosarcoma	1/68	0.036779474955290804	0.05005753054866103	0	0	29.734328358208955	98.20699568293153	EGFR
Leishmaniasis	1/68	0.036779474955290804	0.05005753054866103	0	0	29.734328358208955	98.20699568293153	NOS2
Precocious Puberty	1/68	0.036779474955290804	0.05005753054866103	0	0	29.734328358208955	98.20699568293153	INSR
Simple Partial Status Epilepticus	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	NOS2
Grand Mal Status Epilepticus	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	NOS2
Hepatolenticular Degeneration	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	APOE
hiv-infection/aids	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	APOE
Status Epilepticus, Subclinical	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	NOS2
Malignant neoplasm of salivary gland	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	EGFR
Mucoepidermoid Carcinoma	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	EGFR
Non-Convulsive Status Epilepticus	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	NOS2
Chronic otitis media	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	TAP1
Complex Partial Status Epilepticus	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	NOS2
Diphtheria	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	EGFR
Progressive supranuclear palsy	1/69	0.03731105207809084	0.050376118154605035	0	0	29.29558823529412	96.33753689320037	APOE
Angina, Unstable	1/70	0.037842362503763806	0.0507364849561539	0	0	28.869565217391305	94.52837096535384	APOE
Respiratory Tract Infections	1/70	0.037842362503763806	0.0507364849561539	0	0	28.869565217391305	94.52837096535384	STAT1
Funny looking face	1/70	0.037842362503763806	0.0507364849561539	0	0	28.869565217391305	94.52837096535384	INSR
Leukoplakia, Oral	1/70	0.037842362503763806	0.0507364849561539	0	0	28.869565217391305	94.52837096535384	EGFR
Squamous cell carcinoma of oropharynx	1/70	0.037842362503763806	0.0507364849561539	0	0	28.869565217391305	94.52837096535384	EGFR
alpha-Thalassemia	1/70	0.037842362503763806	0.0507364849561539	0	0	28.869565217391305	94.52837096535384	HBA1
Neck Neoplasms	1/70	0.037842362503763806	0.0507364849561539	0	0	28.869565217391305	94.52837096535384	EGFR
Philadelphia chromosome-positive acute lymphoblastic leukemia	1/70	0.037842362503763806	0.0507364849561539	0	0	28.869565217391305	94.52837096535384	HSP90AB1
Deformity of face	1/70	0.037842362503763806	0.0507364849561539	0	0	28.869565217391305	94.52837096535384	INSR
Distortion of face	1/70	0.037842362503763806	0.0507364849561539	0	0	28.869565217391305	94.52837096535384	INSR
Autism Spectrum Disorders	2/572	0.037852613776343164	0.0507364849561539	0	0	7.570760233918128	24.787087254804586	NOS2;IRS2
Diffuse Large B-Cell Lymphoma	2/575	0.03821667709890402	0.051164541805057445	0	0	7.529959278650378	24.581426204672795	NOS2;STAT1
Rhabdoid Tumor	1/71	0.038373406353793084	0.051164541805057445	0	0	28.455714285714286	92.77674343537714	EGFR
Splenic Marginal Zone B-Cell Lymphoma	1/71	0.038373406353793084	0.051164541805057445	0	0	28.455714285714286	92.77674343537714	BHLHE40
Tracheal Diseases	1/71	0.038373406353793084	0.051164541805057445	0	0	28.455714285714286	92.77674343537714	EGFR
Neurofibromatoses	1/71	0.038373406353793084	0.051164541805057445	0	0	28.455714285714286	92.77674343537714	EGFR
Pediatric Obesity	1/71	0.038373406353793084	0.051164541805057445	0	0	28.455714285714286	92.77674343537714	APOE
Duodenal Ulcer	1/71	0.038373406353793084	0.051164541805057445	0	0	28.455714285714286	92.77674343537714	NOS2
Pterygium	1/71	0.038373406353793084	0.051164541805057445	0	0	28.455714285714286	92.77674343537714	EGFR
Hallucinations	1/72	0.03890418375818435	0.05173645379360641	0	0	28.053521126760565	91.0800620630536	APOE
Hyperuricemia	1/72	0.03890418375818435	0.05173645379360641	0	0	28.053521126760565	91.0800620630536	APOE
alpha^+^ Thalassemia	1/72	0.03890418375818435	0.05173645379360641	0	0	28.053521126760565	91.0800620630536	HBA1
Rectal Neoplasms	1/72	0.03890418375818435	0.05173645379360641	0	0	28.053521126760565	91.0800620630536	EGFR
Intellectual Disability	4/2503	0.039076206083153604	0.05193123005949518	0	0	3.999314011318813	12.966742008200848	STAT1;INSR;APOE;HBA1
Guillain-Barre Syndrome	1/73	0.039434694821538385	0.05220280122303974	0	0	27.6625	89.43588520720674	APOE
Urinary tract infection	1/73	0.039434694821538385	0.05220280122303974	0	0	27.6625	89.43588520720674	NOS2
Withdrawal Symptoms	1/73	0.039434694821538385	0.05220280122303974	0	0	27.6625	89.43588520720674	NOS2
Attention Deficit Disorder	1/73	0.039434694821538385	0.05220280122303974	0	0	27.6625	89.43588520720674	APOE
Marfan Syndrome	1/73	0.039434694821538385	0.05220280122303974	0	0	27.6625	89.43588520720674	NOS2
Bone neoplasms	1/73	0.039434694821538385	0.05220280122303974	0	0	27.6625	89.43588520720674	EGFR
Malignant Neoplasms	3/1438	0.03956158621170711	0.05233668175923754	0	0	4.848606271777004	15.66049728373705	NOS2;STAT1;EGFR
Hamartoma	1/74	0.03996493967487146	0.052664563825770956	0	0	27.28219178082192	87.84191112168185	EGFR
Spondylarthritis	1/74	0.03996493967487146	0.052664563825770956	0	0	27.28219178082192	87.84191112168185	STAT1
Hereditary gingival fibromatosis	1/74	0.03996493967487146	0.052664563825770956	0	0	27.28219178082192	87.84191112168185	EGFR
Acoustic Neuroma	1/74	0.03996493967487146	0.052664563825770956	0	0	27.28219178082192	87.84191112168185	EGFR
Marginal Zone B-Cell Lymphoma	1/74	0.03996493967487146	0.052664563825770956	0	0	27.28219178082192	87.84191112168185	NOS2
Chronic heart failure	1/74	0.03996493967487146	0.052664563825770956	0	0	27.28219178082192	87.84191112168185	NOS2
Medulloblastoma	2/590	0.04005786532716664	0.05275280774128491	0	0	7.332199546485261	23.590840524980877	IRS2;EGFR
Shy-Drager Syndrome	1/75	0.04049491842710541	0.053121803901793545	0	0	26.91216216216216	86.2959682120762	APOE
Breast Fibrocystic Disease	1/75	0.04049491842710541	0.053121803901793545	0	0	26.91216216216216	86.2959682120762	EGFR
Central Nervous System Neoplasms	1/75	0.04049491842710541	0.053121803901793545	0	0	26.91216216216216	86.2959682120762	EGFR
MYOTONIC DYSTROPHY 1	1/75	0.04049491842710541	0.053121803901793545	0	0	26.91216216216216	86.2959682120762	INSR
Comatose	1/75	0.04049491842710541	0.053121803901793545	0	0	26.91216216216216	86.2959682120762	APOE
Endometrial Hyperplasia	1/75	0.04049491842710541	0.053121803901793545	0	0	26.91216216216216	86.2959682120762	APOE
Machado-Joseph Disease	1/76	0.041024631208246766	0.053643533214387015	0	0	26.552	84.79600603121183	APOE
Autoimmune thrombocytopenia	1/76	0.041024631208246766	0.053643533214387015	0	0	26.552	84.79600603121183	STAT1
Chest Pain	1/76	0.041024631208246766	0.053643533214387015	0	0	26.552	84.79600603121183	NOS2
Congenital pectus carinatum	1/76	0.041024631208246766	0.053643533214387015	0	0	26.552	84.79600603121183	HBA1
Petit mal status	1/76	0.041024631208246766	0.053643533214387015	0	0	26.552	84.79600603121183	NOS2
Niemann-Pick Disease, Type C	1/77	0.0415540781399269	0.05419633297838989	0	0	26.201315789473686	83.34008705275691	APOE
High-Grade Prostatic Intraepithelial Neoplasia	1/77	0.0415540781399269	0.05419633297838989	0	0	26.201315789473686	83.34008705275691	EGFR
Non-small cell lung cancer stage I	1/77	0.0415540781399269	0.05419633297838989	0	0	26.201315789473686	83.34008705275691	EGFR
PANIC DISORDER 1	1/77	0.0415540781399269	0.05419633297838989	0	0	26.201315789473686	83.34008705275691	APOE
Full lower lip	1/78	0.042083259330542556	0.05450170998066442	0	0	25.85974025974026	81.92637908684091	INSR
Sicca Syndrome	1/78	0.042083259330542556	0.05450170998066442	0	0	25.85974025974026	81.92637908684091	HBA1
Stereotyped Behavior	1/78	0.042083259330542556	0.05450170998066442	0	0	25.85974025974026	81.92637908684091	EGFR
Sudden infant death syndrome	1/78	0.042083259330542556	0.05450170998066442	0	0	25.85974025974026	81.92637908684091	APOE
Thick lower lip vermilion	1/78	0.042083259330542556	0.05450170998066442	0	0	25.85974025974026	81.92637908684091	INSR
Androgen-Insensitivity Syndrome	1/78	0.042083259330542556	0.05450170998066442	0	0	25.85974025974026	81.92637908684091	EGFR
Marinesco-Sjogren syndrome	1/78	0.042083259330542556	0.05450170998066442	0	0	25.85974025974026	81.92637908684091	EGFR
Peripheral Vascular Diseases	1/78	0.042083259330542556	0.05450170998066442	0	0	25.85974025974026	81.92637908684091	APOE
Dyskinetic syndrome	1/78	0.042083259330542556	0.05450170998066442	0	0	25.85974025974026	81.92637908684091	APOE
Pulmonary Edema	1/78	0.042083259330542556	0.05450170998066442	0	0	25.85974025974026	81.92637908684091	NOS2
Pulmonary Embolism	1/78	0.042083259330542556	0.05450170998066442	0	0	25.85974025974026	81.92637908684091	APOE
Congenital Abnormality	2/607	0.04218605283185794	0.05460003780530912	0	0	7.1199265381083565	22.539306617195834	STAT1;INSR
Glioblastoma, IDH-Wildtype	1/79	0.04261217490903927	0.05504636962184856	0	0	25.526923076923076	80.55314827174135	EGFR
Gliosis	1/79	0.04261217490903927	0.05504636962184856	0	0	25.526923076923076	80.55314827174135	EGFR
Malignancy	1/79	0.04261217490903927	0.05504636962184856	0	0	25.526923076923076	80.55314827174135	EGFR
Dementia, Vascular	1/80	0.04314082499469826	0.05555269733157596	0	0	25.20253164556962	79.21875265135186	APOE
Intestinal Diseases	1/80	0.04314082499469826	0.05555269733157596	0	0	25.20253164556962	79.21875265135186	NOS2
Luminal B Breast Carcinoma	1/80	0.04314082499469826	0.05555269733157596	0	0	25.20253164556962	79.21875265135186	EGFR
Paroxysmal kinesigenic choreoathetosis	1/80	0.04314082499469826	0.05555269733157596	0	0	25.20253164556962	79.21875265135186	EGFR
Prion Diseases	1/80	0.04314082499469826	0.05555269733157596	0	0	25.20253164556962	79.21875265135186	APOE
Sensory neuropathy	1/81	0.04366920970201921	0.056090919162138445	0	0	24.88625	77.92163622636126	APOE
Vascular lesions	1/81	0.04366920970201921	0.056090919162138445	0	0	24.88625	77.92163622636126	APOE
Peptic Ulcer	1/81	0.04366920970201921	0.056090919162138445	0	0	24.88625	77.92163622636126	EGFR
Primary immune deficiency disorder	1/81	0.04366920970201921	0.056090919162138445	0	0	24.88625	77.92163622636126	STAT1
Hyperlipidemia, Familial Combined	1/82	0.04419732915189926	0.05669758386152733	0	0	24.57777777777778	76.6603234550211	APOE
Cholecystolithiasis	1/82	0.04419732915189926	0.05669758386152733	0	0	24.57777777777778	76.6603234550211	APOE
Carcinoma, Neuroendocrine	1/83	0.044725183473176736	0.05714782732428555	0	0	24.276829268292683	75.43341417316094	EGFR
Hay fever	1/83	0.044725183473176736	0.05714782732428555	0	0	24.276829268292683	75.43341417316094	EGFR
Hydatidiform Mole	1/83	0.044725183473176736	0.05714782732428555	0	0	24.276829268292683	75.43341417316094	EGFR
Van der Woude syndrome	1/83	0.044725183473176736	0.05714782732428555	0	0	24.276829268292683	75.43341417316094	STAT1
Maturity onset diabetes mellitus in young	1/83	0.044725183473176736	0.05714782732428555	0	0	24.276829268292683	75.43341417316094	INSR
Protein Deficiency	1/83	0.044725183473176736	0.05714782732428555	0	0	24.276829268292683	75.43341417316094	STAT1
Huntington Disease	2/627	0.04474517385479247	0.05714782732428555	0	0	6.884977777777777	21.390054024918047	IRS2;APOE
Arthritis	2/630	0.04513412740528976	0.05760838372333467	0	0	6.85102618542109	21.225278043983863	NOS2;EGFR
Skin Ulcer	1/84	0.0452527727730833	0.057615059069489515	0	0	23.983132530120482	74.23957890820988	TAP1
Soft Tissue Neoplasms	1/84	0.0452527727730833	0.057615059069489515	0	0	23.983132530120482	74.23957890820988	EGFR
Hemochromatosis	1/84	0.0452527727730833	0.057615059069489515	0	0	23.983132530120482	74.23957890820988	APOE
Chronic sinusitis	1/84	0.0452527727730833	0.057615059069489515	0	0	23.983132530120482	74.23957890820988	TAP1
Hurthle Cell Tumor	1/85	0.0457800971719973	0.05814072340843657	0	0	23.696428571428573	73.07755450297252	EGFR
Increased tendency to bruise	1/85	0.0457800971719973	0.05814072340843657	0	0	23.696428571428573	73.07755450297252	HBA1
Demyelinating Diseases	1/85	0.0457800971719973	0.05814072340843657	0	0	23.696428571428573	73.07755450297252	EGFR
Prostatic Hyperplasia	1/85	0.0457800971719973	0.05814072340843657	0	0	23.696428571428573	73.07755450297252	EGFR
Esophageal Neoplasms	2/637	0.04604678621099005	0.05844289168065696	0	0	6.773053368328959	20.84811733888924	NOS2;EGFR
Cystadenocarcinoma, Serous	1/86	0.04630715680061324	0.05855391575534916	0	0	23.416470588235295	71.94614007723759	EGFR
Leishmaniasis, Visceral	1/86	0.04630715680061324	0.05855391575534916	0	0	23.416470588235295	71.94614007723759	NOS2
Malaria, Cerebral	1/86	0.04630715680061324	0.05855391575534916	0	0	23.416470588235295	71.94614007723759	NOS2
Leukoencephalopathies	1/86	0.04630715680061324	0.05855391575534916	0	0	23.416470588235295	71.94614007723759	APOE
Myocardial Reperfusion Injury	1/86	0.04630715680061324	0.05855391575534916	0	0	23.416470588235295	71.94614007723759	NOS2
Postnatal growth retardation	1/86	0.04630715680061324	0.05855391575534916	0	0	23.416470588235295	71.94614007723759	INSR
Immunologic Deficiency Syndromes	2/641	0.046571494485717395	0.05885154029538417	0	0	6.729264475743349	20.637083747632698	STAT1;EGFR
Gynecomastia	1/87	0.04683395176457438	0.05903634614492254	0	0	23.143023255813954	70.84419329504821	INSR
Actinic keratosis	1/87	0.04683395176457438	0.05903634614492254	0	0	23.143023255813954	70.84419329504821	EGFR
Chronic active hepatitis	1/87	0.04683395176457438	0.05903634614492254	0	0	23.143023255813954	70.84419329504821	STAT1
Dysmorphic facies	1/87	0.04683395176457438	0.05903634614492254	0	0	23.143023255813954	70.84419329504821	INSR
Brain Tumor, Primary	1/88	0.04736048219236788	0.05951546061526996	0	0	22.875862068965517	69.77062685533508	EGFR
Retroviridae Infections	1/88	0.04736048219236788	0.05951546061526996	0	0	22.875862068965517	69.77062685533508	EGFR
Iron Overload	1/88	0.04736048219236788	0.05951546061526996	0	0	22.875862068965517	69.77062685533508	APOE
Alcohol Use Disorder	1/88	0.04736048219236788	0.05951546061526996	0	0	22.875862068965517	69.77062685533508	BHLHE41
Chordoma	1/88	0.04736048219236788	0.05951546061526996	0	0	22.875862068965517	69.77062685533508	EGFR
Malaria, Falciparum	1/89	0.04788674820170976	0.059991289978960693	0	0	22.614772727272726	68.72440526863295	NOS2
Bronchioloalveolar Adenocarcinoma	1/89	0.04788674820170976	0.059991289978960693	0	0	22.614772727272726	68.72440526863295	EGFR
Nasopharyngeal Neoplasms	1/89	0.04788674820170976	0.059991289978960693	0	0	22.614772727272726	68.72440526863295	EGFR
Chagas Disease	1/89	0.04788674820170976	0.059991289978960693	0	0	22.614772727272726	68.72440526863295	NOS2
Creutzfeldt-Jakob disease	1/89	0.04788674820170976	0.059991289978960693	0	0	22.614772727272726	68.72440526863295	APOE
Skin carcinoma	1/90	0.04841274991635465	0.06050105032597334	0	0	22.359550561797754	67.70454183296923	EGFR
Hip circumference	1/90	0.04841274991635465	0.06050105032597334	0	0	22.359550561797754	67.70454183296923	INSR
Adenovirus Infections	1/90	0.04841274991635465	0.06050105032597334	0	0	22.359550561797754	67.70454183296923	EGFR
Dehydration	1/90	0.04841274991635465	0.06050105032597334	0	0	22.359550561797754	67.70454183296923	HBA1
Prolactinoma	1/91	0.048938487444328285	0.06108292781749084	0	0	22.11	66.71009583505662	EGFR
Embryonal Rhabdomyosarcoma	1/91	0.048938487444328285	0.06108292781749084	0	0	22.11	66.71009583505662	EGFR
Thyroid associated opthalmopathies	1/92	0.04946396091014192	0.06162524130558454	0	0	21.865934065934066	65.74016991684287	STAT1
Adrenal Cortical Adenoma	1/92	0.04946396091014192	0.06162524130558454	0	0	21.865934065934066	65.74016991684287	EGFR
Premature aging syndrome	1/92	0.04946396091014192	0.06162524130558454	0	0	21.865934065934066	65.74016991684287	APOE
Liver Cirrhosis, Alcoholic	1/93	0.049989170431872655	0.061862359511306475	0	0	21.627173913043478	64.79390764349345	APOE
Small for gestational age (disorder)	1/93	0.049989170431872655	0.061862359511306475	0	0	21.627173913043478	64.79390764349345	INSR
Speech Disorders	1/93	0.049989170431872655	0.061862359511306475	0	0	21.627173913043478	64.79390764349345	HBA1
PARKINSON DISEASE, LATE-ONSET	1/93	0.049989170431872655	0.061862359511306475	0	0	21.627173913043478	64.79390764349345	APOE
Intraepithelial Neoplasia	1/93	0.049989170431872655	0.061862359511306475	0	0	21.627173913043478	64.79390764349345	EGFR
Low Birth Weights	1/93	0.049989170431872655	0.061862359511306475	0	0	21.627173913043478	64.79390764349345	INSR
Mucinous Adenocarcinoma	1/93	0.049989170431872655	0.061862359511306475	0	0	21.627173913043478	64.79390764349345	EGFR
Panic Disorder	1/93	0.049989170431872655	0.061862359511306475	0	0	21.627173913043478	64.79390764349345	APOE
Coughing	1/93	0.049989170431872655	0.061862359511306475	0	0	21.627173913043478	64.79390764349345	EGFR
Pregnancy Complications	1/93	0.049989170431872655	0.061862359511306475	0	0	21.627173913043478	64.79390764349345	EGFR
Edema	1/93	0.049989170431872655	0.061862359511306475	0	0	21.627173913043478	64.79390764349345	APOE
Traditional Serrated Adenoma	1/94	0.05051411613720297	0.062397984188934004	0	0	21.393548387096775	63.87049121569168	EGFR
airway disease	1/94	0.05051411613720297	0.062397984188934004	0	0	21.393548387096775	63.87049121569168	EGFR
Myelodysplasia	1/94	0.05051411613720297	0.062397984188934004	0	0	21.393548387096775	63.87049121569168	IRS2
Small cell carcinoma of lung	2/673	0.0508512898874977	0.06273820343132686	0	0	6.397747971518464	19.057930203287096	TAP1;EGFR
Malignant neoplasm of esophagus	2/673	0.0508512898874977	0.06273820343132686	0	0	6.397747971518464	19.057930203287096	NOS2;EGFR
Renal cyst	1/95	0.051038798139041684	0.06277895751727161	0	0	21.164893617021278	62.96913934936651	EGFR
Sciatic Neuropathy	1/95	0.051038798139041684	0.06277895751727161	0	0	21.164893617021278	62.96913934936651	APOE
Gastric ulcer	1/95	0.051038798139041684	0.06277895751727161	0	0	21.164893617021278	62.96913934936651	NOS2
Membranous glomerulonephritis	1/95	0.051038798139041684	0.06277895751727161	0	0	21.164893617021278	62.96913934936651	APOE
Congenital diaphragmatic hernia	1/95	0.051038798139041684	0.06277895751727161	0	0	21.164893617021278	62.96913934936651	INSR
Autistic Disorder	2/677	0.051396373124504534	0.06315639303255123	0	0	6.358518518518519	18.87327627116092	NOS2;APOE
Renal failure in adulthood	1/96	0.051563216555611455	0.06315639303255123	0	0	20.94105263157895	62.08910527455818	APOE
Steroid Sulfatase Deficiency Disease	1/96	0.051563216555611455	0.06315639303255123	0	0	20.94105263157895	62.08910527455818	EGFR
PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	1/96	0.051563216555611455	0.06315639303255123	0	0	20.94105263157895	62.08910527455818	EGFR
Werner Syndrome	1/96	0.051563216555611455	0.06315639303255123	0	0	20.94105263157895	62.08910527455818	INSR
Aortic Aneurysm	1/96	0.051563216555611455	0.06315639303255123	0	0	20.94105263157895	62.08910527455818	APOE
Broad forehead	1/96	0.051563216555611455	0.06315639303255123	0	0	20.94105263157895	62.08910527455818	HBA1
Neoplasms, Intracranial	1/97	0.052087371500602615	0.0637215766942953	0	0	20.721875	61.22967487540231	EGFR
Ductal Breast Carcinoma	1/97	0.052087371500602615	0.0637215766942953	0	0	20.721875	61.22967487540231	EGFR
Secondary malignant neoplasm of lung	2/683	0.05221814169224765	0.06384311908462528	0	0	6.300538423886442	18.601239008057117	INSR;EGFR
Frontotemporal Lobar Degeneration	1/98	0.052611263106800116	0.06416931970769378	0	0	20.507216494845363	60.390164935250596	APOE
Henoch-Schoenlein Purpura	1/98	0.052611263106800116	0.06416931970769378	0	0	20.507216494845363	60.390164935250596	NOS2
Hypercalcemia	1/98	0.052611263106800116	0.06416931970769378	0	0	20.507216494845363	60.390164935250596	EGFR
Central Serous Chorioretinopathy	1/98	0.052611263106800116	0.06416931970769378	0	0	20.507216494845363	60.390164935250596	EGFR
Oral Cavity Carcinoma	1/100	0.05365825675086383	0.06532868646959575	0	0	20.09090909090909	58.768318421882675	EGFR
Polymyositis	1/100	0.05365825675086383	0.06532868646959575	0	0	20.09090909090909	58.768318421882675	NOS2
Rash and Dermatitis Adverse Event Associated with Chemoradiation	1/100	0.05365825675086383	0.06532868646959575	0	0	20.09090909090909	58.768318421882675	EGFR
Sleep disturbances	1/101	0.054181359025060244	0.06584720187734594	0	0	19.889	57.98475574455278	APOE
Neuromuscular Diseases	1/101	0.054181359025060244	0.06584720187734594	0	0	19.889	57.98475574455278	APOE
Otitis Media	1/101	0.054181359025060244	0.06584720187734594	0	0	19.889	57.98475574455278	NOS2
Heart Decompensation	1/102	0.05470419842989522	0.06620543848096908	0	0	19.69108910891089	57.218658530075224	NOS2
Hypertrophy of lower jaw	1/102	0.05470419842989522	0.06620543848096908	0	0	19.69108910891089	57.218658530075224	INSR
Inflammatory Breast Carcinoma	1/102	0.05470419842989522	0.06620543848096908	0	0	19.69108910891089	57.218658530075224	EGFR
Adult Acute Myeloblastic Leukemia	1/102	0.05470419842989522	0.06620543848096908	0	0	19.69108910891089	57.218658530075224	EGFR
mandibular excess (physical finding)	1/102	0.05470419842989522	0.06620543848096908	0	0	19.69108910891089	57.218658530075224	INSR
Mandibular hyperplasia	1/102	0.05470419842989522	0.06620543848096908	0	0	19.69108910891089	57.218658530075224	INSR
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	1/102	0.05470419842989522	0.06620543848096908	0	0	19.69108910891089	57.218658530075224	INSR
Ichthyosis, X-Linked	1/103	0.055226775078966374	0.06671867239028519	0	0	19.49705882352941	56.46947550554387	EGFR
HIV Coinfection	1/103	0.055226775078966374	0.06671867239028519	0	0	19.49705882352941	56.46947550554387	HSP90AB1
Hydrops Fetalis	1/103	0.055226775078966374	0.06671867239028519	0	0	19.49705882352941	56.46947550554387	HBA1
Respiratory distress	1/104	0.05574908910260626	0.06707054414238953	0	0	19.306796116504856	55.73667787879545	EGFR
Increased size of the mandible	1/104	0.05574908910260626	0.06707054414238953	0	0	19.306796116504856	55.73667787879545	INSR
Acute pancreatitis	1/104	0.05574908910260626	0.06707054414238953	0	0	19.306796116504856	55.73667787879545	APOE
Xerosis	1/104	0.05574908910260626	0.06707054414238953	0	0	19.306796116504856	55.73667787879545	INSR
Ischemia	1/104	0.05574908910260626	0.06707054414238953	0	0	19.306796116504856	55.73667787879545	APOE
Macrostomia	1/104	0.05574908910260626	0.06707054414238953	0	0	19.306796116504856	55.73667787879545	INSR
Carcinoid tumor no ICD-O subtype	1/104	0.05574908910260626	0.06707054414238953	0	0	19.306796116504856	55.73667787879545	EGFR
Leukoencephalopathy, Progressive Multifocal	1/105	0.0562711406066492	0.06753866374052639	0	0	19.120192307692307	55.01975823103713	STAT1
Mixed Salivary Gland Tumor	1/105	0.0562711406066492	0.06753866374052639	0	0	19.120192307692307	55.01975823103713	EGFR
Pick Disease of the Brain	1/105	0.0562711406066492	0.06753866374052639	0	0	19.120192307692307	55.01975823103713	APOE
Premature Obstetric Labor	1/105	0.0562711406066492	0.06753866374052639	0	0	19.120192307692307	55.01975823103713	EGFR
Heart Failure, Right-Sided	1/106	0.056792929712261776	0.06804435918355893	0	0	18.937142857142856	54.31822944685532	NOS2
Teratocarcinoma	1/106	0.056792929712261776	0.06804435918355893	0	0	18.937142857142856	54.31822944685532	APOE
Malignant Testicular Germ Cell Tumor	1/106	0.056792929712261776	0.06804435918355893	0	0	18.937142857142856	54.31822944685532	APOE
Dermatitis, Allergic Contact	1/107	0.05731445654280469	0.06854795508827495	0	0	18.75754716981132	53.63162372466097	EGFR
Basal cell carcinoma	1/107	0.05731445654280469	0.06854795508827495	0	0	18.75754716981132	53.63162372466097	EGFR
Pleural effusion disorder	1/107	0.05731445654280469	0.06854795508827495	0	0	18.75754716981132	53.63162372466097	EGFR
Thyroid carcinoma	2/721	0.05753600019133821	0.06877244258164662	0	0	5.955802812548292	17.005868427531887	STAT1;EGFR
Red cell distribution width determination	1/108	0.057835721217223385	0.06880690018348824	0	0	18.581308411214952	52.959491641957904	APOE
Carcinoma, Lewis Lung	1/108	0.057835721217223385	0.06880690018348824	0	0	18.581308411214952	52.959491641957904	EGFR
Secondary Neoplasm	1/108	0.057835721217223385	0.06880690018348824	0	0	18.581308411214952	52.959491641957904	EGFR
Tumor Promotion	1/108	0.057835721217223385	0.06880690018348824	0	0	18.581308411214952	52.959491641957904	STAT1
Waldenstrom Macroglobulinemia	1/108	0.057835721217223385	0.06880690018348824	0	0	18.581308411214952	52.959491641957904	NOS2
Myocardial Failure	1/108	0.057835721217223385	0.06880690018348824	0	0	18.581308411214952	52.959491641957904	NOS2
Class III malocclusion	1/108	0.057835721217223385	0.06880690018348824	0	0	18.581308411214952	52.959491641957904	INSR
RDW - Red blood cell distribution width result	1/108	0.057835721217223385	0.06880690018348824	0	0	18.581308411214952	52.959491641957904	APOE
Abortion, Tubal	1/110	0.058877464556040184	0.06976035450604877	0	0	18.238532110091743	51.65693734856973	APOE
Reperfusion Injury	1/110	0.058877464556040184	0.06976035450604877	0	0	18.238532110091743	51.65693734856973	NOS2
Hyperplastic Polyp	1/110	0.058877464556040184	0.06976035450604877	0	0	18.238532110091743	51.65693734856973	EGFR
Luminal A Breast Carcinoma	1/110	0.058877464556040184	0.06976035450604877	0	0	18.238532110091743	51.65693734856973	EGFR
Borderline Personality Disorder	1/110	0.058877464556040184	0.06976035450604877	0	0	18.238532110091743	51.65693734856973	EGFR
Post-Traumatic Stress Disorder	1/110	0.058877464556040184	0.06976035450604877	0	0	18.238532110091743	51.65693734856973	APOE
Dry skin	1/110	0.058877464556040184	0.06976035450604877	0	0	18.238532110091743	51.65693734856973	INSR
Umbilical hernia	1/111	0.059397943461760805	0.07029506180215374	0	0	18.07181818181818	51.02570047699274	INSR
Plasmacytoma	1/111	0.059397943461760805	0.07029506180215374	0	0	18.07181818181818	51.02570047699274	STAT1
Glomerulosclerosis (disorder)	1/112	0.059918160687097384	0.07066378555785369	0	0	17.90810810810811	50.40730639649694	APOE
Synovitis	1/112	0.059918160687097384	0.07066378555785369	0	0	17.90810810810811	50.40730639649694	STAT1
Uric acid measurement (procedure)	1/112	0.059918160687097384	0.07066378555785369	0	0	17.90810810810811	50.40730639649694	INSR
Infectious disease of lung	1/112	0.059918160687097384	0.07066378555785369	0	0	17.90810810810811	50.40730639649694	EGFR
Bilateral cataracts (disorder)	1/112	0.059918160687097384	0.07066378555785369	0	0	17.90810810810811	50.40730639649694	EGFR
Merkel cell carcinoma	1/112	0.059918160687097384	0.07066378555785369	0	0	17.90810810810811	50.40730639649694	EGFR
Astrocytoma	2/741	0.060411531615229615	0.07119434921004049	0	0	5.788603217561269	16.246150646831335	APOE;EGFR
Adenocarcinoma, Clear Cell	1/113	0.06043811633234245	0.07119434921004049	0	0	17.74732142857143	49.80138528268159	EGFR
Carcinoma, Endometrioid	1/114	0.060957810539318535	0.0716401290473209	0	0	17.58938053097345	49.20758106608857	EGFR
Head and Neck Carcinoma	1/114	0.060957810539318535	0.0716401290473209	0	0	17.58938053097345	49.20758106608857	EGFR
Neuroectodermal Tumor, Primitive	1/114	0.060957810539318535	0.0716401290473209	0	0	17.58938053097345	49.20758106608857	EGFR
leiomyosarcoma	1/114	0.060957810539318535	0.0716401290473209	0	0	17.58938053097345	49.20758106608857	IRS2
Neurodegenerative Disorders	2/745	0.06099282640347694	0.0716401290473209	0	0	5.756243457454763	16.100207318979436	APOE;EGFR
Pancreatic intraepithelial neoplasia	1/115	0.061477243410223426	0.07216739376636279	0	0	17.43421052631579	48.62555082904469	EGFR
Organic Mental Disorders, Substance-Induced	1/116	0.06199641507314463	0.07265093161974043	0	0	17.281739130434783	48.05496419291303	INSR
Ischemic cardiomyopathy	1/116	0.06199641507314463	0.07265093161974043	0	0	17.281739130434783	48.05496419291303	APOE
Prescription Drug Abuse	1/116	0.06199641507314463	0.07265093161974043	0	0	17.281739130434783	48.05496419291303	INSR
Carcinoma, Small Cell	1/117	0.06251532564178373	0.07313249378474644	0	0	17.13189655172414	47.49550276790471	EGFR
Hyperhomocysteinemia	1/117	0.06251532564178373	0.07313249378474644	0	0	17.13189655172414	47.49550276790471	APOE
Diastolic blood pressure	1/117	0.06251532564178373	0.07313249378474644	0	0	17.13189655172414	47.49550276790471	INSR
Anemia, Hemolytic	1/118	0.06303397522541687	0.07361209060807304	0	0	16.984615384615385	46.94685961789818	HBA1
Erectile dysfunction	1/118	0.06303397522541687	0.07361209060807304	0	0	16.984615384615385	46.94685961789818	NOS2
Systolic Pressure	1/118	0.06303397522541687	0.07361209060807304	0	0	16.984615384615385	46.94685961789818	INSR
Retrognathia	1/119	0.06355236396517258	0.0740048158035706	0	0	16.839830508474577	46.408738746473205	HBA1
Giant Cell Arteritis	1/119	0.06355236396517258	0.0740048158035706	0	0	16.839830508474577	46.408738746473205	NOS2
Von Hippel-Lindau Syndrome	1/119	0.06355236396517258	0.0740048158035706	0	0	16.839830508474577	46.408738746473205	EGFR
Muscle Rigidity	1/119	0.06355236396517258	0.0740048158035706	0	0	16.839830508474577	46.408738746473205	APOE
Drug Use Disorders	1/119	0.06355236396517258	0.0740048158035706	0	0	16.839830508474577	46.408738746473205	INSR
Liver Failure, Acute	1/120	0.06407049195104964	0.07456542934967518	0	0	16.69747899159664	45.88085464119431	NOS2
Hypodontia	1/121	0.06458835932221495	0.07508212021895926	0	0	16.5575	45.362931793382586	EGFR
Polyhydramnios	1/121	0.06458835932221495	0.07508212021895926	0	0	16.5575	45.362931793382586	HBA1
Pilocytic Astrocytoma	1/122	0.06510596618845048	0.07564055076897162	0	0	16.419834710743803	44.85470428875659	EGFR
Substance-Related Disorders	1/123	0.06562331267019857	0.07615452389825442	0	0	16.284426229508195	44.3559153884753	INSR
Peripheral T-Cell Lymphoma	1/123	0.06562331267019857	0.07615452389825442	0	0	16.284426229508195	44.3559153884753	NOS2
Hernia, Inguinal	1/124	0.06614039888187752	0.07662331272974636	0	0	16.151219512195123	43.86631714557356	INSR
Uterine Cervical Neoplasm	1/124	0.06614039888187752	0.07662331272974636	0	0	16.151219512195123	43.86631714557356	EGFR
CNS disorder	1/124	0.06614039888187752	0.07662331272974636	0	0	16.151219512195123	43.86631714557356	APOE
Familial M??ni??re disease	1/125	0.06665722494334128	0.07709019982064284	0	0	16.02016129032258	43.385670033586294	NOS2
Tetralogy of Fallot	1/125	0.06665722494334128	0.07709019982064284	0	0	16.02016129032258	43.385670033586294	APOE
Peripheral Arterial Diseases	1/125	0.06665722494334128	0.07709019982064284	0	0	16.02016129032258	43.385670033586294	APOE
Laryngeal Squamous Cell Carcinoma	1/126	0.06717379097360096	0.07751115460440497	0	0	15.8912	42.91374259788014	EGFR
Myocarditis	1/126	0.06717379097360096	0.07751115460440497	0	0	15.8912	42.91374259788014	NOS2
Nodule	1/126	0.06717379097360096	0.07751115460440497	0	0	15.8912	42.91374259788014	EGFR
Congenital anomaly of face	1/126	0.06717379097360096	0.07751115460440497	0	0	15.8912	42.91374259788014	INSR
Gastritis, Atrophic	1/127	0.0676900970783306	0.07801830814700385	0	0	15.764285714285714	42.45031112549025	EGFR
Hyperkeratosis	1/127	0.0676900970783306	0.07801830814700385	0	0	15.764285714285714	42.45031112549025	INSR
Ependymoma	1/128	0.06820614339416273	0.07843513490488889	0	0	15.639370078740157	41.99515931789825	EGFR
Hereditary Nonpolyposis Colorectal Cancer	1/128	0.06820614339416273	0.07843513490488889	0	0	15.639370078740157	41.99515931789825	EGFR
Biliary Tract Cancer	1/128	0.06820614339416273	0.07843513490488889	0	0	15.639370078740157	41.99515931789825	EGFR
Peritonitis	1/128	0.06820614339416273	0.07843513490488889	0	0	15.639370078740157	41.99515931789825	APOE
Rett Syndrome	1/129	0.06872193003096003	0.07876083577152328	0	0	15.51640625	41.54807800311569	NOS2
Hepatitis, Autoimmune	1/129	0.06872193003096003	0.07876083577152328	0	0	15.51640625	41.54807800311569	NOS2
Malignant neoplasm of larynx	1/129	0.06872193003096003	0.07876083577152328	0	0	15.51640625	41.54807800311569	EGFR
Chronic liver disease	1/129	0.06872193003096003	0.07876083577152328	0	0	15.51640625	41.54807800311569	APOE
early pregnancy	1/129	0.06872193003096003	0.07876083577152328	0	0	15.51640625	41.54807800311569	EGFR
Endometrial adenocarcinoma	1/129	0.06872193003096003	0.07876083577152328	0	0	15.51640625	41.54807800311569	EGFR
Tauopathies	1/130	0.06923745710256594	0.0792176310993322	0	0	15.395348837209303	41.1088648413353	APOE
Uveitis	1/130	0.06923745710256594	0.0792176310993322	0	0	15.395348837209303	41.1088648413353	STAT1
Aortic Valve Stenosis	1/130	0.06923745710256594	0.0792176310993322	0	0	15.395348837209303	41.1088648413353	APOE
Neoplastic Cell Transformation	1/131	0.0697527247352707	0.07971739969745222	0	0	15.276153846153846	40.677324049781355	NOS2
Disorder of eye	1/131	0.0697527247352707	0.07971739969745222	0	0	15.276153846153846	40.677324049781355	APOE
Sleep Apnea, Obstructive	1/132	0.07026773302402173	0.08021574916000682	0	0	15.158778625954199	40.253266151913586	APOE
Mouth Neoplasms	1/132	0.07026773302402173	0.08021574916000682	0	0	15.158778625954199	40.253266151913586	EGFR
High forehead	1/134	0.07129697211276262	0.08120821038852782	0	0	14.929323308270677	39.42687111437837	HBA1
Large auricle	1/134	0.07129697211276262	0.08120821038852782	0	0	14.929323308270677	39.42687111437837	INSR
Large pinnae	1/134	0.07129697211276262	0.08120821038852782	0	0	14.929323308270677	39.42687111437837	INSR
Macrotia	1/134	0.07129697211276262	0.08120821038852782	0	0	14.929323308270677	39.42687111437837	INSR
Hormone refractory prostate cancer	1/135	0.07181120313483334	0.08151975685473818	0	0	14.817164179104477	39.02418433444003	EGFR
Middle Cerebral Artery Occlusion	1/135	0.07181120313483334	0.08151975685473818	0	0	14.817164179104477	39.02418433444003	APOE
Motor Neuron Disease	1/135	0.07181120313483334	0.08151975685473818	0	0	14.817164179104477	39.02418433444003	APOE
Mycoses	1/135	0.07181120313483334	0.08151975685473818	0	0	14.817164179104477	39.02418433444003	STAT1
Neurilemmoma	1/135	0.07181120313483334	0.08151975685473818	0	0	14.817164179104477	39.02418433444003	EGFR
Dystonia Disorders	1/135	0.07181120313483334	0.08151975685473818	0	0	14.817164179104477	39.02418433444003	APOE
Amyotrophic Lateral Sclerosis, Sporadic	1/136	0.07232517529799497	0.08201158270397643	0	0	14.706666666666667	38.628280717587586	APOE
Vasculitis	1/136	0.07232517529799497	0.08201158270397643	0	0	14.706666666666667	38.628280717587586	NOS2
Lymphopenia	1/137	0.07283888870776588	0.08241014579854136	0	0	14.597794117647059	38.23899878007725	STAT1
Prominent eyes	1/137	0.07283888870776588	0.08241014579854136	0	0	14.597794117647059	38.23899878007725	INSR
Protruding eyes	1/137	0.07283888870776588	0.08241014579854136	0	0	14.597794117647059	38.23899878007725	INSR
Pruritus	1/137	0.07283888870776588	0.08241014579854136	0	0	14.597794117647059	38.23899878007725	EGFR
Hamartoma Syndrome, Multiple	1/138	0.0733523435107302	0.0828066455632243	0	0	14.49051094890511	37.8561820013699	EGFR
Spontaneous abortion	1/138	0.0733523435107302	0.0828066455632243	0	0	14.49051094890511	37.8561820013699	APOE
Ureteral obstruction	1/138	0.0733523435107302	0.0828066455632243	0	0	14.49051094890511	37.8561820013699	NOS2
Drug habituation	1/138	0.0733523435107302	0.0828066455632243	0	0	14.49051094890511	37.8561820013699	INSR
Differentiated Thyroid Gland Carcinoma	1/139	0.07386553979752421	0.08329343888377867	0	0	14.384782608695652	37.47967865613064	EGFR
Prominent globes	1/139	0.07386553979752421	0.08329343888377867	0	0	14.384782608695652	37.47967865613064	INSR
Cholangitis, Sclerosing	1/140	0.0743784776967384	0.08373244691400135	0	0	14.280575539568344	37.10934161629211	NOS2
Substance Dependence	1/140	0.0743784776967384	0.08373244691400135	0	0	14.280575539568344	37.10934161629211	INSR
Thyroid Diseases	1/140	0.0743784776967384	0.08373244691400135	0	0	14.280575539568344	37.10934161629211	INSR
Exophthalmos	1/142	0.07540357879431908	0.08474561510511967	0	0	14.076595744680851	36.38659995556786	INSR
Vascular inflammations	1/142	0.07540357879431908	0.08474561510511967	0	0	14.076595744680851	36.38659995556786	APOE
Clear-cell metastatic renal cell carcinoma	1/142	0.07540357879431908	0.08474561510511967	0	0	14.076595744680851	36.38659995556786	INSR
Substance Use Disorders	1/143	0.07591574223870662	0.08522695482268057	0	0	13.976760563380282	36.0339226016509	INSR
Myositis	1/143	0.07591574223870662	0.08522695482268057	0	0	13.976760563380282	36.0339226016509	APOE
Generalized osteopenia	1/145	0.0769392954545684	0.08628071101748509	0	0	13.78125	35.345302987506315	STAT1
Nerve Degeneration	1/145	0.0769392954545684	0.08628071101748509	0	0	13.78125	35.345302987506315	APOE
Hematological Disease	1/147	0.07796181792371293	0.08737915831273287	0	0	13.591095890410958	34.67817161188282	EGFR
Mild cognitive disorder	1/150	0.07949367100398377	0.08904693466377894	0	0	13.315436241610739	33.71572144348522	APOE
Lung Diseases, Interstitial	1/151	0.0800037743240655	0.08947037392762856	0	0	13.226	33.40466307421403	EGFR
Thickened facial skin with coarse facial features	1/151	0.0800037743240655	0.08947037392762856	0	0	13.226	33.40466307421403	INSR
Malignant Squamous Cell Neoplasm	1/151	0.0800037743240655	0.08947037392762856	0	0	13.226	33.40466307421403	EGFR
Coarse facial features	1/152	0.08051362066732017	0.08994154876085463	0	0	13.137748344370861	33.09830919045184	INSR
Decreased platelet count	1/152	0.08051362066732017	0.08994154876085463	0	0	13.137748344370861	33.09830919045184	APOE
Squamous cell carcinoma of tongue	1/153	0.08102321014440983	0.09041140198431674	0	0	13.050657894736842	32.79655934812105	EGFR
Hyperlipoproteinemia Type IIa	1/153	0.08102321014440983	0.09041140198431674	0	0	13.050657894736842	32.79655934812105	APOE
Myeloid Leukemia, Chronic	2/876	0.08110086314620708	0.09044838304780066	0	0	4.860157640478007	12.209015742767305	STAT1;EGFR
Breast Cancer, Familial	1/154	0.08153254285811609	0.0908301135349188	0	0	12.964705882352941	32.49931587760663	EGFR
Myoclonus	1/154	0.08153254285811609	0.0908301135349188	0	0	12.964705882352941	32.49931587760663	APOE
Substance abuse problem	1/155	0.08204161892727208	0.09119724817298516	0	0	12.87987012987013	32.20648378609581	INSR
Abnormality of metabolism/homeostasis	1/155	0.08204161892727208	0.09119724817298516	0	0	12.87987012987013	32.20648378609581	HBA1
Aplastic Anemia	1/155	0.08204161892727208	0.09119724817298516	0	0	12.87987012987013	32.20648378609581	NOS2
Other specified transient cerebral ischemias	1/155	0.08204161892727208	0.09119724817298516	0	0	12.87987012987013	32.20648378609581	APOE
Malignant tumor of cervix	2/884	0.08239223724012909	0.09153691966754636	0	0	4.814058956916099	12.017162331623163	TAP1;EGFR
Hypertriglyceridemia	1/157	0.08305900162289738	0.09222726300422267	0	0	12.713461538461539	31.63368662685563	APOE
Intestinal Neoplasms	1/158	0.08356730847927372	0.09274099990709132	0	0	12.631847133757962	31.35354417908075	EGFR
Turner Syndrome	1/160	0.08458315378296152	0.09371481378788321	0	0	12.471698113207546	30.805345769798908	NOS2
Hypotrophic malar bone	1/160	0.08458315378296152	0.09371481378788321	0	0	12.471698113207546	30.805345769798908	HBA1
Malar flattening	1/160	0.08458315378296152	0.09371481378788321	0	0	12.471698113207546	30.805345769798908	HBA1
Familial multiple trichoepitheliomata	1/161	0.08509069246445834	0.09422576953012499	0	0	12.393125	30.537126243364618	EGFR
Nephritis	1/162	0.08559797531574136	0.09473588553463314	0	0	12.315527950310559	30.27272103834212	NOS2
Inflammatory dermatosis	1/163	0.08610500246845536	0.09519334331659482	0	0	12.238888888888889	30.012053634065264	EGFR
Metastatic malignant neoplasm to brain	1/163	0.08610500246845536	0.09519334331659482	0	0	12.238888888888889	30.012053634065264	EGFR
TARSAL-CARPAL COALITION SYNDROME	1/165	0.0871182901028945	0.09620889428754437	0	0	12.088414634146341	29.50163602107077	EGFR
Bone Diseases	1/165	0.0871182901028945	0.09620889428754437	0	0	12.088414634146341	29.50163602107077	EGFR
invasive cancer	1/166	0.08762455080335183	0.09661046512881763	0	0	12.014545454545454	29.25174245169941	EGFR
Anaplastic astrocytoma	1/166	0.08762455080335183	0.09661046512881763	0	0	12.014545454545454	29.25174245169941	EGFR
Classical Hodgkin's Lymphoma	1/166	0.08762455080335183	0.09661046512881763	0	0	12.014545454545454	29.25174245169941	STAT1
Follicular thyroid carcinoma	1/167	0.08813055627545927	0.09706303000093942	0	0	11.94156626506024	29.005299838184783	EGFR
Transitional cell carcinoma of bladder	1/167	0.08813055627545927	0.09706303000093942	0	0	11.94156626506024	29.005299838184783	EGFR
Developmental Disabilities	1/170	0.0896470423587413	0.09867973460073799	0	0	11.727810650887575	28.286014139881967	EGFR
Keloid	1/171	0.09015202801117	0.09912820396033413	0	0	11.658235294117647	28.052720002675226	EGFR
Blood Coagulation Disorders	1/171	0.09015202801117	0.09912820396033413	0	0	11.658235294117647	28.052720002675226	APOE
Increase in blood pressure	1/174	0.0916654573897091	0.10073780931091882	0	0	11.454335260115608	27.371390211455186	EGFR
Well Differentiated Oligodendroglioma	1/176	0.09267313851462232	0.10168024700956402	0	0	11.322285714285714	26.932056271780073	EGFR
Anaplastic thyroid carcinoma	1/176	0.09267313851462232	0.10168024700956402	0	0	11.322285714285714	26.932056271780073	EGFR
Mucosa-Associated Lymphoid Tissue Lymphoma	1/176	0.09267313851462232	0.10168024700956402	0	0	11.322285714285714	26.932056271780073	NOS2
Refractory cancer	1/177	0.09317659789866893	0.10212235540997587	0	0	11.257386363636364	26.716689950337756	EGFR
Hemoglobin low	1/177	0.09317659789866893	0.10212235540997587	0	0	11.257386363636364	26.716689950337756	HBA1
Scleroderma	1/179	0.09418275481990468	0.10316946511808427	0	0	11.129775280898876	26.29429648508577	EGFR
Epilepsy, Temporal Lobe	1/181	0.09518789678290693	0.1042143352709412	0	0	11.005	25.88268679130435	APOE
Mental impairment	1/182	0.09569008743413483	0.10465137656951667	0	0	10.94364640883978	25.680804597127995	INSR
Nephrotic Syndrome	1/182	0.09569008743413483	0.10465137656951667	0	0	10.94364640883978	25.680804597127995	APOE
cervical cancer	2/965	0.09584082683317137	0.10475984944863057	0	0	4.390446521287643	10.295889133629759	TAP1;EGFR
Myocardial Infarction	2/966	0.0960109379905892	0.10488936881552541	0	0	4.385661595205164	10.276890803219555	NOS2;APOE
Immune thrombocytopenic purpura	1/183	0.09619202467720508	0.10497432553387795	0	0	10.882967032967032	25.481475089201393	STAT1
oligodendroglioma	1/183	0.09619202467720508	0.10497432553387795	0	0	10.882967032967032	25.481475089201393	EGFR
Ulcer	1/184	0.09669370864692724	0.10546517228693297	0	0	10.822950819672132	25.28465280718741	NOS2
Respiratory Failure	1/185	0.09719513944744818	0.10584165238864666	0	0	10.763586956521738	25.09029334075939	EGFR
Adrenocortical carcinoma	1/185	0.09719513944744818	0.10584165238864666	0	0	10.763586956521738	25.09029334075939	EGFR
Malignant neoplasm of testis	1/185	0.09719513944744818	0.10584165238864666	0	0	10.763586956521738	25.09029334075939	APOE
Vomiting	1/187	0.0981972419952157	0.10681841313398197	0	0	10.646774193548387	24.708790265386604	EGFR
Craniofacial Abnormalities	1/187	0.0981972419952157	0.10681841313398197	0	0	10.646774193548387	24.708790265386604	EGFR
Acquired Immunodeficiency Syndrome	1/188	0.09869791397691897	0.10713363312024538	0	0	10.589304812834225	24.521562804501926	APOE
Malignant Peripheral Nerve Sheath Tumor	1/188	0.09869791397691897	0.10713363312024538	0	0	10.589304812834225	24.521562804501926	EGFR
Bronchopulmonary Dysplasia	1/188	0.09869791397691897	0.10713363312024538	0	0	10.589304812834225	24.521562804501926	EGFR
Dyspnea	1/188	0.09869791397691897	0.10713363312024538	0	0	10.589304812834225	24.521562804501926	EGFR
Dermatitis	1/190	0.09969849992916127	0.10816196041433834	0	0	10.476190476190476	24.153953454960053	EGFR
Transient Ischemic Attack	1/191	0.10019841413797581	0.10858836134846232	0	0	10.420526315789473	23.973493243187676	APOE
Platelet Count measurement	1/191	0.10019841413797581	0.10858836134846232	0	0	10.420526315789473	23.973493243187676	APOE
Disseminated Malignant Neoplasm	1/195	0.10219554842566242	0.11069368571478999	0	0	10.20360824742268	23.273074961378544	EGFR
Carcinoma, Papillary	1/196	0.1026942019426715	0.1111153452329651	0	0	10.150769230769232	23.103146910880294	HSP90AB1
Spinal Muscular Atrophy	1/196	0.1026942019426715	0.1111153452329651	0	0	10.150769230769232	23.103146910880294	APOE
Tuberous Sclerosis	1/197	0.10319260367144364	0.11153583545764548	0	0	10.098469387755102	22.93522053097424	EGFR
Allergic asthma	1/197	0.10319260367144364	0.11153583545764548	0	0	10.098469387755102	22.93522053097424	TAP1
Congenital clubfoot	1/198	0.10369075371831592	0.11201467918958956	0	0	10.046700507614213	22.769262652105503	HBA1
Aplasia Cutis Congenita	1/199	0.10418865221778634	0.11249274245831127	0	0	9.995454545454546	22.605240812445	EGFR
Arthritis, Psoriatic	1/201	0.10518369495092054	0.11350678074363811	0	0	9.8945	22.28287885995274	NOS2
Short neck	1/204	0.10667437520831993	0.11493230669316337	0	0	9.74679802955665	21.81308356459046	HBA1
Brachydactyly	1/204	0.10667437520831993	0.11493230669316337	0	0	9.74679802955665	21.81308356459046	INSR
Osteogenesis Imperfecta	1/204	0.10667437520831993	0.11493230669316337	0	0	9.74679802955665	21.81308356459046	INSR
Embryonal Carcinoma	1/205	0.10717076670990663	0.11540593426313212	0	0	9.698529411764707	21.660033820099166	EGFR
Cytopenia	1/206	0.10766690745627318	0.11587879022836181	0	0	9.650731707317073	21.508711292758836	HBA1
Liver Dysfunction	1/207	0.10816279753621168	0.11635087590978407	0	0	9.603398058252427	21.359088583232527	NOS2
Addictive Behavior	1/208	0.10865843710367488	0.11676041469839629	0	0	9.556521739130435	21.21113884815151	EGFR
Congenital anemia	1/208	0.10865843710367488	0.11676041469839629	0	0	9.556521739130435	21.21113884815151	HBA1
Osteosarcoma of bone	2/1042	0.10920999586831938	0.11729107378669396	0	0	4.048931623931624	8.966288964248077	BHLHE41;EGFR
Germ cell tumor	1/210	0.10964896506938845	0.11751408070727708	0	0	9.464114832535886	20.920153674500032	EGFR
Glomerulonephritis	1/210	0.10964896506938845	0.11751408070727708	0	0	9.464114832535886	20.920153674500032	STAT1
Lupus Nephritis	1/210	0.10964896506938845	0.11751408070727708	0	0	9.464114832535886	20.920153674500032	STAT1
Neurofibromatosis 1	1/210	0.10964896506938845	0.11751408070727708	0	0	9.464114832535886	20.920153674500032	EGFR
Congenital contractural arachnodactyly	1/212	0.11063849224487966	0.11851208025387217	0	0	9.373459715639811	20.635551764562276	EGFR
Carcinoid Tumor	1/213	0.11113288082569198	0.11897893247513493	0	0	9.32877358490566	20.495583013545666	EGFR
Parkinsonian Disorders	1/214	0.11162701955717426	0.11938215986325164	0	0	9.284507042253521	20.357137235289958	APOE
Craniosynostosis	1/214	0.11162701955717426	0.11938215986325164	0	0	9.284507042253521	20.357137235289958	EGFR
Skeletal muscle atrophy	1/215	0.11212090854714335	0.11978427243312055	0	0	9.240654205607477	20.220191150159177	INSR
Neurogenic muscle atrophy, especially in the lower limbs	1/215	0.11212090854714335	0.11978427243312055	0	0	9.240654205607477	20.220191150159177	INSR
Adenocarcinoma of prostate	1/216	0.11261454790645747	0.12018527381613528	0	0	9.19720930232558	20.084721938062458	EGFR
Alopecia	1/216	0.11261454790645747	0.12018527381613528	0	0	9.19720930232558	20.084721938062458	EGFR
Severe Combined Immunodeficiency	1/217	0.11310793775107597	0.12064846693448103	0	0	9.154166666666667	19.950707227164973	STAT1
Invasive Ductal Breast Carcinoma	1/218	0.11360107821608022	0.12111090815061647	0	0	9.111520737327188	19.818125081966986	EGFR
Nonorganic psychosis	1/220	0.11458661137040567	0.12209753240936777	0	0	9.027397260273972	19.55717288750184	APOE
Status Epilepticus	1/221	0.11507900429547771	0.12255793329581273	0	0	8.985909090909091	19.428761066206413	NOS2
Downward slant of palpebral fissure	1/222	0.11557114829217854	0.12301758686731629	0	0	8.944796380090498	19.301698248715226	HBA1
Tremor	1/226	0.11753723704642699	0.1249794168908109	0	0	8.784	18.806544742864613	APOE
Ventricular Septal Defects	1/226	0.11753723704642699	0.1249794168908109	0	0	8.784	18.806544742864613	APOE
Neurogenic Muscular Atrophy	1/228	0.11851879070185428	0.1259572085283305	0	0	8.705726872246697	18.566562316427337	INSR
Endometrioma	1/229	0.11900919523586632	0.12628025311711769	0	0	8.667105263157895	18.448406065583505	EGFR
Seminoma	1/229	0.11900919523586632	0.12628025311711769	0	0	8.667105263157895	18.448406065583505	EGFR
Drug abuse	1/229	0.11900919523586632	0.12628025311711769	0	0	8.667105263157895	18.448406065583505	INSR
Ductal Carcinoma	1/230	0.11949935173976756	0.12673417679290588	0	0	8.62882096069869	18.331449785225676	EGFR
Anemia, Sickle Cell	1/231	0.11998926031220872	0.1271873640868065	0	0	8.59086956521739	18.215676378264007	HBA1
Osteosarcoma	2/1103	0.12016581321625873	0.12730809825622405	0	0	3.8122918558885863	8.077799311012534	BHLHE41;EGFR
Hyperlipidemia	1/232	0.12047892105945494	0.12750685812125648	0	0	8.553246753246754	18.101069061728012	APOE
Metastasis from malignant tumor of prostate	1/232	0.12047892105945494	0.12750685812125648	0	0	8.553246753246754	18.101069061728012	EGFR
Feeding difficulties in infancy	1/233	0.12096833412743813	0.1278250935761593	0	0	8.515948275862069	17.987611357432982	INSR
Hamman-Rich syndrome	1/233	0.12096833412743813	0.1278250935761593	0	0	8.515948275862069	17.987611357432982	EGFR
Promyelocytic leukemia	1/233	0.12096833412743813	0.1278250935761593	0	0	8.515948275862069	17.987611357432982	EGFR
Encephalopathies	1/234	0.1214574995857652	0.1282752802277936	0	0	8.478969957081546	17.875287093283262	APOE
Uveal melanoma	1/236	0.1224350881991886	0.12924057102376688	0	0	8.405957446808511	17.653975642779464	EGFR
Periodontitis	1/237	0.12292351156490608	0.12968877232600684	0	0	8.369915254237288	17.544957550907927	APOE
Endometrial Neoplasms	1/238	0.12341168780848488	0.1301362478603224	0	0	8.334177215189873	17.43701107096589	EGFR
Allergic disposition	1/240	0.12438729930510922	0.13102902653601967	0	0	8.263598326359833	17.22427413818764	TAP1
Pituitary Diseases	1/240	0.12438729930510922	0.13102902653601967	0	0	8.263598326359833	17.22427413818764	HSP90AB1
Metastatic Prostate Carcinoma	1/241	0.1248747347838204	0.13140624602833922	0	0	8.22875	17.119454929894243	EGFR
Chondrosarcoma	1/241	0.1248747347838204	0.13140624602833922	0	0	8.22875	17.119454929894243	EGFR
Kidney Neoplasm	1/246	0.12730821416208352	0.1338976662408663	0	0	8.058775510204082	16.610298800727964	EGFR
Dystonia	1/251	0.12973554032791773	0.13638004032401907	0	0	7.8956	16.12484599337011	APOE
Mental Retardation	2/1158	0.130294981402708	0.1368973124148411	0	0	3.620338331410996	7.378084110882614	APOE;HBA1
Hydrocephalus	1/253	0.13070475104625986	0.1372568755173127	0	0	7.832142857142857	15.936956349877427	HBA1
Congenital Epicanthus	1/255	0.1316729803945433	0.1382022190917934	0	0	7.769685039370079	15.752522464585367	HBA1
Skin Neoplasms	1/256	0.1321567273135563	0.13863834274710707	0	0	7.738823529411765	15.661573608125947	EGFR
Urothelial Carcinoma	1/257	0.1326402292481628	0.13900203498311853	0	0	7.708203125	15.57145567091446	EGFR
Neuroendocrine Tumors	1/257	0.1326402292481628	0.13900203498311853	0	0	7.708203125	15.57145567091446	EGFR
Narcolepsy	1/258	0.13312348626463927	0.13943655880914793	0	0	7.677821011673152	15.482158028373968	TAP1
Epilepsy	2/1177	0.13384568708751454	0.140120781124075	0	0	3.5582033096926713	7.155787858304797	INSR;APOE
Lymphoma, T-Cell, Cutaneous	1/260	0.13408926610168828	0.1403034957356491	0	0	7.617760617760617	15.30598198570044	STAT1
Hepatitis A	1/261	0.1345717890784102	0.1407359111720687	0	0	7.588076923076923	15.219083198139	NOS2
Male infertility	1/263	0.1355361018640255	0.14159864215305903	0	0	7.5293893129770995	15.04761434661509	NOS2
Malignant neoplasm of gastrointestinal tract	1/263	0.1355361018640255	0.14159864215305903	0	0	7.5293893129770995	15.04761434661509	EGFR
Memory impairment	1/267	0.1374617975671696	0.14353667659634567	0	0	7.4146616541353385	14.713723070907315	APOE
Myopia	1/269	0.13842318229185882	0.14439214908473158	0	0	7.358582089552239	14.55115271071661	APOE
Pancreatitis	1/269	0.13842318229185882	0.14439214908473158	0	0	7.358582089552239	14.55115271071661	HSP90AB1
Infant, Small for Gestational Age	1/275	0.1413014945692657	0.14716793283687743	0	0	7.195255474452555	14.08010339743365	INSR
Concave bridge of nose	1/275	0.1413014945692657	0.14716793283687743	0	0	7.195255474452555	14.08010339743365	INSR
Depressed nasal root/bridge	1/275	0.1413014945692657	0.14716793283687743	0	0	7.195255474452555	14.08010339743365	INSR
Depressed nasal bridge	1/277	0.14225898764381306	0.14801344746145834	0	0	7.142391304347826	13.92842032223927	INSR
Dwarfism	1/277	0.14225898764381306	0.14801344746145834	0	0	7.142391304347826	13.92842032223927	STAT1
Intrauterine retardation	1/278	0.14273737013074572	0.14843517712675297	0	0	7.116245487364621	13.853543144407354	INSR
Pheochromocytoma	1/280	0.14369340749900536	0.14935294324193293	0	0	7.064516129032258	13.705679569952114	INSR
Anaplasia	1/283	0.14512564631064567	0.15068743653716504	0	0	6.988297872340426	13.488500773764908	EGFR
Low density lipoprotein cholesterol measurement	1/283	0.14512564631064567	0.15068743653716504	0	0	6.988297872340426	13.488500773764908	APOE
Low set ears	1/293	0.14988406177009467	0.15554873009031275	0	0	6.745547945205479	12.802329611071912	INSR
Pituitary Adenoma	1/294	0.15035857652347376	0.15596152501056593	0	0	6.722184300341297	12.73673990495629	EGFR
Pituitary Neoplasms	1/296	0.1513068837331026	0.15686509578860433	0	0	6.675932203389831	12.607131871186194	EGFR
Secondary malignant neoplasm of lymph node	2/1271	0.15176768973452917	0.15719588914375088	0	0	3.2781717888100865	6.180679135210321	APOE;EGFR
Idiopathic pulmonary arterial hypertension	1/297	0.15178067642718465	0.15719588914375088	0	0	6.65304054054054	12.543101865269113	NOS2
Epithelioma	1/298	0.15225422863912622	0.15760600743489783	0	0	6.63030303030303	12.479580222549849	EGFR
Adenocarcinoma Of Esophagus	1/299	0.15272754050288706	0.1580154594205023	0	0	6.6077181208053695	12.416561310898693	EGFR
Senile Plaques	1/301	0.1536734435981435	0.15883236896817274	0	0	6.563	12.292009558497487	APOE
Cutaneous Melanoma	1/301	0.1536734435981435	0.15883236896817274	0	0	6.563	12.292009558497487	NOS2
Malignant neoplasm of skin	1/307	0.15650539574784453	0.16167715513961364	0	0	6.432352941176471	11.929858529552073	EGFR
Fibroid Tumor	1/310	0.15791813884055803	0.16305368807114526	0	0	6.368932038834951	11.755000860858848	EGFR
Body Height	1/314	0.15979845022018752	0.16491135136994467	0	0	6.286261980830671	11.528010891065435	INSR
Agenesis of corpus callosum	1/317	0.1612061780406288	0.16619530886786288	0	0	6.225632911392405	11.362222857260356	EGFR
Psychotic Disorders	1/317	0.1612061780406288	0.16619530886786288	0	0	6.225632911392405	11.362222857260356	APOE
Kaposi Sarcoma	1/323	0.1640152030795641	0.1689198644995815	0	0	6.1077639751552795	11.041592222297407	INSR
Barrett Esophagus	1/323	0.1640152030795641	0.1689198644995815	0	0	6.1077639751552795	11.041592222297407	EGFR
Mental disorders	1/329	0.16681567360777794	0.17171704598328508	0	0	5.994207317073171	10.73482104409115	APOE
Broad flat nasal bridge	1/330	0.16728158864940687	0.1721094623471366	0	0	5.975683890577508	10.684981292406533	HBA1
Nasal bridge wide	1/333	0.16867791303426824	0.17345825874779	0	0	5.92078313253012	10.537597988558531	HBA1
Graves Disease	1/335	0.16960761309601163	0.17423795238174702	0	0	5.884730538922156	10.441087130654903	TAP1
Malignant mesothelioma	1/335	0.16960761309601163	0.17423795238174702	0	0	5.884730538922156	10.441087130654903	EGFR
Mood Disorders	1/336	0.1700721085674156	0.174626844168261	0	0	5.866865671641791	10.393344758256514	APOE
Cerebral atrophy	1/338	0.17100039097628056	0.1754913103352536	0	0	5.831454005934718	10.298869316815766	APOE
Recurrent tumor	1/347	0.17516599240653713	0.1796755661635959	0	0	5.677167630057803	9.889746518468769	EGFR
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	1/349	0.17608909351687269	0.18053130071961923	0	0	5.643965517241379	9.802242893925362	STAT1
Muscle Spasticity	1/353	0.1779324788436298	0.18232919667688138	0	0	5.578693181818182	9.630783295057284	APOE
Precursor B-cell lymphoblastic leukemia	1/367	0.18435484026174914	0.18881503801001726	0	0	5.361475409836066	9.065680697686828	INSR
Finding of body mass index	1/370	0.1857251120161259	0.19002690212324663	0	0	5.317073170731708	8.951226702384801	INSR
Body mass index	1/370	0.1857251120161259	0.19002690212324663	0	0	5.317073170731708	8.951226702384801	INSR
Abnormal behavior	1/372	0.1866374635108292	0.19086428075188974	0	0	5.287870619946092	8.876152158071937	APOE
Calcification of coronary artery	1/375	0.1880042484056369	0.19216530822950412	0	0	5.244652406417113	8.765338888630843	APOE
Idiopathic Pulmonary Fibrosis	1/379	0.18982338029375415	0.19392715372393585	0	0	5.188095238095238	8.6208566449	EGFR
Age related macular degeneration	1/382	0.1911852969766757	0.19522036354603264	0	0	5.146456692913386	8.514875282160894	APOE
Mitochondrial Diseases	1/384	0.19209208483148293	0.19604777316804287	0	0	5.1190600522193215	8.445325009335896	NOS2
Invasive carcinoma of breast	1/385	0.1925451320812088	0.1964115001952893	0	0	5.10546875	8.41087532568674	EGFR
Cardiomyopathy, Familial Idiopathic	1/388	0.19390288845570164	0.1976972751339617	0	0	5.065116279069767	8.30880570334129	EGFR
Carcinoma breast stage IV	1/392	0.195710001649184	0.1994396807177241	0	0	5.01227621483376	8.175630489677399	EGFR
Ischemic stroke	1/394	0.19661217647312826	0.20025861784130156	0	0	4.986259541984733	8.11026153046214	APOE
Retrusion of lower jaw	1/395	0.19706291878467247	0.20031608352699073	0	0	4.973350253807107	8.077875706384882	HBA1
Hypoplastic mandible condyle	1/395	0.19706291878467247	0.20031608352699073	0	0	4.973350253807107	8.077875706384882	HBA1
Decreased projection of lower jaw	1/395	0.19706291878467247	0.20031608352699073	0	0	4.973350253807107	8.077875706384882	HBA1
Decreased projection of mandible	1/395	0.19706291878467247	0.20031608352699073	0	0	4.973350253807107	8.077875706384882	HBA1
Anxiety Disorders	1/396	0.19751343119746428	0.20067364609662372	0	0	4.960506329113924	8.04568674665867	APOE
Aplasia/Hypoplasia of the mandible	1/397	0.19796371382498257	0.2010306179372137	0	0	4.947727272727272	8.013692994877477	HBA1
Carcinoma, Transitional Cell	1/399	0.19886359005698306	0.20184356393396083	0	0	4.922361809045226	7.950284581920076	EGFR
Micrognathism	1/400	0.19931318386921895	0.20219889646642683	0	0	4.909774436090226	7.918866697062786	HBA1
Dermatologic disorders	1/406	0.20200593341871595	0.204828371610195	0	0	4.835555555555556	7.734269026727764	EGFR
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	1/408	0.20290168544362802	0.20563402734237013	0	0	4.811302211302212	7.674189290190283	STAT1
Cryptorchidism	1/414	0.20558345991009783	0.20824805111531344	0	0	4.739951573849879	7.498144546143135	HBA1
Inflammation	1/429	0.21225204908642542	0.21489594606059614	0	0	4.570327102803739	7.083919257785029	NOS2
Muscle hypotonia	1/460	0.2258728087239384	0.22857248372860697	0	0	4.254901960784314	6.330371788481757	HBA1
Anxiety	1/464	0.2276146413112045	0.23022048339689774	0	0	4.217278617710583	6.24199935225321	APOE
Septicemia	1/468	0.22935291025361143	0.2318632406145962	0	0	4.180299785867238	6.155463714629547	NOS2
Thyroid Neoplasm	1/476	0.2328187833862566	0.23525000887164269	0	0	4.10821052631579	5.987695815177929	EGFR
Congenital chromosomal disease	1/497	0.2418493878837182	0.244253457345783	0	0	3.9300403225806453	5.578456870504974	EGFR
Myeloid Leukemia	1/501	0.24355850601349568	0.24585736920984758	0	0	3.8978	5.505245291640269	STAT1
Malignant neoplasm of thyroid	1/505	0.2452641208131339	0.2474561536704509	0	0	3.8660714285714284	5.433452579945899	EGFR
Hepatocarcinogenesis	1/527	0.2545826678476642	0.2567305116955105	0	0	3.700190114068441	5.062339884089301	EGFR
Sepsis	1/529	0.25542460011143586	0.2574517794773996	0	0	3.6857954545454548	5.030476912673014	NOS2
Metastatic Neoplasm	1/544	0.2617115888657632	0.26365788228816595	0	0	3.5812154696132596	4.800662982753082	EGFR
Hematologic Neoplasms	1/557	0.2671212337227653	0.2689744038278786	0	0	3.4951438848920864	4.613773998931812	EGFR
Small head	1/570	0.2724948199315028	0.2742493680538949	0	0	3.413005272407733	4.437369911863363	HBA1
Liver and Intrahepatic Biliary Tract Carcinoma	1/607	0.28759342011316674	0.28930189587621524	0	0	3.1985148514851485	3.9860132991413297	EGFR
Esophageal carcinoma	1/685	0.318493755397133	0.3202272691573351	0	0	2.8223684210526314	3.229219632126913	EGFR
Liver Cirrhosis, Experimental	1/801	0.3621988959952859	0.3639901862821073	0	0	2.398625	2.435951878366893	NOS2
Malignant neoplasm of liver	1/805	0.3636594556528153	0.36527731778869044	0	0	2.3861940298507465	2.41372453026245	EGFR
Solid Neoplasm	1/840	0.3763102504595221	0.3777976427538285	0	0	2.2824791418355184	2.2307612267182266	EGFR
Low intelligence	1/947	0.4135808586652226	0.41480567858229633	0	0	2.013002114164905	1.777284069041436	HBA1
Dull intelligence	1/947	0.4135808586652226	0.41480567858229633	0	0	2.013002114164905	1.777284069041436	HBA1
Cognitive delay	1/966	0.41998320819013557	0.4210191805833032	0	0	1.97139896373057	1.7102685393000292	INSR
Poor school performance	1/985	0.4263219497510037	0.42716282144676504	0	0	1.9314024390243902	1.6466373664596705	HBA1
Mental and motor retardation	1/1021	0.43815978343570644	0.43880762934517276	0	0	1.859705882352941	1.534576539404351	INSR
Mental deficiency	1/1032	0.4417323471816037	0.4419498421826779	0	0	1.8387972841901068	1.502391398311796	HBA1
Primary malignant neoplasm	1/1032	0.4417323471816037	0.4419498421826779	0	0	1.8387972841901068	1.502391398311796	EGFR
Global developmental delay	1/1102	0.4639871855161477	0.4639871855161477	0	0	1.7155313351498638	1.3173536723012638	INSR
